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Osteoarthritis (OA) is the most common form of arthritis, with chronic pain 
being the most frequent and debilitating consequence. Current analgesics are 
inadequate in treating OA pain due to poor efficacy or serious side effects. 
Mechanistic studies in humans suggest dysfunction of descending inhibitory 
pathways in symptomatic knee OA is a key contributor in the development and 
maintenance of chronic pain. Such inhibitory pathways are recruited by diffuse 
noxious inhibitory controls (DNIC), whereby inhibition of spinal dorsal horn 
neuronal excitability to a ‘test’ stimulus can be induced by applying a noxious 
‘conditioning’ stimulus to widespread areas of the body outside the peripheral 
excitatory receptive field (RF) of the neuron (heterotopic stimulation); hence 
DNIC can be used to study whether inhibition of spinal neural transmission has 
been compromised. In this respect spinally organised nociceptive withdrawal 
reflexes (NWRs) are functionally characterised population responses, 
modularly organised to most effectively move a limb away from a source of 
pain, with descending inhibitory pathways helping to set an appropriate 
activation threshold. The aim of this thesis was therefore to investigate 
whether descending inhibition was altered in an experimental model of OA pain 
by electrophysiologically measuring DNIC of reflexes in hindlimb muscles. 
 
In alfaxalone-anaesthetised rats, electromyograms (EMGs) to noxious 
stimulation of the heel or toes were recorded in the ankle extensor medial 
gastrocnemius (MG), the knee flexor biceps femoris (BF) and the ankle flexor 
tibialis anterior (TA) of the left hindlimb before and after a noxious 
‘conditioning’ capsaicin injection into the contralateral hind or forelimb. In 
naïve animals, depending on the reflex, responses were inhibited by capsaicin 
(50 µg, 500 µg or 5 mg) in a dose-related manner to a median of between 14 – 
76% of controls for 29 to 63 min. For all reflexes this inhibition was abolished 
by spinalization and reduced by decerebration for heel-MG and toes-BF when 




conditioning site, reduced alfaxalone levels led to significantly greater 
inhibition. Reflexes were inhibited to a similar level irrespective of whether 
electrical (up to 10 mA, 8 x 2 ms pulses at 1 Hz) or graded mechanical (10 – 300 
g von Frey (vF) monofilaments) stimuli were used although the latter appeared 
to offer a better means by which to detect changes in DNIC as both A- and C-
fibre responses were measured along with the range of stimulus intensities. 
 
Subsequent experiments investigated DNIC of reflex responses in a model of 
OA pain induced by knee joint injection of monosodium iodoacetate (MIA). At 
28-35 days post-injection, MIA-injected animals had severe cartilage damage 
and established pain behaviour. However, DNIC of reflex responses was to a 
similar degree for all three reflexes after injection of capsaicin into the 
contralateral hind or forelimb. In contrast, 3-4 days post-injection, MIA animals 
had very little to no cartilage damage accompanied by pain behaviour. 
Although DNIC of reflex responses was similar following injection of capsaicin 
into the contralateral forelimb, a reduced efficacy in DNIC inhibition was found 
after hindlimb injection. 
 
These data show that stimulus-evoked inhibition (DNIC) of spinal reflexes 
originates from regions caudal to the colliculi (likely within the pons and 
medulla) but higher brain areas may modify this inhibition. Similar to other 
general anaesthetics, alfaxalone levels affect the degree of DNIC. A reduction 
in DNIC efficacy is present in early stages of OA, but there was no evidence of 
compromised DNIC in established OA. Mechanical test stimuli provided a more 
sensitive method for detecting changes in DNIC whilst findings were also 
dependent on choice of conditioning site. Similarly, differential sensitivities to 
DNIC highlights the importance of studying multiple reflex responses in 
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Osteoarthritis (OA) is a degenerative musculoskeletal condition affecting 
structures within joints (Felson, 2006). OA is the most common form of arthritis 
with an estimated 8.75 million people aged 45 and over having sought 
treatment in the UK and it is estimated that 8.3 million people could have knee 
OA alone by 2035 (Arthritis Research UK, 2013). It can be found in any joint in 
the body; just over half of all people who have sought treatment for OA have 
knee OA and 24% suffer from hip OA but it can also be found in the hands, 
wrists, facet joints and feet (Arthritis Research UK, 2013; Litwic et al., 2013). 
The prevalence of OA varies between geographical locations with hand OA 
indicated as the most prevalent form of OA in the USA and knee OA being less 
frequent (Lawrence et al., 2008; Litwic et al., 2013). There are also variations 
within countries, for example between rural and urban communities where 
rural communities have a higher prevalence of OA in countries such as China, 
Bangladesh and India, possibly due to the physical nature of living in a rural 
community and the overloading of joints (Chopra, 2013). OA sufferers find their 
lives greatly affected by the disease with crippling pain being the most 
burdensome symptom associated with the condition (Swagerty and Hellinger, 
2001). In 2016 over 33.5 million prescription items were dispensed for 
musculoskeletal & joint diseases, of which OA is included, at a cost of nearly 
£206 million to the National Health service (NHS)(NHS Digital, 2017). However, 
many patients find that their pain relief is inadequate for their condition 




sufferers felt dissatisfied with the treatment they were receiving for their long 
lasting pain (Breivik et al., 2006). There are a wide range of analgesics available 
for treating OA pain, however patients have variable results with all of them. 
Oral analgesics also have severe side effects, from nausea and vomiting to 
stomach ulcers and other gastrointestinal problems. This leads to patients 
having to change analgesics regularly or stop them completely even if they are 
effective in treating their pain. This has led to the conclusion that the treatment 
of OA pain is not a “one size fits all” concept that a given efficacious drug will 
cure all patients of their pain, some drugs work for some and not for others and 
some patients find no relief from any current treatments. Therefore, a better 
understanding of the mechanisms underlying OA pain will not only enable us to 
fully comprehend the changes in the joint but also in the central nervous system 
(CNS) which occur in an OA patient and so begin to understand why each 
patients pain is unique. This study uses an animal model to investigate the 
underlying central mechanisms associated with OA pain by measuring reflex 
responses to examine the effects of a noxious stimulus on a descending 
inhibitory pathway. 
 
1.2. The pain pathway 
Pain is “an unpleasant sensory and emotional experience associated with actual 
or potential tissue damage, or described in terms of such damage” (Loeser and 
Treede, 2008). Whilst pain and nociception are linked, there is a distinct 




encoding and processing noxious stimuli” (Loeser and Treede, 2008). The basic 
pain pathway for the perception of pain consists of three main stages. The first 
stage is transduction, where pain is detected in the periphery. The second stage 
is transmission of the signals from the periphery to the dorsal horn of the spinal 
cord. The final stage is transmission of signals to higher brain centres via the 
CNS which is typically via two routes; ascending pathways carrying information 
from the spinal cord to the brain and descending pathways from the brain to 
the reflex organs (Yam et al., 2018). 
 
1.2.1. Primary afferent fibres 
Primary afferent fibres (PAFs) are sensory neurons in the peripheral nervous 
system that transduce information on the mechanical, chemical and thermal 
state of the body to the CNS. They can transmit both innocuous and noxious 
stimuli and are classified into three groups based on their conduction velocities, 
sensitivities, structure and size (Lawson, 2002)(Table 1.1). 
 
A-fibres are broadly classified as myelinated fibres, however, can be broken 
down into smaller sub-categories. Aα and Aβ-fibres have large myelinated 
axons with average diameters of 20 µm and 10 µm respectively which enables 
them to have the fastest action potential conduction velocities, between 40 
and 120 m s-1, and they are activated by innocuous mechanical stimuli (Harper 
and Lawson, 1985a; Julius and Basbaum, 2001; McGlone and Reilly, 2010). Aα-




proprioceptive function whereas Aβ-fibres were traditionally only thought to 
be involved in innocuous mechanosensation (Niissalo et al., 2002; Djouhri and 
Lawson, 2004; Wu and Henry, 2010). However, both Aα and Aβ-fibres have also 
been shown to be involved in nociception under normal and diseased states 
such as OA whereby as much as 19% of Aα/β-fibres were nociceptive (Djouhri 
and Lawson, 2004). 
 
Aδ-fibres are small diameter (2 – 5 µm) myelinated fibres, with slower 
conduction velocities and their main role is as high-threshold 
mechanoreceptors (HTMs) or mechano-heat receptors (MHRs)(McGlone and 
Reilly, 2010). It has been proposed that there are two distinct types of Aδ-fibre, 
both of which respond to intense mechanical stimuli classified as type I and 
type II, with approximately 90% as type II responding to chemical stimuli such 
as capsaicin and moderately noxious temperatures above 45 °C, whilst type I 
represent 10% of the Aδ-fibres, are capsaicin insensitive and respond to 
temperatures above 52 °C (Julius and Basbaum, 2001; Ringkamp et al., 2013). 
 
C-fibres are the smallest diameter axons at < 1 µm and are unmyelinated, 
making them the slowest conducting afferents (< 1.3 m s-1)(McGlone and Reilly, 
2010). High-threshold C-fibres signal threatening and damaging stimuli in a 






Table 1.1. Primary afferent fibre properties (Adapted from Harper and Lawson, 1985a, b). 
 
Fibre Type Myelinated Axon diameter (µm) Conduction velocity (m s-1) Modality 
Aα Yes 10 – 20 70 – 120 Innocuous mechanical: pressure, vibration, stroking, muscle 
stretch, proprioception 
Aβ Yes 2.5 – 10 40 – 70 Innocuous mechanical: pressure, vibration, stroking, muscle 
stretch, proprioception 
Aδ (I) Yes 1 – 2.5 1 – 15 High-threshold heat > 52 °C (thermal receptors) 
Aδ (II) Yes 1 – 2.5 1 – 15 Cooling (thermal receptors), noxious mechanical, chemical 
and heat > 45 °C (nociceptors) 
C – pain No < 1 < 1.3 Noxious mechanical, chemical and cold/heat (< 5 °C and > 43 
°C)(nociceptors) 




1.2.2. Sensory receptors 
When investigating sensory receptors in the skin it becomes quickly evident 
that there are different groups of receptors which can be separated by common 
characteristics and can be grouped based on the stimuli they respond to 
(Bessou and Perl, 1969). 
 
1.2.2.1. Mechanoreceptors 
Mechanoreceptors can be found in a variety of tissues such as skin, muscle 
spindles and the gastrointestinal tract and are stimulated by changes in 
pressure, stretch or distortion (Kandel et al., 2013). Mechanoreceptors account 
for a large proportion of the sensory receptors innervated by unmyelinated 
fibres of cutaneous nerves (Bessou and Perl, 1969). LTMs respond to innocuous 
or low intensity mechanical stimuli via Pacinian corpuscles, Meissner’s 
corpuscles, Merkel’s discs and Ruffini endings (Basbaum et al., 2009; McGlone 
and Reilly, 2010). These cutaneous receptors are located in different layers of 
the skin to differentially adapt to various types of stimuli; with Pacinian 
corpuscles and Meissner’s corpuscles classified as fast adapting, where they 
react to the initial and final changes in the skin due to the stimuli, and Merkel’s 
discs and Ruffini endings are slow adapting, continuously firing for the duration 
the stimulus is in contact with the skin (McGlone and Reilly, 2010). All non-






Thermal stimuli that differ from a set homeostatic point cause changes in 
ambient temperature which are detected by thermoreceptors (McGlone and 
Reilly, 2010). Within these fibres there are two distinct groups; one responding 
to heat and the other to cold, within the innocuous range of 20 – 45 °C 
(McGlone and Reilly, 2010). Thermoreceptors are exclusively activated by 
thermal stimuli, with changes in temperature as slight as 2 °C being detected 
(Hensel, 1973; Kuhtz-Buschbeck et al., 2010). Rapid changes in temperature 
produce increases in impulse frequency, therefore thermoreceptors respond to 
both dynamic and static temperature (Hensel and Boman, 1960; Kuhtz-
Buschbeck et al., 2010). Thermal stimuli are detected by a specific family of 
transduction proteins known as transient receptor potential (TRP) channels 
which are nonselective cation receptor-channels with six transmembrane 
domains (Kandel et al., 2013). All TRP channels are gated by temperature and 
the various chemical ligands that bind to them. There are many subgroups of 
TRP channels including; TRP melastatin (TRPM), TRP ankryin (TRPA) and TRP 
canonical (TRPC) of which individual receptors have different functions, for 
example TRPM8 and TRPA1 are activated by cold stimuli (Kandel et al., 2013). 
Another subgroup is the TRP vanilloid (TRPV) group of which the TRPV1 channel 
is a member. This channel is found on a subpopulation of PAFs and activated by 
noxious heat above 43 °C and acidic conditions of pH < 6.0 (Ringkamp et al., 
2013). TRPV1 is a non-selective ion channel, therefore when activated it allows 




terminal and generation of an action potential. In inflammatory conditions, 
TRPV1 is increased in the joint as axonal transport of TRPV1 messenger 
ribonucleic acid (mRNA) is induced, with TRPV1-labelled unmyelinated axons in 
the periphery increased by 100% (Ringkamp et al., 2013; Kelly et al., 2013a). 
Also known as the capsaicin receptor, TRPV1 is activated by this compound, 
which is the chemical responsible for the pungency of chilli peppers. It binds to 
TRPV1 proteins in nociceptors and induces the release of substance P (SP) and 
calcitonin gene-related peptide (CGRP) causing pain in the form of a burning 
sensation. Injection of capsaicin causes transient pain followed by 




Nociceptors are sensory receptors responsible for encoding pain by connecting 
all peripheral tissues such as muscles, tendons and joints to the CNS (Kandel et 
al., 2013; Malfait and Schnitzer, 2013). They are pseudounipolar and highly 
specialised primary afferent neurons with their cell bodies lying in the dorsal 
root ganglia (DRG) and bifurcating axons, projecting to both the periphery and 
the CNS to terminate in the dorsal horn of the spinal cord or trigeminal nucleus 
(Malfait and Schnitzer, 2013). Unmyelinated C-fibre nociceptors are the most 
common fibre type in the peripheral nervous system and represent the vast 
majority of nociceptors; however a small proportion of nociceptors are thinly 




with their differing conduction velocities produce two distinct perceptions of 
pain known as first and second pain. First pain is produced by the faster 
conducting Aδ-fibres and is perceived as an initial sharp or prickling sensation 
that is responsible for controlling withdrawal reflexes to move the tissue away 
from the potentially damaging stimuli (McGlone and Reilly, 2010). Second pain 
is transmitted to the CNS by C-fibres where it evokes an emotional response to 
the pain and is described by delayed sensations such as dull, aching, radiating, 
throbbing and burning (Melzack, 1975; Kandel et al., 2013). Nociceptors are all 
high-threshold receptors and can be divided into four main groups based on 
the type of noxious stimuli they respond to; mechanical, thermal, polymodal 
and silent nociceptors (Bessou and Perl, 1969; Kandel et al., 2013). 
 
Mechanical nociceptors are activated by intense pressure and often cannot be 
activated by or are inconsistently activated by any other form of stimulation 
(Burgess and Perl, 1967; Bessou and Perl, 1969; Kandel et al., 2013). They are 
classified as HTMs and account for approximately 15% of the Aδ-fibres (Bessou 
and Perl, 1969). HTMs adapt to maintained mechanical stimuli fairly rapidly, 
however if subjected to repeated noxious stimuli become inactive (Bessou and 
Perl, 1969).  
 
Thermal nociceptors detect extreme temperatures, usually greater than 45 °C 
or less than 5 °C, and are usually conducted by Aδ-fibres at conduction 




and cold are conducted by separate groups of fibres, however noxious cold 
does not produce responses as strongly as noxious heat (Julius and Basbaum, 
2001). Whilst noxious heat activates around 50% of fibres, noxious cold only 
excites approximately 10 – 15% of fibres within the same receptive field (RF) 
(Julius and Basbaum, 2001). 
 
Polymodal nociceptors respond to noxious thermal, mechanical and chemical 
stimuli and are usually small unmyelinated C-fibres (Fein, 2012). They are the 
most common type of nociceptors with around 50% of unmyelinated axons 
classified as polymodal (Schmidt et al., 1995; McGlone and Reilly, 2010). These 
units vary in their sensitivity to noxious stimuli and are 5 – 10 times more 
sensitive than LTMs, however polymodal nociceptors tend to have a pattern in 
their sensitivity, for example receptors with lower mechanical thresholds also 
have lower thermal thresholds (Bessou and Perl, 1969). Chemical stimulants 
such as dilute hydrochloric acid consistently evoke activity in polymodal 
nociceptors where impulses were low in frequency but maintained for the 
duration that the stimulant was in contact with the RF (Bessou and Perl, 1969). 
After noxious stimulation polymodal nociceptors have increased sensitivity to 
stimuli, resulting in altered responsiveness to rapid cooling and a reduction in 
thresholds, sometimes for periods of up to 2 hours after the initial stimulus was 
applied, which may be key in sensitization (see section 1.2.5) (Bessou and Perl, 





Silent nociceptors are unmyelinated heat sensitive fibres that are activated by 
chemical stimuli and therefore classed as inflammatory mediators (Fein, 2012). 
During prolonged periods of inflammation or injury, silent or sleeping 
nociceptors can also become increasingly activated by mechanical stimuli 
(Basbaum et al., 2009). This would suggest that during states of pain such as in 
OA, recruitment of silent nociceptors contributes to sensitization in humans by 
adding a component of spatial summation (Schmidt et al., 1995; McGlone and 
Reilly, 2010). 
 
1.2.3. Spinal cord dorsal horn 
Central terminals of PAFs extend to the dorsal horn of the spinal cord or the 
trigeminal nucleus in the face where they terminate and synapse onto 
secondary nociceptive projection neurons or excitatory and inhibitory 
interneurons (Vanegas et al., 2010; Malfait and Schnitzer, 2013). The spinal 
cord grey matter is divided into ten distinct laminae, numbered dorsal to 
ventral from I to X, and separated based on their shape, size and the relative 
number of nerve cells they contain in both cats (Rexed, 1952) and rats 
(Molander et al., 1984, 1989)(Figure 1.1). Sensory information from the knee 
joint enters the spinal cord via primary afferents in the L5 – L7 dorsal roots 
which terminate in laminae I – VI (Craig et al., 1988; Schaible and Grubb, 1993). 
Spinal cord neurons in these laminae receive convergent input from the knee 






Figure 1.1. Organisation of the Rexed laminae of the spinal cord dorsal horn. 
Primary afferent fibres (PAFs) terminate in different locations depending on 






Lamina I, or the marginal layer, forms a small outermost cover of the dorsal 
horn and contains both projection neurons and interneurons (Todd and 
Koerber, 2013). A large majority of the neurons in lamina I receive inputs from 
Aδ primary afferents in response to high-threshold mechanical, intense cold, 
chemical and noxious heat stimulation (Fields and Basbaum, 1978; Longstaff, 
2000; Millan, 2002). Due to the selectivity of these neurons to noxious stimuli 
they are termed nociceptive-specific (NS) neurons (Kandel et al., 2013). Lamina 
I also receive small inputs from graded innocuous to highly noxious mechanical 
stimuli and these are termed wide-dynamic range (WDR) neurons (Kandel et 
al., 2013). However, only 5% of lamina I neuronal population equates to these 
type of neurons, despite containing the highest density of projection neurons 
in the dorsal horn (Todd and Koerber, 2013).  
 
Lamina II, the substantia gelatinosa, contains predominantly interneurons 
which are densely packed and receive nociceptive input from Aδ and C-fibres 
(Longstaff, 2000; Todd and Koerber, 2013; Todd, 2010). The interneurons in 
laminae II are both excitatory (glutamatergic) and inhibitory (GABA-ergic or 
glycinergic), responding selectively to nociceptive inputs or both nociceptive 
and innocuous inputs (Todd, 2010; Kandel et al., 2013). Lamina II can be 
subdivided into two regions; the inner region which has lower neuronal density 
and receives non-peptidergic C-fibre afferents and the outer region receiving 





Laminae III – VI form the deep dorsal horn, with lamina III and IV occupying the 
larger part of the head of the dorsal horn (Rexed, 1952). These laminae contain 
significantly less nociceptive input than the superficial layers, however some 
tracing has shown PAFs present in lamina III (Molander and Grant, 1986). 
Lamina III is characterized by densely populated interneurons, that are slightly 
larger than those in lamina II, and large projection neurons (Molander et al., 
1984; Todd, 2010). Predominantly terminating in lamina III, are Aβ-fibres 
innervating innocuous mechanoreceptors, however Aβ-fibres also terminate in 
lamina IV, V and VI but to a much lesser extent (Millan, 1999). 
 
The intermediate and ventral grey matter comprise of lamina VII – X and are 
targets for both myelinated and non-myelinated primary afferents mostly from 
visceral inputs (Longstaff, 2000). Lamina VII receives autonomic preganglionic 
fibres and lamina IX contains cell bodies of both α and γ-motoneurons which 
extend to skeletal muscles (Longstaff, 2000). 
 
1.2.4. Neurotransmitters 
There are many neurotransmitters, neuropeptides, ion channels and receptors 
expressed by nociceptors. Neuronal components of the dorsal horn are 
interconnected in a highly complex synaptic circuit, demonstrating the many 
potential mechanisms that can modulate nociceptor activity and transmission 











Glutamate C, Aδ, Aβ Excitation 
mGluR GPCR Glutamate C, Aδ Excitation 
NK1 GPCR Substance P C, Aδ Excitation 
NK2 GPCR Neurokinin A (NKA) C, Aδ Excitation 
CGRP 
receptor 
GPCR CGRP C, Aδ, Aβ Excitation 
BK1 & BK2 GPCR Bradykinin C Excitation 
P2X Ligand-gated 
ion channel 
ATP C Excitation 
Ca2+ Ion channel Ca2+ C, Aδ Excitation 
Nav1.9 Ion channel Na+ C Excitation 
Nav1.7 & 
Nav1.8 
Ion channel Na+ C, Aδ Excitation 
GABAA Ligand-gated 
ion channel 
GABA Aδ, Aβ Inhibition 
GABAB GPCR GABA Aδ, Aβ Inhibition 
GlyR Ligand-gated 
ion channel 
Glycine C, Aδ Inhibition 
Gal1-3 GPCR Galanin C, Aδ Inhibition 
NPYR1-5 GPCR Neuropeptide Y C Inhibition 
SST1-5 GPCR Somatostatin C Inhibition 
 
Table 1.2. Neurotransmitters and peptides expressed by nociceptors in primary 
afferent fibres (PAFs). GPCR = G protein-coupled receptor. Table modified from 




Glutamate is the primary excitatory neurotransmitter involved in nociceptive 
signalling released from primary afferents, projection neurons and excitatory 
interneurons (Sorkin and Yaksh, 2013). Its release from central terminals of 
nociceptors generates excitatory postsynaptic currents (EPSCs) in secondary 
dorsal horn neurons (Basbaum et al., 2009). It is found in both myelinated and 
unmyelinated fibres and acts at several different receptors including the 
ionotropic alpha-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), N-
methyl-D-aspartate (NMDA) and kainate receptors as well as many 
metabotropic glutamate receptors (mGluR). AMPA, NMDA and kainate 
receptors are all expressed on the spinal terminals of Aδ and C-fibres, however 
mGluR receptors are differentially expressed by Aδ and C-fibres depending on 
the receptor subtype (Sorkin and Yaksh, 2013; Todd and Koerber, 2013). 
Ionotropic Glu receptors directly regulate the opening of ion channels to Na+ 
and K+, and mGluR and NMDA receptors are also permeable to Ca2+ (Budai, 
2000).  
 
Neuropeptides SP, neurokinin A (NKA) and CGRP are also excitatory 
neurotransmitters released by primary afferent nociceptors (Todd and Koerber, 
2013). SP is found to be present in the central terminals of primary afferent 
neurons where it produces long-lasting enhancement of dorsal horn neurons, 
especially when combined with NMDA where it produces profound effects to 
noxious mechanical stimulation (Budai, 2000). SP also enhances the release of 
glutamate from the spinal cord dorsal horn to potentiate nociceptive signals 




terminals, where NKA has a slower degradation rate and so persists in the 
dorsal horn for much longer periods. Neurokinin receptors are the main targets 
for both these neurotransmitters, with SP targeting NK1 and NKA targeting NK2 
(Levine et al., 1993). CGRP is in high concentrations in the small DRG nerve cells 
and the majority of PAFs associated with pain transmission contain this peptide, 
including unmyelinated and small-diameter myelinated fibres (Levine et al., 
1993; Budai, 2000). Whilst CGRP has limited effects itself it potentiates the 
effects of other compounds such as SP in response to noxious thermal, 
mechanical or electrical stimulation (Levine et al., 1993). Bradykinin is an 
excitatory peptide neurotransmitter which acts on BK1 and BK2 receptors to 
activate phospholipase C (PLC) and protein kinase C (PKC) pathways and is 
released in the spinal cord within minutes of nociceptor C-fibre input 
(Ringkamp et al., 2013; Woolf and Ma, 2007). Adenosine triphosphate (ATP) is 
expressed by C-fibre nociceptors and released in response to tissue damage or 
noxious stimulation primarily from heat stimulation (North, 2004). In the 
presence of its purinogenic receptor (P2X) on the central terminals of PAFs, ATP 
increases EPSCs by evoking the release of glutamate from DRG cells (Budai, 
2000; North, 2004). Ion channels also facilitate excitatory nociception by 
voltage-gated calcium channels (VGCCs) and voltage-gated sodium channels 
(VGSCs)(Sorkin and Yaksh, 2013). Depolarization of primary afferent terminals 
leads to the opening of VGCC, resulting in a number of important functions such 
as generating depolarizing membrane currents at the terminal, initiating 
activation via phosphorylation of other receptors, for example NMDA, and 




(PLA2)(Malmberg and Yaksh, 1994; Sorkin and Yaksh, 2013). VGSCs are essential 
for regulating encoding receptor potentials into action potentials, however 
Nav1.7, Nav1.8 and Nav1.9 are the three main VGSCs that are found in the DRG 
neurons (Strickland et al., 2008; Fein, 2012). Nav1.7 and Nav1.8 are 
predominantly found in small diameter nociceptive afferents and in chronic 
pain states all three receptor sub-types are overexpressed in joint afferent 
neurons (Strickland et al., 2008). 
 
Inhibitory interneurons in the dorsal horn express the amino acids gamma-
aminobutyric acid (GABA) and/or glycine as their main neurotransmitter (Todd, 
2010). Immunostaining shows that glycine is only found in GABA containing 
cells within laminae I – III which suggests these interneurons co-release glycine 
and GABA or they only release GABA (Todd, 2010). GABA has two receptor 
targets which are the ionotropic GABAA and metabotropic GABAB receptors 
(Fein, 2012). GABAA mediates rapid transmission whilst GABAB mediates a 
variety of transmissions and is found in greater numbers than GABAA (Budai, 
2000). Glycine is found predominantly in lamina III of the dorsal horn and 
receives significant inputs from myelinated LTMs as well as small diameter 
nociceptive afferents (Budai, 2000). Glycine receptors (GlyR) are ligand-gated 
ion channels which when activated hyperpolarize neurons (Millan, 1999). 
Galanin, neuropeptide Y (NPY) and somatostatin are inhibitory neuropeptides 
that in the superficial dorsal horn are exclusively found in GABA-ergic cells 




nociceptive-specific spinal cord neurons by hyperpolarization of the primary 
afferent and by inhibiting the release of SP (Levine et al., 1993; Sorkin and 
Yaksh, 2013).  NPY and its receptors NPYR1-5 are found in lamina III of the dorsal 
horn where they inhibit the release of bradykinin (Niissalo et al., 2002). The role 
of NPYRs in the dorsal horn is to differentially decrease nociception by 
enhancing K+ currents and reducing Ca2+ currents (Millan, 1999). Somatostatin 
is also a peptide hormone found in limited populations in the small cells of the 
DRG and small dorsal horn neurons (Sorkin and Yaksh, 2013). It acts through G 
protein-coupled receptors (GPCRs) SST1-5, some of which inhibit the opening of 
VGCCs, producing long-lasting depression in response to noxious stimuli (Sorkin 
and Yaksh, 2013).  
 
1.2.5. Sensitization 
Sensitization is defined as “increased responsiveness of neurons to their normal 
input or recruitment of a response to normally subthreshold inputs” (Loeser 
and Treede, 2008). There are two main types of sensitization; peripheral 
sensitization and central sensitization.  
 
1.2.5.1. Peripheral sensitization 
The body becomes peripherally sensitized during injury where inflammation 
drives the sensitization of nociceptors reducing their thresholds and increasing 




the periphery results in the accumulation of several molecules collectively 
called an ‘inflammatory soup’. Some components of this include bradykinin, 
protons (H+), prostaglandins (PGE2), serotonin or 5-hydroxytryptamine (5-HT), 
ATP, nerve growth factor (NGF), tumor necrosis factor alpha (TNF-α) and 
interleukins (IL-1β, IL-6). 
 
Activation of the nociceptors causes the damaged tissue to release adenosine, 
ATP and protons resulting in activation of P2X receptors and acid sensing ion 
channels (ASICs) as well as sensitization of TRP channels. Other inflammatory 
cells such as mast cells, macrophages, platelets and endothelial cells release 
further chemicals such as bradykinin, interleukins (IL-1β, IL-6), NGF, TNF-α, 
PGE2, 5-HT and histamine which act at the peripheral nociceptors on various 
receptors including GPCRs, receptor tyrosine kinase (RTK) and two-pore 
potassium channels (K2P)(Woolf and Costigan, 1999; Julius and Basbaum, 2001; 
Ringkamp et al., 2013). Once activated these processes trigger further 
secondary cascades, protein kinase A and C (PKA, PKC) and these actions can 
be enhanced by the phosphorylation of receptors, ultimately resulting in 
primary hyperalgesia (Ringkamp et al., 2013). Sensitization of peripheral 
nociceptors in conditions such as OA is characterized by primary hyperalgesia 
or a sensitivity to pain and allodynia or pain in response to previous innocuous 
stimuli at the site of injury. It is therefore suggested that joint pain is driven by 
peripheral nociceptors and this is necessary for the development and 





1.2.5.2. Central sensitization 
In many clinical syndromes with pain as the main symptom, pain is no longer a 
protective mechanism. Ongoing nociceptor activity following peripheral 
sensitization causes hyperexcitability of neurons in the spinal cord resulting in 
a phenomena known as central sensitization where nociceptive neurons within 
the CNS have increased responsiveness (Schaible et al., 2002; Loeser and 
Treede, 2008). The excessive nociceptor input can increase membrane 
excitability, facilitate synaptic strength or decrease inhibitory effects in dorsal 
horn neurons (Latremoliere and Woolf, 2009). This increased responsiveness is 
initially only in the area of tissue damage (peripheral sensitization) however 
after excessive stimulation from inflammatory mediators in the periphery, 
neurons have enhanced responses to pressure applied to normal tissue 
(Schaible et al., 2002). Key features of these heightened pain situations are 
allodynia and hyperalgesia at the site of injury in the periphery, however once 
pain spreads beyond the site of injury this is known as secondary hyperalgesia 
and is a common symptom of central sensitization (Latremoliere and Woolf, 
2009). This phenomenon is facilitated by abnormal inputs to nociceptive 
pathways such as large Aβ-fibre LTMs which now begin to mediate pain 
(Latremoliere and Woolf, 2009). Often in musculoskeletal pain conditions, such 
as OA, another key feature of  RFs are also significantly enlarged when 
compared to pain free individuals which is indicative of secondary hyperalgesia 




maintained by the excessive and continuous peripheral inflammatory inputs 
(Neugebauer et al., 1996; Schaible et al., 2002). 
 
1.2.6. Ascending pain pathways 
Projection neurons in the dorsal horn relay nociceptive inputs to the thalamus, 
brainstem and higher brain centres via several ascending pathways (Malfait and 
Schnitzer, 2013). There are three main projections which are involved in 
nociception; the spinothalamic tract (STT), spinobulbar projections and the 
spinohypothalamic tract (SHT)(Dostrovsky and Craig, 2013). 
 
The STT is the projection pathway most closely linked to pain and temperature 
and these projection neurons originate in the superficial dorsal horn in lamina 
I, the deep dorsal horn in laminae IV – lV and the intermediate zone of laminae 
VII – VIII (Dostrovsky and Craig, 2013). Lamina I contains approximately half of 
the STT projection neurons and is selectively responsive to nociceptive and 
thermoreceptive modalities (Zhang and Craig, 1997; Craig et al., 2002). The 
main supraspinal targets for projection neurons from lamina I are the caudal 
ventrolateral medulla (CVLM), the nucleus of the solitary tract (NTS), the lateral 
parabrachial (LPb) area, the periaqueductal grey (PAG) and select nuclei of the 
thalamus (Todd, 2010). The remaining 50% of STT cells are split equally 
between laminae IV – V and laminae VII – VIII where they relay high-threshold 
mechanical stimuli and convergent inputs from large diameter skin and deep 




termination field of STT cells is in the posterior region of a dedicated 
nociceptive and thermoreceptive relay nucleus, the ventromedial posterior 
(VMpo) nucleus of the thalamus, which primarily originate from lamina I (Zhang 
and Craig, 1997; Dostrovsky and Craig, 2013). Projections from laminae IV – V 
primarily terminate in the ventral posterior (VP) nuclei and lamina VII – VIII 
projection neurons also project to regions of the thalamus, however it is argued 
how much of a role these projections play in pain perception (Craig, 2003; 
Dostrovsky and Craig, 2013). The VMpo and VP nuclei then project to the dorsal 
insular cortex and anterior cingulate cortex which are important for the 
sensation of pain to be established and are particularly active in chronic pain 
patients (Craig, 2003). 
 
Spinobulbar projections (spinoparabrachial pathway - SPBT) to the brain stem 
are important for the integration of nociceptive activity such as behavioural and 
homeostatic mechanisms (Dostrovsky and Craig, 2013). Spinobulbar 
projections originate in similar laminae to the STT, especially found in lamina I, 
V and VII in the monkey, cat and rat (Wiberg et al., 1987). Spinobulbar 
projections terminate in the lateral parabrachial nucleus of which a high 
proportion of the neurons (50 – 70%) project to the amygdala or the 
hypothalamus and are specifically strongly excited by noxious stimuli (Gauriau 
and Bernard, 2002). These connections are therefore likely to be involved in the 
emotional and autonomic components of pain including stress responses and 




receives significant input from spinobulbar pathways, which is a key site for 
motor limbic output and homeostatic control, but also due to projections to 
other brainstem areas such as the rostral ventromedial medulla (RVM) has an 
important role in antinociception and descending modulation of dorsal horn 
circuits (see section 1.2.7)(Basbaum and Fields, 1978; Dostrovsky and Craig, 
2013; Todd, 2010). 
 
The SHT originates from lamina I, V, VII and X over the entire length of the cord 
(Dado et al., 1994b). This tract has been identified in rats however is not well 
known or understood and has only been proposed as a general pathway in 
mammals with small amounts of evidence for it in primates (Chang and Ruch, 
1949; Morin et al., 1951; Dostrovsky and Craig, 2013). Projections from this 
tract in the rat has shown a complex pathway capable of providing nociceptive 
input to multiple areas of the thalamus and hypothalamus bilaterally (Dado et 
al., 1994a). If established fully in primates this tract could have potentially 
important implications for the autonomic, neuroendocrine and emotional 
aspects of pain (Dostrovsky and Craig, 2013). 
 
1.2.7. Descending pathways 
1.2.7.1. Descending pain modulatory pathways 
Regions of the brain are activated by ascending nociceptive afferent 




to other brain regions allow for modulation and control of pain pathways via 
descending pain modulatory pathways. These pathways originate from various 
brain regions and can be both facilitatory or inhibitory and when working 
together they produce a powerful anti-nociceptive system which is able to 
inhibit dorsal horn neurons in the spinal cord (Gjerstad et al., 2000; Ossipov et 
al., 2014). 
 
1.2.7.2. Noradrenergic pathways 
Noradrenaline (NA) is a catecholamine neurotransmitter along with adrenaline 
and dopamine, all of which can be found in both the periphery and in central 
nociception (Goldstein, 2010). The principal descending NA pathways originate 
in the locus coeruleus and the pontine sub coeruleus regions (Todd, 2010; 
Ossipov et al., 2014). These regions communicate with both the RVM and PAG 
and animal studies have shown that stimulation of all these regions releases NA 
into the spinal cord to produce antinociception (Ossipov et al., 2014). 
Projections from these NA brain regions terminate in the spinal cord dorsal 
horn where they release NA via volume transmission to act on spinal α2 
adrenoceptors causing dose dependent antinociception in intact spinal but not 
spinalized animals (Pertovaara, 2006). During weak noxious stimulation, low 
levels of tonic release of NA causes an inconsistent increase in nociceptive 
withdrawal reflexes (NWRs) and a mild hypersensitivity to thermal but not 
mechanical stimulation, showing a weak and selective tonic pain regulatory 




pain regulation via noradrenergic pathways is more prominent with nociceptive 
responses significantly increased in cases of α2 adrenoceptor knockouts or with 
the use of an antagonist (Jones, 1991; Pertovaara, 2006). Injury results in 
increased synthesis and release of NA and enhanced efficacy of spinal α2 
adrenoceptors, on the other hand, activation of spinal α1 adrenoceptors results 
in pain facilitation (Ossipov et al., 2014). Whilst intact and effective, descending 
NA inhibitory pathways protect against the development of abnormal and 
enhanced pain, however an imbalance between pain facilitation and inhibition 
is believed to result in abnormal pain (Ossipov et al., 2014). 
 
1.2.7.3. Serotonergic pathways 
5-HT is an important molecule in processing and modulation of pain in 
peripheral and central mechanisms (Sommer, 2006). Early studies of 5-HT 
pathways were found to release 5-HT from areas of the brainstem that had an 
analgesic effect in the spinal cord, it was then regarded as a descending 
inhibitory system (Yaksh and Tyce, 1979). The RVM contains the major 
serotonergic nuclei including the nucleus raphe magnus (NRM), the nucleus 
reticularis gigantocellularis-pars alpha and the nucleus paragiganto-cellularis 
(NpGC) lateralis which receive input from the PAG, the RVM as well as the 
thalamus, the parabrachial (PB) region and the locus coeruleus which contains 
the noradrenergic origins (Todd, 2010; Ossipov et al., 2014). Studies have 
demonstrated that lesions of the NRM cause significantly greater hyperalgesia 




responses to noxious heat (Vanegas and Schaible, 2004). 5-HT terminals are 
also involved in tonic inhibition of spinal transmission of nociceptive 
information (Clarke et al., 1996). 5-HT descending pathways are both 
facilitatory and inhibitory and terminate in the trigeminal nucleus caudalis and 
throughout the dorsal horn via volume transmission (Ossipov et al., 2014). The 
various receptor types associated with 5-HT are what determines its analgesic 
or hyperalgesic effects (Sommer, 2006). There are 7 different 5-HT receptors 
with more than 15 sub-types identified which are located in various areas of 
the body including smooth muscle and the gastrointestinal tract (Suzuki et al., 
2004). Most notably involved in nociception are 5-HT1A, 5-HT1B, 5-HT1D, 5-HT2A, 
5-HT3 and 5-HT4 where 5-HT1 receptors are predominantly antinociceptive and 
5-HT2A, 5-HT3 and 5-HT4, are pronociceptive in the spinal cord dorsal horn, 
making 5-HT descending pathways very complex (Sommer, 2004; Bannister et 
al., 2009). 
 
1.3. Diffuse noxious inhibitory controls 
The integrity of descending pathways appears to be necessary for maintaining 
an appropriate excitability of withdrawal reflexes and for maintaining the 
dimensions of their RFs (Schouenborg et al., 1992). This tonic control of reflexes 
by propriospinal and bulbospinal descending neurons from the brain strongly 
control spinal reflexes, however the integrity of descending pathways can be 
assessed by phasic controls of the spinal reflexes whereby noxious stimuli 




that a painful stimulus applied to one area of the body can elicit analgesic 
properties in another area outside the RF of the first in both experimentally 
induced and clinical pain; this phenomenon is a form of “hyperstimulation 
analgesia” termed “diffuse noxious inhibitory controls” (DNIC)(Le Bars et al., 
1979a). Thus, the activity of secondary convergent neurons in the spinal cord 
i.e. neurons that receive both innocuous and noxious inputs from hindlimb 
PAFs, can be greatly inhibited (to between 55 and 100%) in response to a 
noxious stimulus applied elsewhere on the body (Dickenson et al., 1980). This 
kind of hyperstimulation analgesia is the basis for the use of transcutaneous 
electrical nerve stimulation (TENS) as therapeutic relief for chronic pain. TENS 
uses pulses of electrical currents across the surface of the skin with the pulses 
ranging from low to high intensity depending on the level of pain relief required 
(Jones and Johnson, 2009). This therapy is designed to stimulate Aβ-fibres and 
Aδ-fibres that activate endogenous opioid supraspinal anti-nociception 
pathways (Longstaff, 2000). 
 
DNIC is not confined to the spinal cord but is facilitated by an ascending and 
descending mechanism from supraspinal structures or a supraspinal loop (Le 
Bars et al., 1979b). Le Bars and colleagues found that, in the intact rat, WDR 
neurons responding to both noxious and innocuous test stimuli and receiving 
both C and Aα-fibre inputs were strongly inhibited by peripheral noxious 
conditioning stimuli applied to areas of the body outside the peripheral 




the forepaws, ears, muzzle and from the viscerae (Le Bars et al., 1979a). It was 
also noted that innocuous stimuli had no effect when applied to these areas (Le 
Bars et al., 1979a). As well as measuring a range of off-limb sites, Le Bars also 
studied a range of noxious conditioning stimuli including noxious pinch applied 
with forceps, an intraperitoneal (i.p.) injection of bradykinin, noxious heat and 
electrical stimulation (Le Bars et al., 1979a). Le Bars then postulated that in 
order to obtain clear inhibitory effects a certain number of peripheral 
nociceptors must first be recruited, as stimulating a small area was not 
sufficient when using noxious heat applied to the tail, however increasing the 
surface area inserted into the water gave strong inhibitory effects (Le Bars et 
al., 1979a). DNIC is specific in its action that the noxious stimuli applied to the 
distant locations of the body that is the weaker of the two noxious stimuli is the 
one that is inhibited (Le Bars et al., 1979b). This therefore demonstrates a great 
deal of interaction between the test and conditioning stimulus. DNIC has been 
found to inhibit both spontaneous and induced activity using Aα and C-fibres, 
with the latter being more strongly inhibited by noxious stimuli; C-fibre 
response is inhibited to a maximal degree of 98% and Aα-fibres to only 45% (Le 
Bars et al., 1979a). However, this phenomenon is limited to convergent neurons 
and a lack of effect is observed in non-convergent neurons including NS, 
innocuous and proprioceptive neurons (Le Bars et al., 1979b). NS, innocuous 
and proprioceptive cells in the dorsal horn were not affected by various types 
of noxious conditioning stimuli applied to the tail, muzzle, contralateral 
hindpaw or ears of rats (Le Bars et al., 1979b). Spinal sectioning of animals 




stimuli on a number of locations in the rat, even when these stimuli were 
increased to a powerfully noxious level (Le Bars et al., 1979b).  
 
1.3.1. Mechanisms mediating diffuse noxious inhibitory controls  
Electrical stimulation of the sciatic nerve at high but not low intensities was 
found to increase spinal release of 5-HT and NA indicating that these 
descending pathways are influences by noxious stimuli (Tyce and Yaksh, 1981). 
There is pharmacological evidence to suggest that functioning 5-HT 
mechanisms are required for the full effect of DNIC as 5-HT receptor blockers, 
metergoline and cinanserin, strongly reduced the inhibitory effect induced by 
noxious heat and pinch applied to the tail and nose respectively (Chitour et al., 
1982). As well as this, when the serotonin synthesis precursor 5-
hydroxytryptophan (5-HTP) was administered the inhibitory effect of noxious 
heat to the tail was increased (Chitour et al., 1982). When animals are depleted 
of 5-HT using para-chlorophenylalanine (pCPA) at the level of the spinal cord, 
the inhibitory effects of DNIC are partially reduced indicating that serotonergic 
pathways are involved in DNIC but also that they are not the only mechanism 
involved (Dickenson et al., 1981). This reduced efficacy in DNIC was observed 
not only in the magnitude of the C-fibre response but also in a reduction of the 
RF size which would suggest peripheral interactions (Dickenson et al., 1981). 
Serotonergic pathways from the NRM are therefore believed to be the link 
between 5-HT and DNIC as electrical stimulation of the NRM produces powerful 




and NRM inhibition is also reduced in depleted 5-HT states suggesting DNIC and 
NRM-mediated inhibition share common mechanisms (Rivot et al., 1980; 
Dickenson et al., 1981). It can be postulated that as the majority of 5-HT 
originates from the NRM this brain region plays a key role in DNIC, however it 
cannot be ruled out that other raphé nuclei participate in DNIC (Dickenson et 
al., 1981). These other mechanisms that are involved in DNIC may be 
noradrenergic descending modulatory pathways or changes in opioid levels 
within the spinal cord. 
 
When noradrenergic and opioid receptor antagonists are given with capsaicin 
as a conditioning stimulus, inhibitory effects of DNIC on reflex responses are 
abolished which indicates that blocking these two descending pathways with 
antagonists inhibits the inhibitory descending controls which would otherwise 
have reduced the response seen when only capsaicin was given (Gjerstad et al., 
2000). Further investigation into blocking individual receptors indicated that 
when the µ-opioid receptor was blocked with an antagonist and capsaicin was 
also given there was a 40% increase in responses, indicating that the µ-receptor 
has a key role in anti-nociception (Tambeli et al., 2003). When the same tests 
were completed for the κ and δ-receptors there was no hyperalgesia, however 
the anti-nociception was to a significant lesser degree in κ-receptors than that 
seen with only capsaicin but not significant at all with δ-receptors, indicating 
that κ-receptors also play a role in descending inhibitory pathways but δ-




to be exerted by activating the PAG which contains the 5-HT rich NRM of the 
RVM which project to the spinal cord. One believed mechanism of opioids is to 
activate the 5-HT NRM cells which triggers the release of 5-HT in the spinal  cord 
terminals (Matos et al., 1992). Naloxone which blocks opioid actions is often 
given as pain relief medication and its effects upon the spinal cord are to 
decrease the inhibitory effects exerted by NRM stimulation, as previously 
mentioned there is strong evidence to suggest the NRM is linked to DNIC (Rivot 
et al., 1979). From these findings it can be concluded that µ-opioid receptors 
are key in the anti-nociceptive pathway as they block DNIC and that κ-opioid 
receptors partially block this modulatory pathway, which strongly supports the 
suggestion that tonic inhibitory controls descending from the brain are 
mediated by these pathways (Tambeli et al., 2003). 
 
The α adrenoceptor antagonist phentolamine given directly onto the spinal 
cord whilst evoking DNIC using capsaicin produced a slight reduction in the 
inhibitory effects of DNIC (Gjerstad et al., 2000). Adrenergic α2 agonists 
administered spinally have enhanced anti-nociceptive potency and activation 
of the locus coeruleus, which is a key brain structure for descending 
noradrenergic projections, reduce pain signals at the level of the spinal cord 
(Pertovaara, 2013). Lesions of the locus coeruleus and sub coeruleus, which are 
the key nuclei for descending noradrenergic projections, results in a 30 – 40% 
reduction in spinal cord NA in the rat and higher in other mammals such as the 




therefore also showing a net loss of descending inhibition (Vanegas and 
Schaible, 2004). Therefore descending serotonergic and noradrenergic 
pathways are activated during situations requiring anti-nociception, they are 
mediated by opioids in the spinal cord and supraspinal structures and these 
systems must be activated collectively in order for there to be anti-nociception 
as when only one pathway antagonist was given the anti-nociceptive pathway 
was not fully activated (Gjerstad et al., 2000). 
 
The subnucleus reticularis dorsalis (SRD) has been implicated as a potential site 
of action for DNIC. The SRD, also known as the dorsal reticular (DRt) nucleus, is 
located in the medullary reticular formation (MRF) below the cuneate nucleus 
and between the spinal trigeminal nucleus and the NTS and contains neurons 
that respond selectively to and encode noxious stimuli (Bernard et al., 1990; 
Villanueva et al., 1996; Velo et al., 2013). Neurons in this region can be activated 
exclusively by noxious thermal, mechanical or chemical stimuli and are involved 
in pain processing and motor reactions during noxious events (Villanueva et al., 
1988; Bernard et al., 1990). They have properties that make them comparable 
with their involvement in DNIC, as they were preferentially activated by noxious 
stimuli applied to any part of the body (Bouhassira et al., 1992b). Reduction in 
DNIC was observed in rats with unilateral SRD lesions which concurred with 
ideas that the SRD participates in spino-bulbo-spinal loops (Bouhassira et al., 
1992b; Patel and Dickenson, 2019). However only partial blocking of DNIC 




bilateral SRD lesions would result in complete abolishment of DNIC inhibition; 
these studies were not possible to perform as bilaterally operated animals do 
not maintain a good physiological health state for experiments (Bouhassira et 
al., 1992b). Bouharissa investigated other brain structures that may be involved 
in DNIC, suggesting that many mesencephalic structures including the PAG, 
cuneiformis nucleus (CNF) and the PB nucleus may all be involved in DNIC 
(Bouhassira et al., 1990). However much to their surprise the study concluded 
that the PAG, CNF and PB did not participate directly in the inhibitions observed 
in DNIC and that other candidates included the NRM, the locus coeruleus, 
although, currently, the SRD is the only supraspinal structure to contain 
neurons that are responsible for DNIC (Bouhassira et al., 1990). 
 
1.3.2. Diffuse noxious inhibitory controls and chronic pain 
In human studies DNIC is usually referred to as “conditioned pain modulation” 
(CPM), a term introduced in attempt to encapsulate all the pain modulation 
terms and to include the psychophysical paradigms (Yarnitsky, 2010; Yarnitsky 
et al., 2010), however DNIC tends to still be used for animal experimental 
studies therefore for the purposes of this thesis DNIC will be used throughout. 
 
DNIC has been studied in many chronic pain conditions and overwhelmingly the 
results show that individuals with chronic pain demonstrate compromised DNIC 
(van Wijk and Veldhuijzen, 2010). Many spinal cord neurons with joint input are 




However continued input from the periphery leads to central sensitization, 
which in turn can alter these descending inhibitory pathways resulting in the 
maintenance of chronic pain (Danziger et al., 1999). Human DNIC studies have 
demonstrated that DNIC is not only compromised in individuals with OA (Kosek 
and Ordeberg, 2000) but also in many other chronic pain conditions (Peters et 
al., 1992; Kosek and Hansson, 1997; Bragdon et al., 2002; Pielsticker et al., 2005; 
Song et al., 2006). 
 
1.3.3. Factors affecting diffuse noxious inhibitory controls 
DNIC efficacy varies greatly between individuals and personal factors that may 
have an influence on this fluctuation have been largely unexplored. However, 
some studies have been conducted looking at the effect of various personal 
factors such as emotional state, age and gender on the efficacy of DNIC in 
healthy individuals. 
 
Gender has been investigated most frequently in DNIC efficacy studies and 
although there are many studies investigating sex differences in DNIC there are 
variable conclusions. Approximately half of the studies do not indicate any 
effect of sex on the efficacy of DNIC (Baad-Hansen et al., 2005; Ge et al., 2005; 
Arendt-Nielsen et al., 2008). Studies that indicated a difference between males 
and females all showed that males have more efficacious DNIC than females 
(Staud et al., 2003; Ge et al., 2004; Granot et al., 2008; Weissman-Fogel et al., 




(Treister et al., 2010), where the experimenters concluded that their results 
were inconsistent and needed further support. The studies that determined 
men had greater DNIC effects than women indicated that both sexes showed a 
DNIC response, but women showed it to a lesser degree. This may be in part 
explained by experimental differences in that the conditioning and test 
stimulus varied greatly between these experiments and therefore a direct 
comparison is not possible. Also most of these experiments did not control for 
menstrual cycle or contraceptive use in women which can alter the hormone 
levels and effect pain processing (Berkley, 1997). As well as this, psychological 
factors may play a role in the difference between males and females DNIC 
efficacy as one study’s regression model found that gender no longer predicted 
pain modulation when the subjects were controlled for catastrophizing 
(Weissman-Fogel et al., 2008). These studies showed variable results indicating 
that in some cases gender may influence DNIC and that females have 
compromised DNIC in comparison to males. This conclusion would in part 
explain why women have higher incidence of clinical pain syndromes than 
males, however more investigation is required before a firm conclusion is 
reached. 
 
Aging adults have been found to have inferior DNIC when compared to young 
adults and middle-aged or older people sometimes don’t have DNIC at all 
(Washington et al., 2000; Edwards et al., 2003; Larivière et al., 2007; Riley et al., 




young and old adults and compared the differences in DNIC, however one study 
investigated young, middle-aged and elderly healthy individuals which showed 
that DNIC efficacy was negatively correlated with age and that changes in pain 
perception and pain modulation occurred at a much earlier age than previously 
predicted (Larivière et al., 2007). This study contradicts with the results of other 
studies that showed middle-aged individuals do not have any significant 
differences in their DNIC to older adults (Grashorn et al., 2013; Riley et al., 
2014). From these studies, it can be concluded that younger adults have better 
DNIC than older adults, however it is still uncertain at what age this shift in pain 
modulation occurs. Chronic pain is more prevalent in older populations and 
reduced efficacy of DNIC may partly explain why pain in these individuals is 
more common than in young adults.  
 
Ethnic differences have an impact on both clinical and experimental pain 
studies and have continuously demonstrated that African-Americans are more 
sensitive to experimental pain and report higher levels of clinical pain than 
other ethnic groups (Edwards et al., 2001). Few studies have directly 
investigated the effect of different ethnicities on the efficacy of DNIC, however 
those that have found that some ethnic differences do appear. One study 
suggests that African-Americans experience reduced DNIC when compared to 
non-Hispanic whites which may indicate why these individuals have greater 
clinical pain (Campbell et al., 2008). However other studies reported no 




investigation is required before a full conclusion can be drawn (Goodin et al., 
2013; Riley et al., 2014). 
 
A continuous vicious cycle occurs between sleep and pain. Whilst pain disturbs 
and disrupts sleep it is also believed that poor sleep has a negative impact on 
pain (Smith and Haythornthwaite, 2004; Lautenbacher et al., 2006). Two 
studies have both investigated DNIC functionality and its relationship to sleep 
and both concluded that disrupted sleep may contribute to impaired DNIC 
function (Smith et al., 2007; Goodin et al., 2009). Edwards et al. (2009) found 
that patients with chronic pain associated with temporomandibular joint 
disorder (TMD) had reduced DNIC when they also suffered from insomnia 
(reduced sleep efficiency or total sleep time). Similarly, Smith et al. concluded 
that healthy female subjects who had partial sleep deprivation had significant 
reductions in DNIC and higher incidence of spontaneous pain. As no study has 
currently investigated the effect of improved sleep on DNIC, only tentative 
conclusions can be drawn that sleep disturbance has a negative impact on DNIC 
(Edwards et al., 2009). 
  
Physical activity and pain are closely linked in that, especially for chronic 
musculoskeletal conditions such as OA, osteoporosis and low back pain, 
moderate physical activity can improve pain (Vuori, 2001). Very little research 
has been conducted into the effect of physical activity on DNIC, however one 




both more demanding exercise and increased total exercise, had improved 
descending pain modulation (Naugle and Riley, 2014). This may be the reason 
that exercise is so beneficial to individuals with chronic pain. 
 
1.3.4. Relationship between the test and conditioning stimulus 
Few studies have directly investigated the link between the test and 
conditioning stimulus in relation to DNIC. However studies investigating DNIC 
have recognised that these two are interlinked (Le Bars et al., 1979a; Arendt-
Nielsen et al., 2008; Pud et al., 2009). Le Bars first outlined that inhibition can 
be evoked in animals via DNIC when the conditioning stimulus is greater than 
that of the test stimulus (Le Bars et al., 1979a). Le Bars also investigated various 
combinations of noxious stimuli for the test and conditioning stimulus with 
conditioning stimuli such as noxious pinch and radiant heat, electrical 
stimulation with various test stimuli such as pinch to the tail, muzzle and ears, 
heat to the tail, electrical stimulation and bradykinin. The results of these 
experiments showed that all combinations evoked DNIC, however the most 
potent was electrical stimulation with noxious heat and bradykinin combined 
with hot water (Le Bars et al., 1979a). Other studies have likewise tried various 
combinations such as only electrical stimulation for the test stimulus combined 
with mechanical pressure, thermal heat or electrical stimulation for the 
conditioning stimulus and again all three evoked DNIC to differing degrees 
indicating that the interactions between the test and conditioning stimulus and 




DNIC (Danziger et al., 2001). More research has been conducted investigating 
the different conditioning stimuli and how this affects the degree of DNIC 
evoked. Dickenson demonstrated that electrical test stimulus combined with 
bradykinin as the conditioning stimulus resulted in 89% inhibition, however 
when sustained pinch was combined with bradykinin, heat or pinch as the 
conditioning stimulus a maximal inhibition of 60% was observed (Dickenson et 
al., 1980). This demonstrates that certain test and conditioning stimulus 
combinations have a greater inhibitory effect than others. 
 
1.4. Spinal reflexes 
1.4.1. Nociceptive withdrawal reflexes 
An NWR is many polysynaptic motor responses to noxious or potentially 
noxious stimulation. Within a NWR are cutaneomuscular responses to noxious 
stimuli that involve multiple interneuronal pathways to individual muscles 
which enables differential control of these muscles to most effectively move 
the limb from the source of pain (Clarke and Harris, 2004). This process occurs 
entirely within the spinal cord and this is evidenced by experiments involving 
complete transection of the spinal cord which still have functional NWRs 
(Shahani and Young, 1971). To effectively move the limb away from the noxious 
stimulus the nociceptive PAF which enters the dorsal horn is excited when the 
threshold level is reached (Figure 1.2). As previously mentioned (see section 
1.2.3), the primary afferent nociceptor synapses in the dorsal horn onto various 




branch widely with their axons often stretching over several laminae of the 
dorsal horn or both the dorsal and ventral horn (Jankowska and Lundberg, 
1981). The majority of these interneurons appear to be local, synapsing onto 
various other secondary interneurons within the spinal cord, however others 
synapse onto ascending projection tracts (Jankowska and Lundberg, 1981). The 
location and properties of these interneurons is not yet fully established, 
however it is known that laminae II neurons project to the deeper laminae and 
therefore could be the source of the secondary interneurons (Schouenborg, 
2002). In an NWR, excitatory interneurons synapse onto an effector 
motoneuron resulting in contraction of the muscle to move the affected limb 












1.4.2. Organisation of reflexes 
The initial outline of the organization of withdrawal reflexes was put forward 
by Sherrington in the late 1800s who studied NWRs in decerebrate cats. He 
proposed that movement of the hindlimb away from a noxious stimulus was 
due to activation of flexor muscles of the hip, knee and ankle joints 
(Sherrington, 1910). He also proposed concomitant inhibition of extensor 
muscles, hence termed the response the “flexion-reflex of the limb”  
(Sherrington, 1910). Simultaneous inhibition or relaxation in the antagonistic 
extensor muscles was termed “reciprocal innervation” (Sherrington, 1898). 
Sherrington also postulated the “crossed extension reflex” whereby the effect 
of the noxious input in one limb causes excitation of extensors and inhibition 
of flexors in the contralateral limb, which serves to maintain balance in the 
animal (Sherrington, 1906, 1910). 
 
Further research in the flexion reflex realised that if a noxious stimulus was 
applied to the heel, flexion about the ankle joint would cause the area more 
damage by moving it towards the stimulus and therefore extension of the ankle 
was the more appropriate action. This brought about the idea that movement 
during withdrawal was dependent on the location of the noxious stimulus, and 
that whilst the main movement may be flexion, there are also local extension 
reflexes to protect the limb (Hagbarth, 1960; Megirian, 1962). It was therefore 
proposed that describing NWRs as generally flexion reflexes was inappropriate 




pathways are present in separate muscles or groups of synergistic muscles and 
the overall withdrawal movement is the result of activation (or inhibition) of 
these ‘modules’ (Schouenborg et al., 1994). In this capacity a withdrawal 
movement would then be facilitated by a number of reflex modules working 
together or reflex modules would be inhibited in the antagonistic muscles to 
allow controlled movement (Schouenborg et al., 1994; Schouenborg, 2002).  
 
In modular organisation of reflexes, propriospinal neurons within the CNS could 
serve to modulate NWRs, via descending controls, as the number of 
combinations of reflex pathways would be very large and higher thresholds 
would allow for reactions only in the noxious range (Schouenborg et al., 1994). 
 
1.4.3. Reflex receptive fields 
The RF of a reflex was first defined as the “whole area of skin from where the 
reflex can be elicited” (Sherrington, 1906). This definition provides a simplistic 
version of the RF as only increased stimulus intensities evoked reflex responses 
towards the periphery of the RF indicating graded sensitivity (Andersen, 2007). 
Therefore an innocuous stimulus applied to a given area of skin will excite all 
neurons with their RF centres in this location, however a noxious stimulus 
applied to the same place will activate these same neurons as well as other that 





Cutaneous muscle RF patterns are learnt after birth as NWR modules are 
functionally unadapted at birth, often causing movements towards the noxious 
stimulus (Schouenborg, 2002; Clarke and Harris, 2004). Spatial organization of 
RFs is relatively independent to excitability whereby changes in excitability only 
affect the size of the RF and not the location (Schouenborg et al., 1992; Weng 
and Schouenborg, 1996). By mapping the RF borders and sensitivity distribution 
of hindlimb muscles, Schouenborg discovered that each muscle has an 
individual RF with a characteristic sensitivity distribution and can be activated 
independently of other muscle modules (Schouenborg, 2002). Proximal 
muscles tend to have large RFs whilst distally located muscles have smaller RFs 
(Andersen, 2007). The excitatory RF for a muscle is closely linked to the part of 
the limb that would be withdrawn from the ground when the muscle is made 
to contract and the opposite is also true that the inhibitory RF would move the 
area towards the noxious stimulus (Clarke and Harris, 2004).  
 
1.5. Osteoarthritis and chronic pain 
1.5.1. Burden of osteoarthritis to the patient 
The impact and burden of OA on daily life differs from individual to individual, 
however more commonly sufferers find morning stiffness, instability of the 
joint and pain that worsens with activity and decreases during periods of rest 
(Swagerty and Hellinger, 2001). This pain is often the most debilitating 
symptom of the disease and increases during weight bearing and limits 




2001; Palazzo et al., 2016). Hip and knee OA have the greatest burden, often 
leading to significant disability and surgical intervention is usually required due 
to pain (Oliveria et al., 1995). In the UK ranking for leading causes of Years Lived 
with Disability (YLDs) OA ranked 11th in both 1990 and 2010 (Murray et al., 
2013; Cross et al., 2014). Disability of Adjusted Life Year (DALY) is a measure of 
years of potential life lost due to premature mortality and the years of 
productive life lost due to disability for a given condition. The DALY for OA has 
increased by 6.4% between 1990 and 2010 in the UK indicating the ever-
increasing burden that OA has on the lives of sufferers (Murray et al., 2013). 
 
As well as the physical disability of OA there is also a great deal of psychological 
burden that OA places on people’s lives. Often the extent of functional disability 
is an important factor in psychological distress (Penninx et al., 1996). Inability 
to perform everyday tasks leads people to feel devalued in their self-worth and 
the constant pain causes a great deal of distress. One study found that the 
psychological distress is most frequently experienced by patients with OA over 
diabetic, cardiac or stroke patients (Penninx et al., 1996; Hopman et al., 2009). 
This negative effect on mental health associated with disability and pain in OA 
is well established with worse baseline mental health positively correlated with 
worse knee OA pain indicating that mental health is worsened by the condition 
(van Baar et al., 1998; Wise et al., 2010). However, mental health can also have 
adverse effects on OA with one study showing that risk of pain flare is increased 




treatment of depression can significantly improve pain (Lin et al., 2003; Wise et 
al., 2010). 
 
OA can often lead to reduction and/or prevention of social interactions with 
family, friends and partners as well as effecting an individual’s working life 
(Arthritis Research UK, 2013). Sufferers often find themselves having more time 
off sick or being unable to work at all, having a huge impact on the person’s life 
(Arthritis Research UK, 2013). Patients with severe OA are shown to have an 
average of 2 and a half 8 hour days off sick in a 2-week period, which is 5 times 
greater than a healthy individual (Lerner et al., 2002). Employees with OA that 
are present at work may experience reduced productivity caused by functional 
limitations of their condition (Meerding et al., 2005). OA employees lose an 
average of 9% per hour in productivity while the average healthy control is less 
than 1% (Lerner et al., 2002). 
 
1.5.2. Burden of osteoarthritis to the health services 
The total economic cost of OA in the UK has not been studied however a 1997 
study indicated the cost of musculoskeletal disorders, of which OA is the most 
common, totalled 1.1% of the Gross National Product (GNP) of the UK (March 
and Bachmeier, 1997). Of all the musculoskeletal conditions OA is responsible 
for the most inpatient Finished Consultant Episodes (FCEs), which are the 
episodes of admitted patient care with one consultant in a year, at 209,382 




2011). Treatment and management of OA incur significant costs both directly, 
such as due to medication, hospitalization, ambulatory care or physiotherapy, 
and indirectly, such as home care or child care costs (March and Bachmeier, 
1997; Bitton, 2009). Pain medication accounts for 15% of annual drug costs with 
nearly 50% of these medications being non-steroidal anti-inflammatory drugs 
(NSAIDs) which have significant side effects including increased chance of 
gastric ulcers (Gabriel et al., 1991; March and Bachmeier, 1997; Bitton, 2009). 
In 2015, 98,951 patients underwent total knee replacement (TKR) surgery and 
89,288 patients received a hip replacement of which 98% and 90% were due to 
OA respectively (National Joint Registry, 2016). In 2015-2016 the average cost 
of knee and hip procedures on the NHS were £6,253 and £7,089 respectively 
(Department of Health, 2016). TKR and hip replacements are end stage 
treatments for OA and for the most part are successful in treating the joint 
degeneration. Hip and knee replacements in general will last for 10-20 years in 
90% of patients, however as people who are developing OA are getting 
younger, joint replacements revision surgery is becoming more common where 
the joint replacement is changed (Labek et al., 2011). Revision surgeries are 
more complex and have higher risks on post-surgery complications leading to 











1.5.3. Risk factors 
Increased risk of OA is associated with age with 33% of people aged 45 and over 
having consulted a doctor for their condition, rising to almost half in people 
over 75 (Arthritis Research UK, 2013). The mechanism leading to joint damage 
in older individuals is poorly understood, however it is believed to be due to a 
number of factors including thinning of the cartilage, muscle weakness, 
oxidative damage and a reduction in proprioception (Litwic et al., 2013). It is 
also thought that as basic cellular mechanisms that maintain tissue 
homeostasis decrease with age, older joints inadequately respond to stress or 
joint injury which causes tissue loss and destruction (Litwic et al., 2013). 
 
OA is positively correlated with a rising body mass index (BMI) making it one of 
the strongest factors associated with the disease (Litwic et al., 2013; Wluka et 
al., 2013; Kearns et al., 2014). It has been estimated that 24.6% of new OA cases 
are related to the patient being obese (Silverwood et al., 2015). In 2015, 
individuals who underwent hip and knee replacements were found to have 
average BMI of 28.7 and 30.9 respectively indicating that they were in the 
overweight and obese classifications of the BMI (National Joint Registry, 2016). 
Obese patients have increased risk of bilateral OA especially in the case of knee 
OA but also for hip OA (Cimmino and Parodi, 2004). The mechanisms for links 
between OA and obesity occur in 2 ways; the first is increased dynamic stress 
on the joint due to the excess weight (Cimmino and Parodi, 2004). Increased 




may increase stiffness in the subchondral bone and facilitate cartilage 
breakdown (Cimmino and Parodi, 2004). Weight distribution may also play a 
key role in the type of OA observed as weight carried around the waist has to 
be supported by the knee and hip joints whilst weight carried on the thighs or 
hip is supported primarily by the knees (Stürmer et al., 2000). The second way 
is that it may not just be the biomechanical aspects of obesity that gives rise to 
increased risk of OA. Systemic metabolic and inflammatory factors may also 
influence OA with a possible link to insulin-like growth factor (Cimmino and 
Parodi, 2004). One indicator for this is that not just hip and knee OA are 
associated with obesity, correlations are also found with hand OA which would 
suggest other routes than just load-bearing joints (Palazzo et al., 2016). 
 
OA is more commonly found in women over men with women accounting for 
60% of hip and knee replacement operations (National Joint Registry, 2016). 
Female knee joints have been found to have various anatomical differences; 
narrower femurs, a thinner patella, tibial condylar size and a larger quadriceps 
angle, which have led to the implementation of gender-specific TKRs (Merchant 
et al., 2008; Hame and Alexander, 2013). Despite these anatomical differences 
between the male and female knee joint no direct link has been found between 
this and increased risk of OA in women (Hame and Alexander, 2013). However, 
women also have differences in the volume of cartilage which may play a key 
role in their increased risk of developing OA (Hame and Alexander, 2013). One 




knee pain using magnetic resonance imaging (MRI) to investigate the cartilage 
volume and defects (Hanna et al., 2009). After the second MRI 2.3 years later 
they found that the average annual percentage loss of tibial and patella 
cartilage volume was significantly greater in women and that women had a 
greater number of tibiofemoral cartilage defects when compared to men 
(Hanna et al., 2009). These findings may indicate a contributing factor to the 
increased knee OA found in women. Hormonal differences in females may also 
be key to developing OA as postmenopausal women in particular have 
increased risk of developing arthritis (Hame and Alexander, 2013). Post-
menopausal women are more prone to OA due to the reduced levels of 
oestrogen and oestrogen replacement therapy has protective effects in post-
menopausal women (Nevitt et al., 1996; Richmond et al., 2000; Hame and 
Alexander, 2013). This may be caused by oestrogen modulating the synthesis 
of the cartilage matrix and production of matrix and this is supported by the 
presence of oestrogen receptors in articular cartilage (Nevitt et al., 1996; 
Richmond et al., 2000; Hame and Alexander, 2013). It has also been found that 
women who take oestrogen replacement therapy post menopause have 
reduced chances of developing radiographic evidence of knee arthritis (Zhang 
et al., 1998). This shows that oestrogen may have a protective role on cartilage 
as this decrease was positively correlated with the duration that the women 





A traumatic joint injury or surgery is a key risk factor for OA especially for the 
development of knee OA (Arthritis Research UK, 2013; Litwic et al., 2013). 
These injuries can occur in any joint from sports injuries in knee joints to 
dislocations in a finger joint (Arthritis Research UK, 2013). Trauma to any area 
of the joint that compromises the structural integrity are implicated in the 
development of OA (Gelber et al., 2000). Injury to a particular joint changes the 
biomechanics within the joint and this change can lead to secondary OA, 
especially if the individual has OA present in another joint (Cimmino and Parodi, 
2004; Litwic et al., 2013). The knee joint is one of the most commonly injured 
joints, with anterior cruciate ligament (ACL) injuries showing the closest links to 
the development of OA (Øiestad et al., 2009; Palazzo et al., 2016). In ACL 
injuries, 13% of cases develop early-onset knee OA after 10 years of the initial 
injury, whilst ACL injuries associated with meniscal injury have an increased risk 
of developing OA of up to 40% within the same time period post-injury (Øiestad 
et al., 2009). 
 
Certain types of OA have a genetic component making family members more 
at risk from developing OA in later life (Arthritis Research UK, 2013). It is 
thought that genetic factors account for 60% hip and hand and 40% knee OA 
(Spector and MacGregor, 2004). There are many genes that are potentially 
involved in disease onset with the most likely candidate involving the 
production and maintenance of collagen, such as collagen type II which is the 




Parodi, 2004; Palazzo et al., 2016). Other contender genes could be those 
encoding the vitamin D receptor which is located close to the collagen type II 
gene, such as insulin-like growth factor I, cartilage oligomeric protein and the 
human leukocyte antigen (HLA) region (Cimmino and Parodi, 2004; Spector and 
MacGregor, 2004; Palazzo et al., 2016). As well as gene mutations that directly 
affect the site of OA there may be genetic changes that could indirectly 
influence the risk of OA for example the response to injury, effects on body 
weight and muscle mass as well as bone structure and turnover (Spector and 
MacGregor, 2004).  
 
It is widely acknowledged that physically demanding occupations, that require 
repetitive and excessive joint loading, can increase the risk of OA in some joints 
(Arthritis Research UK, 2013; Litwic et al., 2013). Occupations that involve 
squatting and kneeling were found to increase risk of knee OA whilst lifting and 
prolonged standing is associated with hip OA (Cimmino and Parodi, 2004; 
Muraki et al., 2009; Palazzo et al., 2016). Particularly dexterous professions are 
linked to hand OA as well as certain repetitive movements such as a pincer 
action or winding (Hadler et al., 1978; Muraki et al., 2009; Palazzo et al., 2016). 
 
1.5.4. Structure of the knee joint: normal versus osteoarthritic 
OA is a disease affecting the whole joint, including bone, synovium, cartilage 
and capsule (Dieppe, 2005). Normal knee joints allow the bones to move freely 




surrounding the joint (Arthritis Research UK, 2012). The bones in the joint are 
coated in a smooth layer of cartilage that allows the joint to move effortlessly 
against one another and menisci within the joint act as “shock absorbers” to 
spread the load over the joint more evenly (Arthritis Research UK, 2012)(Figure 
1.3). This section will look at each component of the normal knee joint and 
discuss the changes during mild to severe OA. 
 
1.5.4.1. Cartilage 
Articular cartilage is a specialised tissue that is on average approximately 3-4 
mm thick and allows almost frictionless movement across its surface (Brody, 
2015). In a healthy state, articular cartilage has the capacity to withstand a 
lifetime of loading forces, despite its limited ability to repair once damaged 
which is attributed to its lack of nerves, blood vessels and lymphatics (Fox et 
al., 2009; Brody, 2015). Articular cartilage comprises of two main parts; cells 
called chondrocytes which account for approximately 1 – 5% of articular 
cartilage weight and the ECM which predominantly comprises of water, 
collagens and proteoglycans but also has small amounts of lipids, 
phospholipids, non-collagenous proteins and glycoproteins (Bhosale and 
Richardson, 2008; Fox et al., 2009). 
 
Articular cartilage encompasses four different zones based on the shape and 
orientation of chondrocytes and the distribution of collagen fibres within the 




deep and calcified zones representing approximately 15%, 50%, 30% and 5% of 
the total cartilage thickness respectively (Fox et al., 2009). 
 
As we age articular cartilage changes occur due to continuous wear on the joint; 
the most obvious structural change to articular cartilage is increased articular 
surface fibrillation which is abrasions on the surface, which can be 
characterised by microscopic cracks (Meachim et al., 1977; Pritzker et al., 
2006). Chondrocytes, which are cells within the ECM, decrease in density with 
increasing age which reduces the synthesis of collagen fibres and so alters the 
structure of the matrix (Brody, 2015). As well as this, chondrocyte function is 
also reduced during aging as the capacity of the cells to synthesise some types 
of proteoglycans and their response to stimuli including growth factors 
decreases (Guerne et al., 1995; Buckwalter and Mankin, 1997). These changes 
in chondrocyte numbers and function may limit the cells ability to restore and 
maintain the ECM and therefore contribute to cartilage degeneration 
(Buckwalter and Mankin, 1997). Other striking changes in the ECM are 
differences to the proteolytic proteins aggrecans as these macromolecules are 
synthesised much smaller than they are in younger joints (Thonar et al., 1986). 
These changes may be due to degradation of the proteoglycans in the ECM or 
decreased synthesis of proteoglycans (Martin and Buckwalter, 2002). Structural 
changes also occur within the ECM as changes in the proteins results in the 
cross-linking of collagens being altered and changes to the osmolarity of the 




changes are a decreased water concentration and changes in the tensile 
stiffness and strength which may make cartilage vulnerable to injury and repair 
of damaged cartilage slower (Kempson, 1982; Martin and Buckwalter, 2002). 
 
In an OA joint, continuous wear causes damage to the smooth cartilage layer 
which over time degrades and becomes rough (Swagerty and Hellinger, 2001; 
Felson, 2006; Arthritis Research UK, 2012). Cartilage damage is one of the main 
features of the disease and the attempted repair of articular cartilage leads to 
many of the key clinical symptoms of OA (Buckwalter and Martin, 2006). OA 
involves the progressive loss of articular cartilage and most commonly occurs 
in the absence of a known cause which is known as idiopathic or primary OA 
(Buckwalter and Mankin, 1998). Less frequently OA can develop as a result of 
joint damage, injuries or infections such as an intra-articular fracture causing 
damage to the articular cartilage or due to a variety of disorders such as 
haemophilia which can cause joint haemorrhages; this type of OA is called 
secondary OA (Buckwalter and Mankin, 1998). Idiopathic OA rarely occurs in 
people younger than 40 years old, whilst secondary OA can occur in younger 
individuals (Buckwalter and Martin, 2006). The earliest sign of OA in cartilage is 
increased water content or oedema in the ECM of all the cartilage zones, 
however most prominently the pattern of water content is altered, where 
water is now seen in its highest volumes in the middle or transitional zone 
whilst in normal cartilage the higher volumes are observed in the superficial 




cartilage increases to over 90% during OA which is associated with the loss of 
negatively charged glycosaminoglycans (GAGs)(Roberts et al., 1986; Guilak et 
al., 1994; Bhosale and Richardson, 2008). This leads to reduced elasticity of the 
cartilage and so a reduction in load-bearing capability of the articular cartilage, 
disruption of the superficial zone alters mechanical properties thus 
contributing to the development of OA (Bhosale and Richardson, 2008). Early 
changes in OA cartilage are most apparent at the joint surface where 
mechanical forces such as shear stress are at their largest (Andriacchi et al., 
2004). Early changes in OA can often lead to abnormal motion in the joint which 
causes a shift in the location of cartilage contact to an area of the joint that is 
not accustomed to high load-bearing (Andriacchi et al., 2004). This shift in 
motion of the joint may be caused by a traumatic injury or by a chronic problem 
in the joint, however it initiates changes in the superficial zone of articular 
cartilage (Andriacchi et al., 2004). Chondrocytes in normal cartilage are 
normally reasonably dormant cells, however in OA they become “activated” 
and this initiates cell proliferation, cluster formation, and increased production 
of both matrix proteins and matrix-degrading enzymes (Goldring and Marcu, 
2009). In early OA, clusters of two to six cells are found along the eroding 
articular surface, in later stages clusters grow to include up to eight cells or in 
some cases up to ten cells in one cluster (McGlashan et al., 2008). Disruption of 
chondrocyte activity may be viewed as an injury response which leads to 
chondrocytes returning to their developmental programming, causing matrix 
remodelling and inappropriate hypertrophy-like maturation as well as cartilage 




produce a number of cytokines, which stimulate the production of proteinases, 
down-regulate aggrecan production and cease synthesis of proteoglycans 
(Loeser et al., 2012; Roughley and Mort, 2014). Loss of aggrecans and 
proteoglycans from the ECM subsequently results in the production of 
collagenases, and a lack of proteoglycans to cover the collagen fibres leaves 
them vulnerable for degradation, which has been demonstrated in a knockout 
mouse study (Glasson et al., 2005). This degradation of the collagen fibres 
within the ECM disrupts the structure of the ECM and initiates fibrillation or 
microscopic cracks in the superficial zone and erosion of the articular surface 
(Roughley and Mort, 2014). These cracks eventually develop into deep fissures 
that extend into the middle and deep cartilage zones, and branch out 
horizontally across these zones (Pritzker et al., 2006). In late-stage OA, the 
fissures that develop and expand vertically through the articular cartilage 
create gaps for angiogenesis or development of new blood vessels down these 
channels making the normally avascular cartilage a vascular tissue (Walsh et al., 
2007). This may be due to pro-angiogenic factors being released from 
chondrocytes in the deep zone which occurs in hypertrophic chondrocytes, 
however these vascular channels penetrate the tidemark, a separation line 
between the deep and calcified zones, and are accompanied by neural 
components that may play a role in joint pain in later stages of OA (Imhof et al., 
2000; Walsh et al., 2007; Goldring and Goldring, 2016). The reintroduction of 
minerals into this area due to vascularisation of the cartilage results in the 
calcified zone expanding at the osteochondral junction or the point separating 




2006; Loeser et al., 2012). The tidemark also becomes duplicated due to the 
penetration of vascular tissue into the calcified zone and so this widens the 
tidemark (Loeser et al., 2012). Vascularisation of the cartilage also results in 
fragmentation of the ECM, further loss of the matrix structure and introduction 
of other cytokines, this is believed to be a primary cause of chondrocyte 
apoptosis or cell death (Pritzker et al., 2006; Loeser et al., 2012; Hwang and 
Kim, 2015). With the loss of the chondrocytes, no further structural or 
functional tissues can be synthesised resulting in complete delamination of the 
articular cartilage whereby all zones are lost down to the calcified zone and 
widened tidemark (Goldring and Goldring, 2016). 
 
1.5.4.2. Subchondral bone 
Beneath the articular cartilage there is a structure known as the cement line 
and below this is the subchondral bone plate and all of these five components 
make up the osteochondral junction (Suri and Walsh, 2012). The cement line is 
a thin line between the calcified cartilage and subchondral bone which is 
approximately 1 – 5 µm wide (Burr et al., 1988). It is a zone of increased 
calcification between calcified cartilage and bone (Pritzker et al., 2006). The 
morphology of the cement line would suggest that it has mechanical role with 
the surrounding bone matrix in that it is a ductile structure that would allow 
relatively easy crack initiation within the bone structure, however it would 
prevent or slow any significant expansion of this crack therefore allowing time 




line is the subchondral bone, which is a layer of compact bone directly beneath 
the articular cartilage that is a transition between the articular cartilage and the 
rigid skeleton (Suri and Walsh, 2012; Goldring and Goldring, 2016). The 
subchondral bone can be split into three sections; the subchondral bone plate, 
the subchondral trabecular bone and the bone at the joint margins (Goldring 
and Goldring, 2010). The subchondral bone plate, sometimes called the cortical 
endplate, consists of cortical or compact bone which is relatively nonporous 
and poorly vascularised (Goldring and Goldring, 2010). Calcified cartilage is 
interlinked with the subchondral bone plate in an irregular fashion which allows 
for transformation of shear forces during traction and compression (Imhof et 
al., 1999). Subchondral trabecular bone is a delicate bone consisting of fine 
straight or curved rods which form together a meshwork often described as 
looking like a sponge (Singh, 1978). This subchondral trabecular bone is polar 
opposite to the subchondral bone plate in that it is vastly vascularised with a 
high number of arterial and venous vessels  as well as nerves which have small 
branches that extend into the calcified cartilage zone (Imhof et al., 1999). These 
vessels invade the subchondral bone plate to form direct contact passageways 
which allow opportunities for molecular trafficking and the transmission of 
physical forces (Lyons et al., 2006). Therefore the key function of this bone 
region is to supply articular cartilage and more specifically chondrocytes in the 
deeper articular zones with nutrition and oxygen by diffusion (Coimbra et al., 
2004; Suri and Walsh, 2012). Bone is a constantly remodelled structure, and its 
turnover is facilitated by the cells contained within the structure which include 




be tightly regulated as deviations from neutral balance between resorption and 
formation would cause increased risk of fracture or compression syndromes 
(Goldring and Goldring, 2016). Osteoblasts and osteoclasts together form a 
bone multicellular unit (BMU) which is responsible for remodelling both cortical 
and trabecular bone via osteoclast resorption supported by a phase of 
osteoblast-mediated bone formation (Eriksen, 2010). Osteocytes are the third 
bone cell type and are embedded in the bone matrix, they form an 
interconnected network with each other in the bone matrix and with the cells 
on the bone surface to play a critical role in the homeostasis in the adult 
skeleton by regulating osteoblast and osteoclast function (Dallas et al., 2013).  
 
During the progression of OA, subchondral bone undertakes dramatic changes 
in its composition and structural organisation (Loeser et al., 2012). The calcified 
cartilage layer and tidemark above the subchondral bone undergo angiogenesis 
and these blood vessels infiltrate this zone from the subchondral bone (Walsh 
et al., 2007). A pro-angiogenic environment in the subchondral bone as well as 
an increase in NGF expression facilitates the vascularisation and growth of new 
nerves in the articular cartilage (Walsh et al., 2010). This increases bone cross 
talk between the subchondral bone and articular cartilage, where osteoblasts, 
osteoclasts, osteocytes and bone-lining cells engage in molecular interactions 
with the articular cartilage (Suri and Walsh, 2012). This increased cross-talk 
between the subchondral bone and the articular cartilage in early OA leads to 




trabecular bone (Intema et al., 2010b). Subchondral trabecular bone 
deteriorates and its density decreases during early OA; trabecular bone 
thickness decreases as well as increased separation between the trabeculae 
and a reduction in the number of trabeculae (Bolbos et al., 2008). The 
subchondral bone plate also sees a reduction in thickness due to increased 
bone remodelling (Intema et al., 2010b). This is observed in canine animal 
models of OA where early OA can be observed more closely and this coincides 
with degeneration in the articular cartilage (Intema et al., 2010b). Subchondral 
bone plate was found to drastically decrease particularly in the medial part of 
the joint and the porosity of the plate was also found to increase (Intema et al., 
2010a). A feline model of OA investigating early and late stage post-traumatic 
OA also found that the subchondral bone plate thinned during early OA (Boyd 
et al., 2005). Density and thickness of subchondral bone is found to decrease 
with increased age, however this decrease is much more dramatic in cases of 
OA (Yamada et al., 2002; Boyd et al., 2005). The subchondral bone plate and 
subchondral trabecular bone change over the course of OA progression, both 
regions, which decreased in early OA, are found to increase in thickness and 
density in late OA (Goldring and Goldring, 2016). Bone surface of the 
subchondral plate and trabecular bone were decreased with OA, however 
thickness of the subchondral plate was found to positively correlate with 
increased severity of OA (Finnilä et al., 2017). Trabecular bone is found to 
increase in density during OA progression, however this increase in bone 
density also causes increased stiffness in the bone possibly due to the 




progresses, subchondral bone changes become more evident. Bone marrow 
lesions (BMLs) form within the subchondral bone and, observed on MRI, show 
water signals indicating these are oedema filled regions associated with 
inflammation (Eriksen, 2015). Previous trabecular bone deterioration in early 
OA due to increased bone remodelling results in spaces between the marrow 
trabeculae, these spaces are highly associated with BMLs in the subchondral 
bone (Eriksen, 2015). BMLs tend to be associated with cartilage pathology in 
OA and have been found to develop in later stages of OA and depend upon the 
development of pre-existing cartilage damage and are exacerbated by 
increased joint loading (Crema et al., 2010; Kothari et al., 2010). BMLs can also 
develop on MRIs because of fibrovascular replacement of adipose bone 
marrow in OA, which are associated with osteochondral angiogenesis, 
suggesting that subchondral pathology drives vascular invasion into articular 
cartilage or that angiogenesis may stimulate fibrovascular marrow replacement 
(Walsh et al., 2010). Regions within the subchondral bone develop into so called 
subchondral bone cysts (SBCs), these regions are fluid filled or can contain 
fibrous tissue (Li et al., 2013). They are highly correlated with BMLs in that BMLs 
have found to predict the development of SBCs in OA (Carrino et al., 2006). 
They are commonly reported in patients with OA and are strongly associated 
with greater disease progression and severity but also with higher degrees of 
pain (Tanamas et al., 2010). Formation of cysts is hypothesised via two different 
mechanisms; the first is the Synovial Breach Theory where cysts form in spaces 
between trabeculae in the subchondral bone as proliferations of other cells 




myxomatous (tumourous) in histologic appearance and during their expansion 
the lesion compresses all surrounding tissues (Milgram, 1983). Enlargement of 
cysts is undertaken by significant bone resorption occurring and the rupturing 
of these myxomatous cells leaving the mucous fluid in the centre of the cavity, 
lots of smaller cysts can also join to create larger mucosal cavity regions within 
the subchondral bone (Milgram, 1983). Trauma in these regions and on the 
articular surface causes fissures and breach of the osteochondral junction 
whereby synovial fluid is able to infiltrate the subchondral bone (Landells, 
1953). The other method of cyst development is referred to as Bone Contusion 
Theory where damage to the subchondral bone, which can develop from the 
articular surfaces impacting on one another, results in fissures and necrosis of 
the surrounding tissues (Crema et al., 2010). This theory suggests that SBCs are 
induced by abnormal mechanical stress and subsequent microcracks which 
results in inflammation and so oedema of the bone spaces resulting in the 
observed cysts (Dürr et al., 2004; Crema et al., 2010; Li et al., 2013). New bone 
often forms around the edges of these large cysts producing structures that are 
clearly observed radiographically as the new bone is often thicker, a change 
known as sclerosis (Milgram, 1983). Subchondral bone sclerosis is an 
indisputable sign of the progression of OA, however it is unknown whether it is 
present as a driving force for the disease or as a result of damage to the articular 
cartilage (Burr and Gallant, 2012). It is a striking feature of OA radiographs and 
is observed as darkened white patterns indicating the thickened bone 
(Milgram, 1983). Participants in the Framingham Study showed up to 9% 




with no knee OA, however the mechanical consequences of this are not clear 
(Hannan et al., 1993; Burr and Gallant, 2012). Bone sclerosis is believed to be 
caused by dysregulation of bone remodelling whereby abnormal osteoblasts 
have increased metabolic activity that result in an increase in an under-
mineralised osteoid matrix (Hunter and Spector, 2003; Lajeunesse, 2004). 
Osteophytes are another key feature of late stage OA that are due to changes 
in the subchondral bone and are easily observed on radiographs (Goldring and 
Goldring, 2016). Osteophytes are outgrowths of bone at the margin or 
periphery of the joint and radiographically they appear as lips of new bone 
around the edges of the joint (Boegård and Jonsson, 1999). They develop by 
stimulation of cells in the synovial lining of the joint beginning to proliferate, 
cells inside the developing osteophyte then undergo chondrogenesis and 
deposit matrix molecules such as aggrecan causing chondrocytes to further 
differentiate and undergo hypertrophy (van der Kraan and van den Berg, 2007). 
This is followed by ossification of the site and formation of marrow cavities to 
create a fully developed osteophyte which is integrated into the subchondral 
bone (van der Kraan and van den Berg, 2007). It is unclear whether osteophytes 
develop as a manifestation of pathologic joint changes or whether they are part 
of normal remodelling in response to articular cartilage changes (Pottenger et 
al., 1990). It is possible that osteophytes develop as a way of stabilising the joint 
in OA as, in severe OA, joints are frequently found to be unstable (Kolstad et 
al., 1980; Goldring and Goldring, 2016). One study has tested whether this 
hypothesis is true and found that OA knee joints are more unstable than normal 




against the slackened ligaments (Pottenger et al., 1990). All of these changes to 
the subchondral bone result in joint space narrowing and bone attrition 
(Goldring and Goldring, 2016). Joint space narrowing often forms between 
osteophytes at the joint margin and does not appear to correlate or predict 
articular cartilage damage  (Fife et al., 1991). Joint space narrowing results 
predominantly from increased thickness of the subchondral bone plate and due 
to the development of osteophytes (Buckland-Wright, 2004). Bone attrition is 
an altered bone contour resulting from deformation of the subchondral bone 
plate (Goldring and Goldring, 2016). Bone attrition is seen as an additional 
radiographic feature of advanced OA and graded on the degree of flattening of 
the articular surface and can be observed from mild to severe OA but is more 
commonly a feature of severe OA (Reichenbach et al., 2008). The presence of 
bone attrition in sub regions within the knee joint has also been found to 
predict further cartilage loss in that sub region suggesting that these features 
of OA are highly correlated (Neogi et al., 2009). Bone attrition occurs in areas 
of the joint that experienced greater mechanical loading and is increased when 
the joint is misaligned (Neogi et al., 2010). 
 
1.5.4.3. Meniscus 
Meniscus is a smooth lubricated tissue that is crescent shaped wedges of 
fibrocartilage and in the knee joint there are two menisci located between the 
femoral condyles and the tibial plateaux on the medial and lateral aspects of 




the knee are specialised tissues that play a key role in load transmission, joint 
stability and shock absorption as well as stability, nutrition, proprioception and 
joint lubrication (Fox et al., 2012a; Sun et al., 2012). Functions associated with 
load transmission are often discovered by the removal of the meniscus or 
meniscectomy. In 107 cases of meniscectomy individual had overloading of the 
articular surfaces of the joint and increased compression of the articular 
cartilage (Fairbank, 1948). Articular cartilage has elastic properties allowing it 
to withstand forces between the femoral and tibial surfaces, however this is 
only for small forces applied for short periods of time (Fairbank, 1948). 
Comparisons between the contact areas of tibial and femoral surfaces show 
that the contact area with menisci is more than twice as large as knee joints 
without menisci, indicating menisci play a key role in the distribution of loads 
(Fukubayashi and Kurosawa, 1980). Under large load conditions the menisci 
distribute the weight across its surface, placing larger forces on the lateral 
meniscus whereas the medial meniscus carries less load and shares this load 
with the exposed articular cartilage (Walker and Erkman, 1975; Fukubayashi 
and Kurosawa, 1980). The meniscus achieves this load transmission by its 
distinctive shape (Makris et al., 2011). Under normal physiological conditions 
there is continuously repetitive loading on a joint during gait which generates 
intermittent shock waves in every joint and this is attenuated by shock 
absorbers which in the knee joint is the menisci (Voloshin and Wosk, 1983). 
Healthy knees have a 20% higher shock absorbing capacity when compared to 
painful knees or knees which have undergone meniscectomy, however painful 




capacity, indicating menisci can lose their shock absorbing properties even 
when no knee pathology is present (Voloshin and Wosk, 1983). Menisci also aid 
in stabilising the knee joint as the geometric structure of the menisci maintains 
joint congruity and stability (Fox et al., 2012a). The concave and convex shaping 
of the menisci enables the femoral condyles and tibial plateaus to articulate 
against each other and, after joint loading, the knee has multi-directional 
stabilisation, limiting excess motion in all directions (Fox et al., 2012a). When 
the menisci are removed the joint becomes lax and anterior-posterior flexion 
in the knee joint becomes more unstable (Markolf et al., 1976). Menisci have a 
vascular ring which supplies the periphery and sends radial branches into the 
nearby tissues and the inner two-thirds of the menisci is avascular (Bird and 
Sweet, 1988). Canal-like openings have been observed in the surface of calf and 
human menisci which were traced adjacent to blood vessels near the attached 
edge of the menisci which may provide nutrients to the cells of the menisci and 
replenish fluid content (Bird and Sweet, 1987). Lubrication is an important part 
of the menisci as during articulation of the joint there must be the formation of 
a liquid film between the moving surface and its bearing (MacConaill, 1932). 
Menisci contribute to joint lubrication due to their high water content by 
compression forces which squeeze the liquid out into the joint space allowing 
smoother articulation (Levy et al., 1982; Aagaard and Verdonk, 1999). 
Proprioception is a sensory modality that encompasses the sense of relative 
joint position and motion (Karahan et al., 2010). This perception is mediated by 
mechanoreceptors which have been found to be present in the anterior and 




thought that quick-adapting mechanoreceptors such as the Pacinian corpuscles 
mediate the sensation of joint motion whilst slow-adapting receptors such as 
Ruffini endings and Golgi tendon organs mediate the sensation of joint position 
(Reider et al., 2003). These findings along with evidence that there is a reflex 
arc between the medial meniscus and the semimembranosus muscle in rabbits 
suggests that the meniscus plays a key role in joint motion and position 
(Messner and Gao, 1998; Saygi et al., 2005; Akgun et al., 2008). 
 
Injury to the meniscus is a known predisposition of OA and damage of the 
meniscus occurs in 63% of adults with symptomatic knee OA (Englund et al., 
2008). Degeneration of the meniscus is a common feature of OA and this is 
frequently revealed by MRI scanning (Chan et al., 1991). There is a strong 
relationship between meniscal abnormalities in MRI scanning and degenerative 
joint disease (Chan et al., 1991). During OA, the menisci lose their smooth 
surface and become worn, however this does not occur evenly over the menisci 
with the medial menisci often showing a greater degree of wear than the lateral 
menisci (Katsuragawa et al., 2010). Meniscal tears are the most common form 
of intra-articular injury, with peak incidence occurring between the ages of 20 
and 29 and more commonly found in men than women (Bryceland et al., 2017). 
They can be classified into two main categories; traumatic or degenerative, 
with traumatic lesions found in younger active individuals which occur when 
the meniscus becomes trapped between the femoral condyle and the tibial 




classified based upon the pattern of the tear seen during an arthroscopy and 
commonly described patterns include vertical longitudinal, oblique, complex, 
transverse and horizontal (Figure 1.4)(Greis et al., 2002). Traumatic tears 
usually occur in younger active individuals and the meniscus often splits 
vertically and parallel to the collagen fibres, which is known as a vertical 
longitudinal tear, or perpendicular to the collagen fibres, commonly known as 
a transverse or radial tear, these are associated with increased risk of knee OA 
(Englund et al., 2009). Degenerative tears are often described as horizontal 
cleavages, flaps (oblique), complex tears or meniscal maceration or destruction 
and are associated with older aged individuals, who already have degenerative 
diseases, such as OA, and occur due to pre-existing structural changes in the 
meniscus due to early-stage OA (Noble and Hamblen, 1975; Englund, 2009). 
Meniscal tears cause prominent mechanical symptoms in OA such as buckling 










Another change in the meniscus during OA is meniscal subluxation, which is 
defined as a protrusion over the edge of the tibial plateau whereby pressure 
within the joint forces the meniscus to displace (Breitenseher et al., 1997).  This 
causes distension of the capsule and retraction of the meniscotibial and 
meniscofemoral ligaments resulting in retraction of the meniscus from its 
original position (Breitenseher et al., 1997). Meniscal displacement and 
extrusion has also been associated with joint space narrowing which is 
observed on radiographs in OA (Adams et al., 1999; Gale et al., 1999). As well 
as morphological changes to the menisci during OA there are also changes to 
the internal structure (Herwig et al., 1984). Examination of the ECM in OA 
menisci shows that during early degeneration there is a reduction in the 
diameter of collagen fibres and an increase in water content from 70% to 85% 
to fill the gaps created by this in the matrix (Adams et al., 1983; Herwig et al., 
1984). Collagen fibres start to split initially on the surface and fibril bundles 
decrease until they are no longer recognisable (Herwig et al., 1984; 
Katsuragawa et al., 2010). Similarly to OA in articular cartilage, cells within the 
meniscus start to form clusters, particularly in the surfaces where the meniscus 
is most damaged (Katsuragawa et al., 2010). This continuous damage and 
reduction in the collagen fibrils causes the ECM to fill with fluid, resulting in 
overall thickening of the meniscus (Herwig et al., 1984; Katsuragawa et al., 
2010). Changes to the macrostructure of the ECM result in a reduction in 
stability and strength of the menisci, however there are also molecular changes 
which occur, such as the levels of GAGs, which are found to decrease during 




increased water content (Herwig et al., 1984). Normal menisci are rarely found 
in knee joints with OA and are often torn, macerated or totally destroyed 
(Bhattachayya et al., 2003; Englund et al., 2008). A meniscal lesion in a healthy 
knee joint may eventually lead to knee OA because of the loss of meniscal 
function, however knee OA may also lead to meniscal tears (Roos et al., 1995). 
There is also a strong association between meniscal damage and cartilage loss, 
where both are exposed to similar stresses and share similar components 
(Englund, 2009). The active processes in early stage OA lead to cartilage 
destruction and damage to the meniscus, however a tear in the meniscus with 
degenerative changes is often associated with pre-existing structural changes 
in the articular cartilage that are commonly observed in early-onset OA (Noble 
and Hamblen, 1975). It is therefore difficult to conclude whether meniscal 
damage is a cause or a consequence of OA however both are strongly 
associated with each other (Englund, 2009). 
 
1.5.4.4. Ligaments 
Skeletal ligaments are dense bands of collagen fibres that span a joint and 
become anchored to the bone at either end (Frank, 2004). They appear as 
dense white bands of tissue which have unique bony attachments called 
insertions and are usually attached in such a way that is crucial for the 
movement of the ligament and the joint (Frank, 2004; Bray et al., 2005). The 
general function of ligaments within a joint is to provide passive stability to the 




load is applied (Frank, 2004). Other roles include joint homeostasis; due to the 
viscoelastic properties of ligaments, they are able to reduce stress or load on a 
joint by being pulled to a constant deformation, and they are involved in joint 
proprioception where they aid with the perception of the limb position in space 
(Frank, 2004). This is particularly important in the knee joint where the muscle, 
joint and cutaneous receptors provide proprioception and ligaments assist this 
function by invoking neurological feedback signals which activate muscular 
contraction in response to straining of the ligament (Frank, 2004). Ligaments 
are the most fibrous component of the knee joint when compared to meniscus 
and articular cartilage (Eleswarapu et al., 2011). There are three groups of 
major ligaments in the knee joint; the collateral ligaments, the cruciate 
ligaments and the patellar ligament (Eleswarapu et al., 2011). The collateral 
ligaments consist of the medial and lateral collateral ligaments (MCL and LCL) 
which are extracapsular ligaments located on either side of the knee joint (Woo 
et al., 2006). The function of the MCL and LCL are to protect the medial and 
lateral sides of the knee from a contralateral outside or inside bending force, 
respectively (Eleswarapu et al., 2011). The cruciate ligaments, made up of the 
ACL and posterior cruciate ligament (PCL), are intracapsular ligaments, named 
according to their site of attachment to the tibia and, located within the 
capsule, they cross each other obliquely (Woo et al., 2006). The function of the 
ACL and PCL is to stabilise the knee during rotation and bending (Eleswarapu et 
al., 2011). The patellar ligament, sometimes referred to as the patellar tendon, 
is located between the patella and the tibial tubercule (Amiel et al., 1983). Its 




grove and femoral condyles (Eleswarapu et al., 2011). One further ligament, 
only recently described, is the anterolateral ligament (ALL), which is a pearly, 
fibrous band on the anterolateral side of the knee joint connecting the femur 
with the tibia (Claes et al., 2013). The hypothesised function of the ALL was to 
stabilise against internal rotation as it can withstand extreme amounts of 
tension in this manner (Claes et al., 2013). 
 
Ligament alterations during OA cause similar problems to those observed in the 
meniscus in that ligament injury particularly to ACL and MCL have a  
predisposition to OA (Loeser et al., 2012). As well as this, ligament laxity 
associated with hypermobility is also a risk factor for OA (Bird et al., 1978). It is 
also acknowledged that ligaments, particularly the ACL, are often ruptured in 
patients with established OA and examination of 32 ACLs in patients with 
severe OA in one particular study showed 4 with normal ACL, 10 with lax or 
ruptured ACLs and 18 where the ACL was completely missing (Wada et al., 
1999; Watanabe et al., 2011). However, in severe OA it is difficult to determine 
whether ACL degeneration is a consequence of cartilage destruction and 
degradation of the joint or whether a primary lesion within the ACL causes 
articular cartilage damage (Hasegawa et al., 2012). When examining ACLs 
across a range of age groups it has been found that ACL degeneration can occur 
before or progress more rapidly than cartilage degeneration (Hasegawa et al., 
2012). With worsening of the disease there is increased varus-valgus rotation 




clear there is a link between the progression of OA and ACL degradation. There 
is also evidence that the PCL is correlated with disease progression in OA but to 
a lesser degree than the ACL, as severe damage to the ACL occurs in 40% of OA 
knee joints whereas severe PCL damage is seen in only 7% and is very rarely 
completely absent from the joint (Mullaji et al., 2008). The pathology of these 
changes to ligaments during OA has been studied very little, however there are 
known histological changes which occur in the structure of the ligaments during 
OA which have been clearly documented. In OA knee joints, the ACL and PCL 
exhibit changes in their collagen fibre orientation, cystic changes and myxoid 
degeneration as well as mucoid degeneration and loose connective tissue 
(Cushner et al., 2003; Mullaji et al., 2008). Similar changes are observed in 
individuals with early onset hand OA where ligament thickening is also 
observed, this occurs in ligaments during aging and in ligaments in the knee 
during OA (Tan et al., 2006; Arthritis Research UK, 2012). 
 
1.5.4.5. Patella 
The patella is a large flat triangular sesamoid bone located anterior to the knee 
joint within the tendon of the quadriceps femoris muscle (Fox et al., 2012b). 
The patella is coated with its own articular cartilage which has a similar 
structure and the same function as articular cartilage found within the rest of 
the joint, however patellar cartilage has an increased water content and a lower 
proteoglycan content (Froimson et al., 1997). The patella is divided into 3 




transverse ridges (Kwak et al., 1997). The primary function of the patella is to 
improve quadriceps efficiency by increasing the lever arm of the extensor 
mechanism (Grelsamer and Weinstein, 2001). Its second function is to protect 
the anterior aspect to the knee joint, it protects the deeper knee joint and the 
quadriceps tendon from frictional forces. During an increase in patellofemoral 
force an increase in contact pressure would be expected, however the increase 
in contact area during flexion of the patellofemoral joint protects the joint from 
damage (Huberti and Hayes, 1984; Hehne, 1990). In the absence of the patella, 
such as after patellectomy, the quadriceps tendon is found to thin and elongate 
which is believed to be prevented by the presence of the patella (Freehafer, 
1962). 
 
The patella is a key compartment affected in OA and has previously been 
overlooked as OA has been considered a tibiofemoral joint disorder with 
relatively little research into the effects of the patellofemoral compartment 
(Hinman and Crossley, 2007). Similarly to articular cartilage, any damage to the 
patella cartilage disrupts the internal structure of the cartilage resulting in a 
loss of pressure of the internal fluid structure and causing higher stresses on 
the collagen fibres (Ateshian and Hung, 2013). Increased contact stress may 
predispose towards more rapid cartilage degeneration and pain due to 
increased stress on the subchondral bone and the release of cartilage break-
down products causing synovial inflammation (Bellemans, 2003). This loss of 




groove the patella sits in known as the trochlear groove (Saleh et al., 2005). 
Patella malalignment with the femoral trochlea is commonly found in patients 
with patellofemoral joint OA and patella subluxation is found to be highly 
associated with OA pain and disease progression (Hunter et al., 2007). Joints 
with structural changes shown on radiographs in both the tibiofemoral 
compartment and the patellofemoral compartment are more likely to be 
painful and are associated with loss of function when compared to knees where 
only one of these compartments is affected (Szebenyi et al., 2006). 
Patellofemoral OA is found to be present in approximately 41% of early onset 
cases of OA and is classified as a risk factor for progression of tibiofemoral 
osteophytes and joint space narrowing in later stage OA (Mazzuca et al., 2006). 
Dislocation of the patella has been linked to OA as realignment of the extensor 
mechanism after dislocation results in reduced risk of OA in later life (Crosby 
and Insall, 1976). A key indicator of OA is the presence of osteophytes and these 
are also observed in the patellofemoral compartment where they are 
significantly associated with OA pain (Hunter et al., 2003; Kornaat et al., 2006).  
 
1.5.4.6. Synovial joint capsule 
The synovial joint capsule is a liquid-containing cavity enveloped by dense 
fibrous connective tissue and lined with synovium, it forms a sleeve around the 
articulating bones to which it is attached which in the knee is the tibia and the 
femur (Ralphs and Benjamin, 1994; Iwanaga et al., 2000). The wall of the joint 




layer, which is dense fibrous tissue made of bundles of collagen fibres that 
attach to the articulating bones and tendons, sometimes replacing them such 
as in the knee joint where the quadriceps and patellar tendons form the 
anterior portion of the knee joint capsule, and the inner layer which is the 
synovial membrane or synovium and is more cellular in nature (Ralphs and 
Benjamin, 1994; Iwanaga et al., 2000). Nerves and blood vessels are able to 
pass through the joint capsule and there are also gaps where the synovium may 
protrude to form a pouch (Ralphs and Benjamin, 1994). The synovial membrane 
is a soft tissue lining the spaces of the knee joint and is composed of 2 to 3 
layers of specialised cells called synoviocytes (O’Connell, 2000). There are 2 
morphologically different types of synoviocytes; A-cells which are macrophages 
and B-cells which are fibroblast-like cells (Schmidt and Mackay, 1982). A-cells 
are located in the upper part of the synovial tissue nearest to the joint cavity 
and their function is to quickly uptake foreign substances from the joint cavity, 
absorb and degrade these extracellular bodies which may be microorganisms, 
cell debris or antigens, by using their vesicular and lysosomal systems (Ball et 
al., 1964; Southwick and Bensch, 1971; Leach et al., 1988; Iwanaga et al., 2000). 
B-cells are found at a range of depths but more commonly further away from 
the cavity have a secretory function as they secrete collagens, fibronectin and 
other GAGs into the joint cavity (Matsubara et al., 1983; Mapp and Revell, 1985; 
Leach et al., 1988). The joint space in normal joints contain a small amount of 
viscous, transparent fluid called synovial fluid which aims to moisten and 
lubricate the gliding surfaces of the joint as well as supply articular cartilage 




an excellent nerve supply of both thinly myelinated and unmyelinated fibres of 
which there are 2 types; postganglionic sympathetic adrenergic fibres and 
unmyelinated C-fibres (Mapp, 1995). The postganglionic fibres are located 
around the larger blood vessels and are responsible for the flow of articular 
blood, C-fibres, which are responsible for the transmission of pain, are usually 
inactive and are only activated during tissue damage (Mapp, 1995). 
 
Changes to the synovial joint capsule are key features of OA and could also be 
an important contributor to pain in OA. The synovial membrane reacts during 
OA in a number of different ways including synovial hyperplasia where the 
synovial membrane becomes inflamed and thickened which is also known as 
synovitis (Scanzello and Goldring, 2012). In a group of individuals with OA, over 
95% of them are likely to have synovitis present in their joint in both early and 
advanced stages (Roemer et al., 2010). Synovitis in OA encompasses various 
histologic changes including infiltration of macrophages and lymphocytes 
which can be detected in 50% of patients with OA (Pearle et al., 2007). Synovitis 
is associated with subsequent development of cartilage erosion indicating that 
synovial inflammation occurs in early onset OA and predisposes further 
structural progression of the disease (Roemer et al., 2011). Synovitis is also 
correlated with changes in knee pain but not cartilage loss when compared on 
an MRI between the synovial membrane thickening and cartilage loss (Hill et 
al., 2007). Various studies conducted have indicated that synovial inflammation 




increase in their chondropathy score after 1 year or that synovitis is associated 
with an increased risk of fast cartilage loss (Ayral et al., 2005; Roemer et al., 
2009). Angiogenesis, the development of new blood vessels, in OA occurs 
within the synovium and is associated with chronic synovitis, in particular 
macrophage infiltration of the synovium (Haywood et al., 2003). Synovial 
angiogenesis may impair chondrocyte function and affect the homeostasis of 
articular cartilage (Walsh et al., 2007; Mapp et al., 2008). Angiogenesis alone is 
not a cause of pain, however it enables the innervation of tissues and facilitates 
inflammation which in turn contribute to pain in OA (Bonnet and Walsh, 2005). 
Angiogenesis in OA may therefore contribute to both symptoms and disease 
progression (Walsh et al., 2007). In OA joints lymphatic vessels are seen in more 
regions of the synovial membrane rather than just the deep layers (Xu et al., 
2003). OA joints that showed little inflammation presented similar lymphatic 
vessels to normal, however those with inflammation, thickened synovium and 
scatterings of chronic-inflammatory cells the lymphatic vessels were prominent 
in all zones and were either highly dilated or compressed with slit-like lumen 
(Xu et al., 2003). Further inflammatory changes occur in adhesion molecules 
which are expressed by B-cells and may be important in inflammatory arthritis 
by trapping macrophages and lymphocytes within the synovial membrane 
while allowing neutrophils to egress into the synovial fluid (Smith, 2011). These 
additional inflammatory response can in turn sensitise C-fibres located in the 






Figure 1.5. Joint degradation in osteoarthritis (OA) from a normal joint (A) to a joint with mild OA (B) and severe OA (C)(Arthritis Research UK, 
2012). 
 




1.5.5. Pain structures within the knee joint 
The exact source of joint pain after the onset of OA is unknown, although 
several structures within the joint could be the primary cause of pain. 
Nociceptors innervate the joint capsule, ligaments, periosteum, menisci, 
subchondral bone and synovium and pain could therefore arise from any or all 
of these structures within the joint (Malfait and Schnitzer, 2013)(Figure 1.5). 
 
A key feature of OA is degeneration of the articular cartilage, however as 
cartilage is aneural and avascular this structure is unlikely to contribute to pain 
directly (McDougall and Linton, 2012). Correlation between defects in articular 
cartilage and pain in patients is poor, however there are still ways in which 
damage to the cartilage may contribute to pain in OA (Wojtys et al., 1990). One 
way is that nociceptive fibres have been found in the erosion channels running 
through the subchondral plate to the deep surface of the articular cartilage 
where the nerve terminals were observed (Wojtys et al., 1990). During OA 
articular cartilage also becomes vascularised, which in turn leads to innervation 
of the cartilage via these vascular channels and therefore exposing a potential 
source of pain from the cartilage (Suri et al., 2007). 
 
Meniscal changes and damage occurs in 63% of adults with symptomatic knee 
OA including matrix disruption, fibrillation, cell clusters, calcification and cell 
death (Loeser et al., 2012). These morphological changes correlate with those 




The menisci are more intensely innervated towards the outer edges with 
decreasing innervation towards the central thirds which are devoid of 
innervation (Grönblad et al., 1985). However during injury, such as meniscal 
tears which can often result in later development of OA, the meniscus has 
increased levels of vascularisation which is associated with increased sensory 
nerve growth and may contribute to pain (Mine et al., 2000; Ashraf et al., 2010). 
 
Similarly, ligament injury is closely associated with development of OA and 
almost 23% of people with symptomatic knee OA have evidence of complete 
ACL rupture (Loeser et al., 2012). Externally, tenderness is observed in 90% of 
patients in the anterior medial knee joint which is the location of the MCL 
(Ikeuchi et al., 2013). Internal staining of knee ligaments in rabbits and humans 
revealed innervation in the ligaments is comparable between the two species 
but also is closely associated with the vasculature (McDougall et al., 1997). 
Ligaments surrounding the joint are densely populated with myelinated and 
unmyelinated nociceptive fibres making them susceptible to neurogenic 
inflammation and possible centres of articular nociception (McDougall et al., 
1997). 
 
Angiogenesis occurs in the osteochondral junction resulting in a separation of 
the articular cartilage from the subchondral bone forming a “tide-mark” (Loeser 
et al., 2012). These vascular channels have been shown to contain sensory 




pain, as when angiogenesis was inhibited in the osteochondral junction, pain 
behaviour was significantly reduced (Walsh et al., 2010; Ashraf et al., 2011). 
BMLs on MRI are also strongly associated with pain in knee OA (Felson et al., 
2001; Yusuf et al., 2011; Hunter et al., 2013). BMLs are areas that have high-
signals in the medullary space on MRI scans and are thought to represent 
contusions within the marrow (Felson et al., 2001). BMLs are more prevalent in 
those with knee pain than those without it, however there appears to be no 
link to the severity of pain in these individuals therefore showing that OA pain 
has multiple origins (Felson et al., 2001). 
 
Inflammation of the synovium or synovitis occurs in early stages of disease and 
may contribute to OA pain by increasing intra-articular pressure (Schaible and 
Grubb, 1993; Felson, 2006; Yusuf et al., 2011). Nociceptors found in the 
synovium may also be activated by irritation of the nerve endings within the 
synovium, the release of PGs and other inflammatory agents and also by 
osteophytes (Grönblad et al., 1985; Hunter et al., 2013). Whilst there may be 
many factors that contribute to OA pain in the synovium, it is clear that there 
is direct correlation between the two as increased synovitis has been found to 
produce worse pain in subjects with knee OA and that pain changed over time 





1.5.6. Treatment of pain in osteoarthritis 
Pain in OA is currently assessed via questionnaires inquiring about the 
presence, severity and intensity of pain the patient is feeling (Neogi and Felson, 
2013). The most commonly used is the Western Ontario and McMaster 
Universities (WOMAC) index which asks patients about pain, stiffness and 
physical function of their joints, however other pain indices are also used such 
as the Visual Analogue Scale (VAS), Numeric Scale for Pain (NRS Pain) and the 
McGill Pain Questionnaire (MPQ)(Hawker et al., 2011). 
 
Current treatments for OA involve attempting to rectify the mechanical 
malalignment of the joint, repairing joint instability, education about managing 
the condition and alleviating pain, which will be the focus of this section. There 
are various types of treatment for pain in OA such as oral medication, topical 
creams, steroid injections, TENS and surgery as the final resort. Oral medication 
for the treatment of pain in OA is usually found in NSAIDs, cyclooxygenase-2 
(COX-2) inhibitors, cannabinoids, paracetamol/acetaminophen and opioids 
(Felson, 2006). NSAIDs and COX-2 are the most efficacious for treating knee OA 
pain, however whilst they do provide some symptomatic relief they do not 
alleviate pain long-term across the lifespan of the patient (Felson, 2006; 
McDougall and Linton, 2012). High doses of NSAIDs taken over many years can 
lead to toxicity, gastrointestinal bleeding, ulcers and increased risk of heart 
attack and stroke and whilst COX-2 drugs are more specific in their action they 




insomnia (Arthritis Research UK, 2012; Felson, 2006; McDougall and Linton, 
2012). Cannabinoids have been found to be very efficacious in treating OA pain 
however also have centrally-mediated side effects such as motor impairment, 
dizziness, dysphoria, memory loss and possible dependence (McDougall and 
Linton, 2012). Paracetamol, also known as acetaminophen, is considered a first 
action medication in the treatment of OA, in the majority of cases it is self-
medicated and useful for mild to moderate pain (Jordan et al., 2003). Short-
term paracetamol use has been found to very efficacious and it can be safely 
taken long term however its efficacy is questionable for long periods of time 
and there is also controversy over the gastrointestinal safety of using 
paracetamol (Jordan et al., 2003). Opioids are a useful alternative for patients 
who have found NSAIDs or COX-2 drugs ineffective however are not without 
risk as they have high potential for dependency (Jordan et al., 2003). 
 
Topical applications such as capsaicin or NSAIDs are commonly used and well 
tolerated by patients (Jordan et al., 2003). They can be very effective when 
administered regularly and the effects can last for several days (Arthritis 
Research UK, 2012). 
 
Steroid injections are sometimes administered directly into the osteoarthritic 
joint and are usually corticosteroids. They are useful for short term treatment 
of OA pain, have fast onset of pain relief and their effects can last for up to two 





TENS is a non-invasive analgesic technique used for relieving musculoskeletal 
pain where electrical impulses are delivered across the surface of the skin 
(Jones and Johnson, 2009). It is self-administered, inexpensive and useful for 
treating moderate to severe pain with results showing improved motility (Jones 
and Johnson, 2009; Osiri et al., 2009; Arthritis Research UK, 2012). 
 
Surgery in the form of a total joint replacement is used if the pain is very severe 
and motility has become very difficult or impossible (Arthritis Research UK, 
2012). The effectiveness of surgeries such as TKR is very good for those who are 
severely incapacitated however 10 – 20% of patients with knee OA still have 
persistent severe joint pain after surgery (Suokas et al., 2012). 
 
1.5.7. Animal models of osteoarthritis and their similarities to human 
osteoarthritis 
Animal models provide useful tools for investigating the physiological, 
pharmacological and psychological mechanisms of pain (Berge, 2013). There is 
currently no consensus on which animal model best replicates the human 
condition and which might be the most suitable for studying the underlying 
pain mechanisms of human OA (Ameye and Young, 2006; Poole et al., 2010). 
Models are generally developed on how well they mirror the joint structural 




associated pain behaviour in OA (Combe et al., 2004; Fernihough et al., 2004; 
Pomonis et al., 2005; Ferreira-Gomes et al., 2008; Ferland et al., 2011). Models 
of OA are found in a variety of species and their validity is determined by joint 
histopathology (to confirm the presence of the model), physiological 
assessments (e.g. assessing inflammation), pharmacological assessments (e.g. 
drug administration) and behavioural tests (e.g. weight bearing and paw 
withdrawal thresholds (PWTs))(Combe et al., 2004). 
 
1.5.7.1. Models of spontaneously developing osteoarthritis 
Spontaneously occurring OA has been found in the joints of animals including 
guinea pigs, dogs, Syrian hamsters, some strains of mice and non-human 
primates (Bendele, 2001). However these models are limited by the extended 
time frame required to allow them to progress, which can be 18 months for 
severe OA features to develop (Bendele, 2001; Guzman et al., 2003). 
 
The Dunkin Hartley (DH) guinea pig model is considered the most well 
characterised spontaneous OA model with the earliest changes observed at 
approximately 3 months old (Bendele and Hulman, 1988; Bendele, 2001). 
Guinea pigs also indicate a lack of correlation between morphological joint 
degeneration and joint nociception indicating it’s similarity to human OA 
whereby disease severity is a poor predictor of pain (Mcdougall et al., 2009). 
Similar to human OA, spontaneously developing OA in DH guinea pigs is both 




and Hulman, 1991; Jimenez et al., 1997; Mcdougall et al., 2009). Guinea pig 
knee joints are structurally similar to human knee joints and despite being 
much smaller are prone to a spontaneous OA which has a histopathology that 
is very similar to human OA (Jimenez et al., 1997). From early signs of OA at 3 
months to around 18 months old animals exhibit classical histology of OA 
including cartilage degeneration, chondrocyte death, proteoglycan loss, 
fibrillation, osteophytes, degeneration of the menisci, thickening of the 
synovial membranes due to synoviocyte proliferation and sclerosis of the 
subchondral bone affecting gait and extension of the knee joint (Bendele, 
2001). Guinea pigs reach skeletal maturity at approximately 4 months of age 
when bone stops growing, giving them an advantage over other spontaneous 
models and they are very docile and easy to care for (Gregory et al., 2012). 
However, guinea pigs are renowned for their sedentary lifestyle making 
studying the role of exercise in OA very difficult and despite the clinical 
relevance of this model, the severity and onset of OA cannot be controlled 
between animals (Schuelert and McDougall, 2009). The major disadvantages 
with this model are that first signs of OA only appear after 3 months, prolonging 
both the time and cost of any study which is undertaken, and it is difficult to 
identify an adequate control for aged animals as all animals will develop 
bilateral OA making pain behaviour tests unsuitable. 
 
Some mice strains are able to spontaneously develop OA, the causes of which 




2002). All aging mice develop medial compartment cartilage degeneration; 
however it is only in some animals that this progresses to OA (Bendele, 2001). 
Degeneration begins to develop in the medial compartment of the knee at 
around 6 months old which can become severe with full thickness cartilage loss 
and large osteophytes by the time the mice are 15 months old (Bendele, 2001). 
One particular strain, the STR/ort strain, is prone to OA with lesions developing 
around 10-20 weeks, starting with cartilage degeneration in the medial tibial 
plateau and eventual exposure of the subchondral bone, resulting in joint 
instability (Mason et al., 2001). By 35 weeks old, 85% of mice have developed 
OA lesions (Gaffen et al., 1995). With the mouse having a fully sequenced 
genome, these models are excellent for investigating the genetic component of 
OA and the genotypic-phenotypic relationships in OA and have been used for 
this purpose extensively and with much success (Gregory et al., 2012). 
However, mouse knee joints are very small, making them difficult to study, 
especially when investigating load and biomechanic involvement in OA 
(Glasson et al., 2010). Another issue with spontaneous OA models in mice is 
that mouse knee cartilage is very thin compared to other mammals which 
makes grading cartilage lesions very difficult due to lack of cartilage cell layers 
(Simon, 1970; Glasson et al., 2010). 
 
Naturally occurring OA is considered to be the most common form of joint 
disease in dogs with an estimated 20% of cases resulting in euthanasia 




developmental features to that observed in human OA with notable signs of 
pain including lameness and physical disability (Vainio, 2012). Dogs as young as 
1 year old can develop OA and it is estimated that 20% of dogs over this age 
suffer from OA (Johnston, 1997). Similar to spontaneous mouse OA, non-
human primates develop OA due to an unidentified genetic predisposition, 
however it is also age related with older animals exhibiting the most severe 
lesions (Carlson et al., 1996; Brandt, 2002). OA is found to be most severe in 
the medial plateau and is characterised by articular cartilage fibrillation, clefting 
and eventual loss as well as thickening of the subchondral bone (Carlson et al., 
1996). Naturally occurring OA in monkeys make an excellent model for studying 
human OA as the changes in articular cartilage and subchondral bone are very 
similar to that observed in human OA, although body weight is not found to be 
correlated with severity of disease (Carlson et al., 1994, 1996). However, both 
dogs and non-human primates need to be housed in specialist facilities where 
they are able to be group housed and require the studies to be very long lasting, 
especially if age-related OA is to be investigated, making these studies very 
expensive (Gregory et al., 2012). As well as this, public perception of studies in 
these animals makes these models difficult to use (Gregory et al., 2012). 
 
1.5.7.2. Chemical models of osteoarthritis 
The most widely used chemical model of OA pain is the monosodium 
iodoacetate (MIA) model whereby MIA (typically 1 – 3mg) is administered as an 




(Dunham et al., 1992; Guingamp et al., 1997; Schaible, 2013). MIA is a glycolysis 
inhibitor, specifically, it inhibits activity of glyceraldehyde-3-phophate 
dehydrogenase (G3PD), inducing chondrocyte death (Guzman et al., 2003; 
Sagar et al., 2014). This model mimics the behavioural, pathological and 
pharmacological features associated with human OA, including synovial 
inflammation, chondropathy and osteophytosis (Bove et al., 2003; Mapp et al., 
2013). Intra-articular injection of MIA disrupts chondrocyte metabolism 
resulting in OA-like lesions characterised by chondrocyte necrosis, cell-cloning 
(chondrones), fibrillation and erosion of the cartilage to expose the 
subchondral bone (Bove et al., 2003; Combe et al., 2004). As early as 1 day after 
injection of MIA, inflammatory signs of OA are apparent with more structural 
pathology of OA becoming evident after 14 days and resembling human OA 
after 20 days (Schaible, 2013; Mapp et al., 2013; Nwosu et al., 2016b). Changes 
in pain behaviour associated with weight bearing and gait in MIA injected 
animals can be observed from as early as day 1 post-MIA injection indicating a 
rapid onset of OA-like symptoms (Bove et al., 2003). The MIA model can be 
therapeutically treated with analgesics which reduces pain behaviour 
representing the alleviation of joint pain observed in human OA (Bove et al., 
2003; Sagar et al., 2014). This model has prominent osteophytes making it ideal 
for studying their induction and formation and as well as mimicking the pain, 
biochemical and structural changes of OA, it is also relatively low cost to 
implement and easy to induce (Bendele, 2001; Ameye and Young, 2006; 
Gregory et al., 2012). The MIA model can be easily induced compared to other 




be used in a variety of species including rat, mouse, chicken, horse, guinea pig 
and rabbit, making it highly versatile (Janusz et al., 2001; Bove et al., 2003; 
Gregory et al., 2012; Sagar et al., 2014). This model is also a rapid onset model 
which can exhibit severe OA in short periods of time, this is both an advantage 
for the time frame of studies and a disadvantage as it strays from the condition 
in human OA where disease progression occurs at a much slower rate (Janusz 
et al., 2001). Therefore this model does not mimic the early mechanisms of 
cartilage damage in human OA (Sagar et al., 2014). 
 
1.5.7.3. Surgical models of osteoarthritis 
There are a number of surgical OA models with many of them being widely 
used, including the ACL transection (ACLT) model in dogs and rodents (Ameye 
and Young, 2006). ACLT requires a small surgical incision to expose the knee 
joint and dislocation of the patella, the ACL is then transected (Stoop et al., 
2000). This transection results in instability within the joint causing OA lesions 
that mimic naturally occurring OA but also OA following injury in humans 
(Bendele, 2001; Hayami et al., 2006). The lesions produced take extended 
periods of time to progress to OA and so allow the study of developing OA and 
therefore larger dogs are often used to increase the cartilage degeneration 
(Bendele, 2001). This model shows early changes in articular cartilage and 
subchondral bone as well as other key features of OA such as osteophytes and 
eventually functional loss of the joint (Ameye and Young, 2006; Gregory et al., 




occurring, however due to the slow progression of disease, length of time for 
the study is a key disadvantage (Bendele, 2001). ACLT models are also unhelpful 
if an assessment of pain behaviour is required as these animals do not develop 
weight bearing deficiencies or mechanical allodynia (Ferland et al., 2011). 
 
The meniscal transection (MNX) model requires transection of the MCL 
followed by a half or full thickness cut through the medial meniscus (Sagar et 
al., 2014). This model is useful because it mimics human injury such as meniscal 
tears which are common sports injuries and gives an accelerated severity of OA 
(Sagar et al., 2014). Similarly to the ACLT, this model can be implemented in a 
number of species such as rats, guinea pigs, rabbits, dogs, sheep, mice and 
goats (Bendele, 2001; Gregory et al., 2012). This model is a rapidly progressive 
with cartilage degeneration characterised by chondrocyte and proteoglycan 
loss as well as fibrillation, and chondrocyte cloning (Bendele, 2001). As well as 
significant cartilage damage within 3 weeks post-surgery, MNX animals show 
changes in the subchondral bone by day 7 which are similar to the lesions seen 
in human OA (Bove et al., 2006). By 14 days post-surgery the presence of 
osteophytes can be observed as well as synovitis and increasing chondropathy 
(Mapp et al., 2013). Despite the usefulness of this surgical model it is more 
technically demanding, requires sham-operated controls and characteristically 
has a more rapid onset of disease making looking at early onset or progression 





1.6. Experimental objectives and hypotheses 
Previous work in DNIC has notably focussed on single cell dorsal horn 
recordings and whilst this is an excellent tool for investigating DNIC at the level 
of the spinal cord this thesis aims to utilise nociceptive withdrawal reflex 
responses measured from hindlimb muscles as an alternative to develop the 
field of DNIC. This novel work considered the effects of DNIC at the periphery 
measuring a whole population response whereby both the sensory and motor 
component were considered as well as the effect of modifications from 
interneurons. This is particularly important as DNIC likely reflects the net 
balance between descending inhibitory and facilitatory signalling (Patel and 
Dickenson, 2019). 
 
1.6.1. Chapter 3 
Chapter 3 explored DNIC and the factors affecting DNIC and were to confirm 
that the evoked inhibition was of an adequate size for the experiments to be 
undertaken. These initial experiments ensured that the methodology was 
working, and that the inhibition could be evoked but also was the inhibition 
that was intended to evoke. This was important to determine for the 
background of the rest of the experiments in this thesis and was therefore 
fundamental to undertake for the development of the thesis.  The objectives of 




1. Investigate the ability of capsaicin to evoke DNIC of spinal reflexes from 
different sites of application and to determine its concentration-effect 
to find a dose that caused significant, non-transient inhibition. 
• The hypothesis for these experiments was that the largest dose 
would induce the greatest and longest lasting inhibition of 
reflexes. 
2. Determine whether DNIC of reflexes originated entirely from 
descending supraspinal pathways or whether a spinal component was 
also involved. 
• The hypothesis was that spinalization would abolish the 
observed inhibition. 
3. Assess the contribution of higher brain structures to DNIC of reflexes 
(i.e. regions rostral to the superior colliculi). Hence DNIC would be 
lessened if frontal structures were involved in DNIC. 
• The hypothesis was that DNIC would not be affected by the 
removal of forebrain structures. 
4. Determine the effect of alfaxalone anaesthesia on DNIC by reducing the 
anaesthesia levels. As anaesthesia is known to have strong influences 
on spinal reflexes it was important to acknowledge the effects the 
anaesthesia had on both the spinal reflexes and the induced inhibition 
in the current experiments as this has not previously been investigated. 
• The hypothesis was that DNIC inhibition would be greater in the 




5. Compare different modalities of test stimulus (graded mechanical 
versus electrical) to determine the sensitivity of reflexes evoked by 
these two modalities to inhibition by a fixed capsaicin conditioning 
stimulus. The premise was that more ‘natural’ graded mechanical 
stimuli would allow clearer analysis of the relationship between the test 
and conditioning stimuli as well as providing the sensitivity needed to 
detect changes in DNIC in subsequent studies using the OA model. The 
test and conditioning stimuli are closely linked and whilst many studies 
have looked at different modalities of test stimulus and a range of 
conditioning stimuli few studies have directly compared the induced 
inhibition across different modalities. 
• The hypothesis for these experiments was that a more noxious 
test stimulus (i.e. electrical stimulation) would be inhibited to a 
lesser degree than less noxious (i.e. mechanical) stimulation. 
 
1.6.2. Chapter 4 
In Chapter 4 DNIC of spinal reflexes was investigated in the MIA model of OA 
pain. The objective of these experiments was to determine whether efficacy of 
DNIC of spinal reflexes was altered in the MIA model 28-35 days after induction, 
hence provide evidence for OA-induced changes in reflex responses due to 
modified descending inhibition. To increase the possibility of detecting what 
may be subtle changes in DNIC in ‘normal’ versus OA groups both mechanical 




responses and two concentrations of capsaicin were evaluated in terms of the 
conditioning stimulus.  
• The hypothesis of these experiments was that MIA animals 
would have a reduced level of inhibition post-capsaicin 
injection. Either by a reduction in magnitude of the inhibition, a 
reduction in the duration of inhibition or of the overall 
inhibition. 
 
1.6.3. Chapter 5 
Chapter 5 investigated an acute OA pain state by exploring DNIC in the MIA 
model 3-4 days post-injection. The objective of these experiments was to 
investigate whether the efficacy of DNIC was altered in a 3-4 day MIA model of 
OA pain. Similarly to Chapter 4, these novel experiments measured from 
nociceptive withdrawal reflexes in the MIA model however this chapter also 
allowed the effect of inflammation in the periphery on DNIC to be determined. 
• The hypothesis of these experiments was that MIA animals 
would not have a reduced level of inhibition post-capsaicin 
injection, as these central changes are expected to occur much 













All procedures were performed in accordance with the UK Animals (Scientific 
Procedures) Act 1986 Amendment Regulations 2012, the European Directive 
2010/63/EU and UK Home Office regulations under project licence 30/3156. All 
experiments undertaken were with the approval of the University of 
Nottingham’s Animal Welfare & Ethical Review Body (AWERB) and reported in 
accordance with the Animal Research: Reporting of In Vivo Experiments (ARRIVE) 
guidelines. 
 
Male Sprague Dawley rats (n = 167, 100 – 150 g and 250 – 275 g) were obtained 
from Charles River (Kent, UK) and housed on a 12 hour light-dark cycle at 19 – 
23 °C and 55 ± 10% relative humidity with up to four animals per cage. Animals 
were provided with ad libitum access to food and water as well as 
environmental enrichment in the form of tunnels and chew sticks. 
 
2.2. Electrophysiology 
2.2.1. Surgical preparation for electrophysiological recordings 
All animals underwent the following preparatory surgery prior to 











Rats were deeply anaesthetized until a loss of righting reflex was observed in 
an anaesthetic chamber using inhalation of 3% isoflurane (IsoFlo; Abbott 
Laboratories, Maidenhead, UK) in a 2:1 mixture of nitrous oxide (N2O) and 
oxygen (O2)(flow rates 1.2 L min-1 and 0.6 L min-1 respectively). Animals were 
then transferred to a nose cone where anaesthesia was maintained using 2 – 
2.5% isoflurane in N2O/O2 (flow rates 0.8 L min-1 and 0.4 L min-1 respectively). 
Core body temperature was maintained at 37.5 ± 0.5 °C via a thermostatically-




Sterilization of surgical instruments was performed to make the procedure 
more aseptic using Virusolve+ Concentrate solution (5% dilution in reverse 
osmosis (RO) water; Clinipath Equipment Limited, Hull, UK) for a minimum of 
30 minutes prior to surgery. Instruments were then rinsed in RO water prior to 
use. Virusan gel (Clinipath Equipment Limited, Hull, UK) was also applied to 
non-sterile gloves periodically throughout the procedure to maintain sterility.  
 
Animals were placed in a supine position, hair overlying the throat was 
removed and a Rosse sterile drape placed over the animal (The Vet Store, 




solution (5% dilution in RO water; Clinipath Equipment Limited, Hull, UK) and 
injected subcutaneously with local anaesthetic (3 x 5 µl injections of 2.0% w/v 
solution lignocaine hydrochloride, Lignol®; Dechra Veterinary Products, 
Hadnall, UK) to minimise nociceptive input at the site of the incision. Depth of 
anaesthesia was checked by pinching the skin overlying the trachea, if no 
reaction was observed, surgery then continued. An incision approximately 3 cm 
long was made in the skin along the line of the trachea and the subcutaneous 
fat and connective tissue over the trachea separated via blunt dissection. 
Additional lignocaine solution (10 µl) was injected directly into the sternohyoid 
muscle before it was bisected to reveal the trachea beneath. The trachea was 
cannulated by inserting 1.5 cm of the cannula into the trachea (Portex, fine bore 
polythene cannula, 2.4 mm outside diameter, 1.7 mm internal diameter, ~5.5 
cm long; Scientific Laboratory Supplies Ltd, Nottingham, UK) to maintain the 
airway and so that anaesthesia could be continued via a direct connection to 
this cannula. 
 
Approximately 1 cm of the left carotid artery was cleared of surrounding 
connective tissue and separated from the vagus nerve via blunt dissection, then 
cannulated (Portex, iv cannula, outside diameter 1.0 mm, 30 cm long; Scientific 
Laboratory Supplies Ltd, Nottingham, UK) to allow constant measurement of 
arterial blood pressure. Prior to insertion the cannula was filled with 10 IU mL-
1 heparinised Ringer solution to prevent blood clotting. The left jugular vein was 




cannula filled with Ringer solution (Portex, iv cannula, outside diameter 0.7 
mm, 30 cm long; Scientific Laboratory Supplies Ltd, Nottingham, UK) for 
administration of intravenous (i.v.) anaesthetic. 
 
After cannulation was complete, a small amount of haemostatic gelatin sponge 
(SpongostanTM; Ferrosan Medical Devices, Søborg, Denmark) was placed 
around each vessel and the trachea to stem any bleeding and 50 µl of 5% 
Eutectic Mixture of Local Anaesthetics (EMLA) cream (2.5% lidocaine and 2.5% 
prilocaine, EMLATM; AstraZeneca, Luton, UK) was applied to the incised muscle 
and skin. The skin at the neck incision was then sutured (size 5-0; Harvard 
Apparatus, Kent, UK) to secure the cannulae in place and prevent dehydration 
of the underlying tissue. 
 
2.2.1.3. Earthing electrode 
A section of hair was removed over the upper lumbar vertebrae and after 
swabbing with Virusolve+ Concentrate solution, a 1-2 cm midline incision was 
made in the skin. A silver-silver chloride earth pellet was inserted into the 
exposed muscle and sutured in place. EMLA cream was placed on the incised 
area and the skin sutured. In the spinalized preparation (section 3.2.2.1) the 





2.2.1.4. Cardiovascular recording 
Two needle (length 16 mm, 25-gauge) electrodes were inserted into the 
subcutaneous tissue either side of the chest to record an electrocardiogram 
(ECG). These were connected to an amplifier and triggered an instantaneous 
rate meter (Neurolog NL253; Digitimer Ltd, Hertfordshire, UK). Arterial blood 
pressure measurements were made using a pressure transducer (NL108A; 
Digitimer Ltd, Hertfordshire, UK) attached to the carotid artery cannula. Both 
ECG and blood pressure were recorded on a computer running Spike2 software 
for Windows (version 3; Cambridge Electronic Design (CED), Cambridge, UK) via 
a CED micro1401 interface. 
 
2.2.1.5. Maintenance of anaesthesia 
Following the completion of surgical methodology, animals were transferred to 
an i.v. administration of 10 mg mL-1 alfaxalone (Alfaxan®; Jurox UK Ltd, Crawley, 
UK) anaesthesia for the duration of electrophysiological recordings. An initial 
bolus dose of 3.0 ml hr-1 was administered via the jugular cannula using a 
constant rate infusion (CRI) until a slight drop in blood pressure was observed. 
At this point, isoflurane anaesthesia and N2O were immediately ceased, 
alfaxalone administration was reduced to an appropriate rate and oxygen was 
reduced to a flow rate of 0.2 L min-1 for the duration of the experiment. The 
rate of alfaxalone anaesthesia was determined by the weight of the animal, 





2.2.2. Stimulation and recording 
2.2.2.1. Reflex recording 
The majority of hair was removed from the left hindlimb and paired, 
percutaneous, varnish-insulated copper wire electrodes were inserted into 
three hindlimb muscles; the ankle extensor medial gastrocnemius (MG), the 
ankle flexor tibialis anterior (TA) and the knee flexor biceps femoris (BF) using 
a 25 mm, 23-gauge needle. 
 
Signals were amplified (NeuroLog NL104A, x5000; Digitimer Ltd, Hertfordshire, 
UK), filtered (NeuroLog NL125; Digitimer Ltd, Hertfordshire, UK), digitised (CED 
analogue-digital converter, 1401) and sent to a computer running Signal version 
2.08 (CED) to be averaged and integrated. 
 
2.2.2.2. Reflex stimulation 
Hindlimb NWRs were evoked using either electrical or mechanical stimuli. 
Stimulation was applied every 2 minutes alternatively to the heel and toes, 
resulting in a heel stimulation every 4 minutes. Baseline activity was recorded 
for both electrical and mechanical stimulation. For electrical stimuli, before 
each ‘live’ stimulus train, an additional eight sweeps of data were taken with 
the stimulator switched off to enable subtraction of baseline activity; for 
mechanical stimulation, a 3 second period of baseline activity prior to von Frey 




determined before each experiment and were defined as a single motor unit 
action potential. For electrical stimulation this was established by increasing 
the stimulus strength until a constant response was observed and for 
mechanical stimulation the threshold was determined as the first von Frey 
weight to evoke a response. 
 
2.2.2.2.1. Electrical stimulation 
Electrical stimuli were administered via paired stainless steel 27-gauge needle 
electrodes separated by 2 mm inserted into the plantar skin of the foot at the 
heel and lateral toe. Electrical stimuli were delivered as eight constant current 
pulses of 2 ms duration at 1 Hz using AMPI Isoflex stimulators. The stimulus 
strength was dependent on the threshold of the reflex response but had a 
maximum intensity of 10 mA (for further details see specific results chapter). 
The minimum stimulation strength required to evoke a reflex electromyogram 
(EMG) response in one of the appropriate muscles was recorded as the 
stimulation threshold. Stimulation strengths in each experiment were 
determined based on the requirement to evoke control responses that had the 
capacity to increase as well as decrease in size. Using Signal software, the eight 
electrical responses were averaged up to 250 ms (Figure 2.2). Using positioned 
cursors measurements of the area under the peaks was taken for the A-fibre 
responses (approximately 0.005 – 0.03 seconds) for each of the three muscles, 




Figure 2.2. Example Signal data trace of electrically-evoked reflex response recorded in a naïve rat after stimulation to the toes. Responses are 





2.2.2.2.2. Mechanical stimulation 
Mechanical stimuli were also used to evoke reflex responses via vF 
monofilaments (Ugo Basile, Varese, Italy) where a range of monofilaments (10 
g, 26 g, 60 g, 100 g, 180 g and 300 g) were applied to the skin at the heel and 
lateral toe for 3 seconds each.  In accordance with previous studies, MG was 
recorded in response to stimulation of the heel and BF and TA in response to 
stimulation of the toes (Harris and Clarke, 2003). Using Signal software cursors 
were positioned at the start of the response which was identified using 
keyboard markers inserted at the time the vF monofilament was applied and at 
the end of the three second period the monofilament was applied (Figure 2.3). 
For each three second region the root mean square (RMS) amplitude of the 
waveform response was analysed. This analysis integrates both A- and C-fibre 
responses. 
 
2.2.2.3. Analysis of responses 
For both electrically and mechanically stimulated responses the baseline 
responses (see section 2.2.2.2) were subtracted from the reflex response and  





Figure 2.3. Example Signal data trace of mechanically-evoked reflex response using von Frey (vF) monofilaments 10 g, 26 g, 60 g, 100 g, 180 g 
and 300 g (represented by 1-6) recorded in a naïve rat after stimulation to the toes. Responses are observed in biceps femoris (BF) and tibialis 




2.2.3. Conditioning stimulus 
After measuring stable reflex responses for at least 30 minutes following the 
switch to alfaxalone anaesthesia (section 2.2.1.5), three control reflex 
responses were recorded and a conditioning (DNIC) stimulus was applied to one 
of two stimulus sites; the contralateral carpi radialis muscle (forelimb injection) 
or contralateral MG muscle (hindlimb injection) see section 3.2.1 for full details 
on the capsaicin conditioning stimulus. 
 
Reflex responses were then measured for a minimum of 60 minutes to 
determine the effect of the conditioning stimulus on reflexes. Following 
stabilization of responses, a second injection of capsaicin was given to the site 
not previously stimulated and reflexes were again measured for at least one 
hour. The order of the site receiving the first capsaicin injection was alternated 
between experiments. 
 
Subsequently, after recording had been completed, animals were euthanised 
by overdose of pentobarbital sodium anaesthesia administered via the jugular 
vein cannula. Death was confirmed by cessation of heart rate using carotid 






2.3. Statistical analyses 
Prior to any analysis, all data was tested for adherence to a normal distribution 
using the Kolmogorov-Smirnov normality test. Data was tabularised using 
Excel® for Office 365 (version 1908; Microsoft®, Washington, USA) and all 
statistical analyses were performed in Prism® software (version 7.05; GraphPad 
Software Inc, California, USA). 
 
2.3.1. Control parameters for electrophysiology 
Weight, anaesthetic and reflex response threshold and stimulation (for 
electrical stimulation) parameters were all found to be not normally 
distributed, therefore were analysed using a non-parametric Mann-Whitney or 
Kruskal-Wallis with Dunn’s multiple comparisons test for comparisons between 
groups. Data for weight and anaesthetic parameters are expressed as mean and 
errors are standard error of means (SEMs). Reflex response threshold and 
stimulation values are expressed as medians and errors are interquartile ranges 
(IQRs). 
 
Control reflex responses were calculated as an average of the 3 responses 
directly before any capsaicin was applied and found to be not normally 
distributed, therefore were analysed using a non-parametric Mann-Whitney or 




between groups. Control reflex responses are expressed as medians and errors 
are IQRs. 
 
2.3.2. Effect of capsaicin 
Reflex response data was found to be not normally distributed, therefore, in all 
experiments, reflex responses were normalised to produce the mean of the 
pre-capsaicin control (3 readings prior to hindlimb or forelimb capsaicin 
application) and the control levels were expressed as 100%. In each 
experimental group, data are presented as medians and the scatter of 
responses are indicated by the IQRs of the median values. In individual groups, 
effect of capsaicin on each reflex response over the post-injection time period 
was analysed using Friedman’s ANOVA with Dunn’s multiple comparisons test, 
citing values for inhibition of heel-MG and toes-BF or TA reflexes at 17 min and 
19 min post-capsaicin time points respectively. 
 
Median duration of inhibition or facilitation were calculated by determining 2 
standard deviations (SDs) above and below each time point for individual 
experiments to ascertain when responses were outside this range. These were 
then analysed using a non-parametric Mann-Whitney or Kruskal-Wallis test 





At individual time points significance between groups was established by using 
multiple pairwise, non-parametric Mann-Whitney or Kruskal-Wallis test with 
Dunn’s multiple comparisons test, which were cited on graphical figures. 
 
Area under the curve (AUC) values were calculated in Prism using a baseline 
value of 100% and as the region of interest was inhibition of reflex responses 
only negative peaks were evaluated in this analysis. Area of negative peaks was 
found to be normally distributed therefore were analysed between groups 
using a parametric unpaired t-test, one-way ANOVA with Tukey’s multiple 








3. Factors influencing diffuse noxious 
inhibitory controls of nociceptive withdrawal 






DNIC is an endogenous spino-bulbospinal pain modulatory pathway occurring 
when a response from one noxious (test) stimulus is inhibited by another 
distant noxious (conditioning) stimulus (Le Bars et al., 1979a);  studying DNIC 
can therefore give an important insight into the integrity of these endogenous 
descending analgesic pathways. However the degree and longevity of DNIC can 
be affected by gender, age, species, levels of physical activity and sleep patterns 
(Edwards et al., 2003; Baad-Hansen et al., 2005; Edwards et al., 2009; Naugle 
and Riley, 2014), and experimentally, DNIC is similarly dependent on a number 
of factors - the test/conditioning stimuli, spinal cord integrity and anaesthesia 
- which have therefore been investigated in the following studies. 
 
DNIC relies heavily on the relationship between the test and conditioning 
stimuli. Previous studies have therefore used a variety of conditioning stimulus 
modalities to evoke DNIC including mechanical pinch, noxious heat or cold, and 
chemicals such as bradykinin (Le Bars et al., 1979a), often versus thermal, 
electrical and mechanical evoked test responses measured in single dorsal horn 
neurons or in the trigeminal nucleus caudalis of the brain (Le Bars et al., 1979a; 
Dickenson et al., 1980; Schouenborg and Dickenson, 1985). Where reflexes 
have been used as the test response they have been evoked using a mechanical 
pressure applicator to the surface of the hind paw coupled with a capsaicin 
injection to the fore paw (Da Silva et al., 2018) or by electrical stimulation using 




following studies it was important that the effect of the DNIC conditioning 
stimulus was significant and not transient hence there is a great deal of 
evidence to suggest that chemical stimuli evoke a greater degree and longer-
lasting inhibition (Le Bars et al., 1979a; Dickenson et al., 1980; Gjerstad et al., 
1999). To this end intramuscular injection of the noxious irritant capsaicin (8-
methyl-N-vanillyl-6-nonenamide) is a direct method of delivering a powerful 
inhibitory agent and a dose of 200 µg has been previously shown to induce 
maximal inhibition within 15 minutes of injection with the effects lasting up to 
and beyond 1 hour (Gjerstad et al., 1999). With respect to the test stimulus, 
electrical stimulation evokes clear reflex responses and allows quantitative 
measurement of the strength of stimulation (Danziger et al., 1999). However 
electrical impulses to the skin recruit all nerve fibre types simultaneously which 
is not the normal physiological response. Mechanical stimulation of the skin 
surface using graded von Frey monofilaments give a more physiologically 
natural stimulation with A-fibres being initially activated followed by the slower 
C-fibre response (Bishop, 1946). 
 
Anatomically, it is believed DNIC originates in the brainstem and higher brain 
(see section 1.3.1) centres (Bouhassira et al., 1990, 1992a, 1992b, 1993) as 
sectioning the spinal cord has been found to completely abolish the inhibitory 
effects of DNIC (Le Bars et al., 1979b). However some studies have suggested 
there is also a segmental spinal component to DNIC as some inhibition of test 




stimulus (Fitzgerald, 1982; Cadden et al., 1983). The SRD is believed to be the 
primary region of DNIC action however other regions which are not located in 
the brainstem have also been evaluated. One such region is the infralimbic 
cortex (ILC) located in the pre-fontal cortex which can exert pronociceptive 
facilitation via the SRD which is increased during pain states however whilst it 
is clearly involved in DNIC it is unlikely to be a direct involvement (Patel and 
Dickenson, 2019). Experiments conducted in decerebrated animals therefore 
allow the contribution to DNIC of areas rostral to the colliculi to be assessed 
and spinalization will determine any segmental component to DNIC of spinal 
reflexes. 
 
Pre-clinical neurological studies aim to aid understanding of mechanisms 
underlying chronic pain and are frequently carried out in whole animal models, 
therefore often with the requirement of anaesthesia. However high levels of 
anaesthesia are known to inhibit spinal, hence reflex, excitability as well as 
affecting DNIC (Cervero et al., 1991; Jinks et al., 2003a, 2003b; Arendt-Nielsen 
et al., 2008). Alfaxalone is a neuroactive steroid anaesthetic that heightens the 
effects of the endogenous inhibitory neurotransmitter GABA by binding to its 
ionotropic GABAA receptors (Harrison and Simmonds, 1984). Alfaxalone is an 
excellent choice of anaesthesia for its safety, reduced cardiopulmonary 
depression, lack of pain on injection and very few side effects (Child et al., 1972; 
Michou et al., 2012; Knotek et al., 2013; Santos González et al., 2013; Warne et 




permits reflex responses making it an ideal anaesthesia for electrophysiological 
studies and as such has been used previously for reflex measurements (Clarke 
and Matthews, 1985; Kelly et al., 2013b; Hunt et al., 2016). However, the effect 




Experiments were performed on a total of 66 naïve male Sprague-Dawley rats 
(mean weight 366 g, range 269 – 496 g) housed as previously described (section 
2.1). Under isoflurane in N2O/O2, animals were prepared for 
electrophysiological recording of reflex responses using surgical procedures 
described in section 2.2.1, although some animals also underwent additional 
procedures (decerebration, spinalization) which are described in detail below. 
After switching to alfaxalone anaesthesia (see section 2.2.1.5), reflex recording 
of heel-MG, toes-BF and toes-TA responses to either electrical or mechanical 
(test) stimuli was performed as described in section 2.2.2.1. 
 
3.2.1. Study 1: Effect of capsaicin concentration on DNIC of reflexes 
Initial experiments investigated the optimum concentration of capsaicin to use 
as the conditioning stimulus in order to cause consistent inhibition that was of 
a large enough amplitude to measure but that also showed a certain degree of 




previous studies (Kelly et al., 2013a), a dose of 500 µg was chosen for one group 
(n = 9) whilst 10-fold lower and higher concentrations were used in two other 
experimental groups i.e. 50 µg (n = 10) and 5mg (n = 6) capsaicin. 
 
The three necessary capsaicin stock solutions were prepared by diluting 250 
mg, 25 mg and 2.5 mg (E)-Capsaicin (Tocris, Bristol, UK) in Tween80 and 
absolute ethanol (1:1, 0.25 ml: 0.25 ml) to produce concentrations of 500 mg 
ml-1, 50 mg ml-1 or 5 mg ml-1 respectively. The chosen stock solution was then 
diluted 10-fold with Ringer’s solution just prior to injecting 100 µl 
intramuscularly into either the contralateral forelimb or the contralateral 
hindlimb using a 25-gauge needle (see section 2.2.3). 
 
3.2.2. Study 2: Effect of capsaicin in decerebrated or spinalized animals 
Based on the findings of Study 1, 500 µg was chosen as the capsaicin dose for 
subsequent experiments in naïve animals due to consistency of inhibition 
following hind- or forelimb injection as well as recovery of reflexes over the 60 
minute recording period (section 3.3.1.2). 
 
3.2.2.1. Spinalization 
In order to spinalize animals (n = 10) a laminectomy was performed as follows. 
The hair was removed over the lower thoracic vertebrae and, after swabbing 




midline approximately 1-2 cm in length. Blunt dissection of the superficial fascia 
exposed the latissimi dorsi muscles, which were cut away from the spinous 
processes using a scalpel. Rongeurs were used to remove muscle from the 
vertebral bones between T8 and T10 and then the T8 and T9 vertebrae were 
removed to expose the spinal cord. Using sharp surgical scissors, a small incision 
was made in the dura mater which was extended to further expose the spinal 
cord. A small amount of local anaesthetic (200 µl of 5% EMLA) was applied prior 
to a transverse cut to section the spinal cord. Spongostan soaked in lidocaine 
was then inserted into the gap in the spinal cord to ensure a complete section 
was maintained and cotton wool soaked in Ringer’s solution was placed on and 
around the spinal cord to keep exposed surfaces moist. The muscle and skin 
overlying the laminectomy were then sutured together. 
 
3.2.2.2. Decerebration 
A subset of naïve animals were decerebrated (n = 9) using the methodology of 
Dobson and Harris (2012) which is outlined below. Firstly, as an additional step 
during neck surgery (see section 2.2.1.2), the right carotid artery was exposed 
in the same way as the left, but rather than being ligated, it was reversibly 
occluded using an artery clip; this was to temporarily reduce blood flow to the 
head during the decerebration process hence reduce bleeding. 
 
Decerebration itself consisted of shaving most of the scalp, performing a 




sagittal and transverse sutures of the skull. Two 3 mm holes were bored in the 
cranium either side of the sagittal suture and midway between the coronal and 
transverse sutures using a micro-drill (Minicraft MB150; Electron Electronics, 
Betchwork, UK). These initial holes were extended using rongeurs up to the 
transverse suture, leaving the sagittal suture intact. Rostral and caudal ligatures 
(size 3-0; Harvard Apparatus, Kent, UK) were inserted around the parietal bones 
to occlude the superior sagittal sinus, and the parietal bone region between the 
ligatures was then removed using rongeurs. The dura mater was cut using sharp 
scissors and retracted to expose the cerebral hemispheres. Aspiration of the 
dorsal cerebral cortex was performed using a 1.65 mm (outer diameter) 
cannula attached to a vacuum pump (New Askir 20 electric surgical suction 
pump; CA-MI, Pilastro, Italy) in a caudal to rostral stroking motion until the 
rostral edge of the colliculi were visible. Rapid and complete aspiration of brain 
tissue rostral to the colliculi was then performed. With suction still in place to 
cope with any bleeding from the basilar artery and/or cavernous sinus, a 
cuboidal piece of Spongostan soaked in tissue adhesive (3M Vetbond; Animal 
Care Products, York, UK) was pressed firmly downwards at the rostral edge of 
the colliculi to occlude any ruptured vessels and prevent further bleeding. 
Further Spongostan soaked in tissue adhesive was then inserted into the 
remaining cavity to encourage haemostasis. Pre-warmed to 37 °C, paraffin oil 
(Sigma-Aldrich, Dorset, UK) was then poured into the cranial cavity to prevent 
dehydration of the exposed brain tissue and the skin overlying the skull was 
clipped together. The vessel clip was removed from the right carotid artery to 





3.2.3. Study 3: Effect of alfaxalone level on DNIC of reflexes 
Experiments were performed in animals decerebrated using the protocol 
outlined above (section 3.2.2.2). Alfaxalone anaesthesia was maintained using 
a 10-fold lower concentration than normal of 1 mg mL-1 by diluting with Ringer’s 
solution (n = 13). 
 
3.2.4. Study 4: Effect of DNIC on mechanically-evoked reflexes 
In naïve intact animals (n = 9) mechanical stimuli were used to evoke reflex 
responses via application of a range of vF monofilaments. These are applied to 
the skin surface until the fibre starts to bend, and once this occurs, the force 
applied stays almost constant even if the fibre is bent further (Fruhstorfer et 
al., 2001). Individual monofilaments (10 g, 26 g, 60 g, 100 g, 180 g and 300 g) 
were applied in succession for 3 seconds each alternately to either the skin at 
the heel or the lateral toe at 2 min intervals. In accordance with previous 
studies using electrical stimuli, MG was recorded in response to stimulation of 







3.3.1. Study 1: Effect of capsaicin concentration on DNIC of reflexes 
 
3.3.1.1. Control parameters for electrophysiology 
3.3.1.1.1. Weight and anaesthetic levels 
Weights of animals were taken on the day of electrophysiology with mean 
values being 350 ± 11 g (n = 10), 369 ± 5 g (n = 9) and 380 ± 18 g (n = 6) for 50 
µg, 500 µg and 5 mg treatment groups respectively; no significant difference 
was found between the three groups (p = 0.3383, Kruskal-Wallis test). 
Following an initial bolus dose (see section 2.2.1.5), alfaxalone anaesthesia was 
maintained using a CRI which for 50 µg, 500 µg and 5 mg groups was at a mean 
rate of 51.81 ± 1.76 mg kg-1 hr-1, 48.523 ± 1.94 mg kg-1 hr-1 and 50.08 ± 0.57 mg 
kg-1 hr-1 respectively; again there was no significant difference between the 











Median threshold (mA) 
Median stimulation strength 
(mA) 
Heel-MG Toes-BF/TA Heel-MG† Toes-BF/TA 
50 µg 
(n = 10) 
4.15 
(2.50 – 5.15) 
0.50 
(0.40 – 0.94) 
9.00 
(8.13 – 9.63) 
7.50 
(5.50 – 8.25) 
500 µg 
(n = 9) 
5.30 
(3.35 – 7.80) 
0.50 
(0.28 – 1.45) 
10.00 
(10.00 – 10.00) 
4.00 
(1.70 – 7.00) 
5 mg 
(n = 6) 
3.45 
(3.08 – 3.78) 
0.40 
(0.28 – 0.65) 
8.50* 
(6.60 – 9.00) 
8.00 
(5.38 – 8.25) 
 
Table 3.1. Median electrical stimulation parameters for heel-medial 
gastrocnemius (MG) and toes-biceps femoris (BF) or tibialis anterior (TA) 
reflexes for groups subsequently injected with 50 µg, 500 µg or 5 mg capsaicin. 
Values in brackets are interquartile ranges. †p < 0.05 denotes significant 
difference between groups (Kruskal-Wallis test). *p < 0.05 compared to 500 µg 





No significant differences were found in the electrical threshold values for toes-
BF/TA or heel-MG responses between the three capsaicin groups (p > 0.05, 
Kruskal-Wallis test; Table 3.1). Similarly no significant group differences were 
found for toes-BF/TA stimulation strengths (p > 0.05, Kruskal-Wallis test), 
however there was a significant difference regarding the stimulation strength 
for evoking heel-MG reflexes (p = 0.0161, Kruskal-Wallis test) with animals to 
be injected with 500 µg being stimulated at a higher strength than those to be 
given 5 mg (p = 0.0146, Dunn’s multiple comparisons test). 
 
When pooled across the three dosage groups, median electrical stimulation 
threshold values were significantly higher for heel-MG compared to toes-
BF/TA, responses being 3.85 mA (IQR 2.93 – 5.7 mA) and 0.40 mA (IQR 0.40 – 
0.95 mA) respectively (p < 0.0001, Mann-Whitney test). Consequently, the 
median stimulation strength for evoking measurable heel-MG reflexes was also 
significantly higher than for toes-BF/TA at 9.0 mA (IQR 8.13 – 10.0 mA) 
compared to 6.0 mA (IQR 4.0 – 8.0 mA) respectively (p < 0.0001, Mann-Whitney 
test). 
 
3.3.1.1.3. Control reflex responses 
Median control responses prior to capsaicin injection for each of the three 
reflexes were compared between groups and no significant differences were 







Median control reflex response (µV.ms) 
Heel-MG Toes-BF Toes-TA 
50 µg 
(n = 10) 
92 
(59 – 155) 
171 
(97 – 310) 
52 
(35 – 104) 
500 µg 
(n = 9) 
74 
(34 – 121) 
259 
(111 – 484) 
102 
(61 – 206) 
5 mg 
(n = 6) 
68 
(34 – 101) 
99 
(51 – 189) 
86 
(51 – 208) 
 
Table 3.2. Median control responses to electrical stimulation for heel-medial 
gastrocnemius (MG), toes-biceps femoris (BF) and toes-tibialis anterior (TA) 
reflexes prior to administration of 50 µg, 500 µg or 5 mg capsaicin. Values in 
brackets are interquartile ranges. Between groups there was no significant 






3.3.1.2. Effect of capsaicin 
3.3.1.2.1. Injection into the contralateral hindlimb 
Within the group of animals to receive the 500 µg dose of capsaicin, one animal 
had small and inconsistent heel-MG responses, therefore these data were not 
included in the following analysis of this reflex. Significant inhibition to a 
median of 72% (IQR 61 – 77%) of pre-capsaicin controls and for a median 
duration of 61 min (IQR 37 – 61 min) was induced in heel-MG responses using 
the largest 5 mg (n = 6) capsaicin dose (p = 0.0088, Friedman’s ANOVA; Figure 
3.1A), however no significant inhibition was apparent using lower 50 µg (n = 10) 
and 500 µg (n = 8) doses (p = 0.6116 and p = 0.3347 respectively, Friedman’s 
ANOVA). Further comparison of the dose-dependence of inhibition using 
negative AUC analysis did not further reveal any significant difference between 
the groups (p = 0.7178, one-way ANOVA; Figure 3.2A). 
 
Significant inhibition was produced in toes-BF responses to a median of 64% 
(IQR 45 – 76%) and 8% (IQR 6 – 50%) of controls by 50 µg (n = 10) and 500 µg 
(n = 9) capsaicin injections respectively (p = 0.0005 and p < 0.0001 respectively, 
Friedman’s ANOVA; Figure 3.1B), however, although a decrease in responses 
appeared to be present following the largest 5 mg (n = 6) dose, this was not 
statistically significant (p = 0.1078, Friedman’s ANOVA). Median duration of 
inhibition was 55 min (IQR 32 – 63 min) and 63 min (IQR 41 – 63 min) for 50 µg 
and 500 µg capsaicin respectively which was not significantly different (p = 




significant difference in overall inhibition between 50 µg, 500 µg and 5 mg 
doses (p = 0.0382, one-way ANOVA; Figure 3.2B). 
 
Significant inhibition was induced in toes-TA responses by 50 µg (n = 10) and 
500 µg (n = 9) capsaicin doses to a median of 66% (IQR 51 – 77%) and 13% (IQR 
0 – 63%) of controls respectively (p = 0.0016 and p = 0.0003 respectively, 
Friedman’s ANOVA; Figure 3.1C); however again, even though median 
responses appeared to be reduced following the largest 5 mg (n = 6) dose, this 
was not significant (p = 0.1218, Friedman’s ANOVA). Median duration of 
inhibition was not significantly different between 50 µg and 500 µg doses being 
49 min (IQR 6 – 57 min) and 63 min (IQR 36 – 63 min) respectively (p = 0.1227, 
Mann-Whitney test). Analysis of negative AUC values further supported a 
significant difference in overall inhibition between groups (p = 0.0126, one-way 






Figure 3.1. Effect of intramuscular injection of 50 µg, 500 µg or 5 mg capsaicin 
into the contralateral hindlimb on electrically evoked (A) heel-medial 
gastrocnemius (MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior 
(TA) reflexes. Values plotted are medians and errors are interquartile ranges. 
*p < 0.05 or **p < 0.01 denotes significant difference in inhibition between 50 





Figure 3.2. Effect of intramuscular injection of 50 µg (n = 10), 500 µg (n = 9) or 
5 mg (n = 6) capsaicin into the contralateral hindlimb on electrically evoked (A) 
heel-medial gastrocnemius (MG), (B) toes-biceps femoris (BF) and (C) toes-
tibialis anterior (TA) reflexes. Values plotted are area under curve (AUC) 
determinations for each animal, with horizontal bars indicating medians and 
interquartile ranges. *p < 0.05 or **p < 0.01 denotes significant difference in 




3.3.1.2.2. Injection into the contralateral forelimb 
Significant inhibition to a median of 72% (IQR 70 – 83%) of pre-capsaicin 
controls and for a median duration of 55 min (IQR 4 – 61 min) was induced in 
heel-MG responses using the largest 5 mg (n = 6) dose (p = 0.0327, Friedman’s 
ANOVA; Figure 3.3A). However, no inhibition was induced at 50 µg (n = 10) and 
500 µg (n = 9) doses (p = 0.1730 and p = 0.2357 respectively, Friedman’s 
ANOVA). Further comparison using negative AUC also indicated a significance 
difference in overall inhibition between the three doses (p = 0.0403, one-way 
ANOVA; Figure 3.4A). 
 
Significant inhibition was induced in toes-BF responses using 50 µg (n = 10), 500 
µg (n = 9) and 5 mg (n = 6) capsaicin doses to medians of 76% (IQR 42 – 92%), 
14% (IQR 7 – 29%) and 39% (IQR 6 – 70%) of controls respectively (p = 0.0001, 
p < 0.0001 and p = 0.0001 respectively, Friedman’s ANOVA; Figure 3.3B). 
Median duration of inhibition was significantly different across the three 
groups being 29 min (IQR 16 – 44 min), 63 min (IQR 63 – 63 min) and 51 min 
(IQR 20 – 63 min) for 50 µg, 500 µg and 5 mg respectively (p = 0.0066, Kruskal-
Wallis test) with specific differences indicated between 50 µg and 500 µg (p = 
0.0046, Dunn’s multiple comparisons test). Analysis of negative AUC values also 
supported this significance difference in overall inhibition between doses (p = 





Significant inhibition was induced in toes-TA responses using 50 µg ( n= 10), 500 
µg (n = 9) and 5 mg (n = 6) capsaicin concentrations to medians of 74% (IQR 52 
– 91%), 14% (IQR 11 – 16%) and 40% (IQR 7 – 68%) of controls respectively (p = 
0.0197, p < 0.0001 and p = 0.0001 respectively, Friedman’s ANOVA; Figure 
3.3C). Median duration of inhibition following 50 µg, 500 µg and 50 mg 
capsaicin was 33 min (IQR 0 – 63 min), 63 min (IQR 47 – 63 min) and 57 min 
(IQR 29 – 63 min) respectively but these values were not significantly different 
between the three dosages (p = 0.1001, Kruskal-Wallis test). Similarly analysis 
of negative AUC values supported a significant difference in overall inhibition 






Figure 3.3. Effect of intramuscular injection of 50 µg, 500 µg or 5 mg capsaicin 
into the contralateral forelimb on electrically evoked (A) heel-medial 
gastrocnemius (MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior 
(TA) reflexes. Values plotted are medians and errors are interquartile ranges. 
*p < 0.05 or **p < 0.01 denotes significant difference in inhibition between 50 
µg and 500 µg; #p < 0.05 between 50 µg and 5mg and †p < 0.05 between 500 





Figure 3.4. Effect of intramuscular injection of 50 µg (n = 10), 500 µg (n = 9) or 
5 mg (n = 6) capsaicin into the contralateral forelimb on electrically evoked (A) 
heel-medial gastrocnemius (MG), (B) toes-biceps femoris (BF) and (C) toes-
tibialis anterior (TA) reflexes. Values plotted are area under curve (AUC) 
determinations for each animal, with horizontal bars indicating medians and 
interquartile ranges. *p < 0.05, or ***p < 0.001 denotes significant difference 




3.3.1.2.3. Effect of capsaicin injection site 
Comparison of inhibition of heel-MG, toes-BF or toes-TA responses due to 
hindlimb or forelimb injections at each capsaicin dosage indicated no significant 
differences between these sites in terms of depth of inhibition, duration (in 
each case p > 0.05, Mann-Whitney test) or overall inhibition (i.e. AUC analysis; 





3.3.2. Study 2: Effect of capsaicin in decerebrated or spinalized animals 
Note that throughout this section, data will be compared to that obtained in 
intact animals administered 500 µg capsaicin in Study 1.  
 
3.3.2.1. Control parameters 
3.3.2.1.1. Weight and anaesthetic levels 
Weights of animals were measured on the day of electrophysiology and mean 
values were 371 ± 7 g (n = 10) and 345 ± 19 g (n = 9) for spinalized and 
decerebrate animals respectively; in comparison, the mean weight of intact 
animals was 369 ± 5 g (n = 9). No significant difference was found between 
groups (p = 0.2745, Kruskal-Wallis test). Following an initial bolus dose (see 
section 2.2.1.5), alfaxalone anaesthesia was maintained using a CRI which for 
spinalized and decerebrate animals was at a mean rate of 45.10 ± 1.76 mg kg-1 
hr-1 and 43.58 ± 0.78 mg kg-1 hr-1 respectively and again when compared to 
intact animals (48.23 ± 1.94 mg kg-1 hr-1), there was no significant difference 










Median threshold (mA) 
Median stimulation strength 
(mA) 
Heel-MG Toes-BF/TA Heel-MG † Toes-BF/TA 
Intact 
(n = 9) 
4.60 
(3.55 – 7.60) 
0.50 
(0.28 – 1.45) 
10.00 
(10.00 – 10.00) 
4.00 
(1.70 – 7.00) 
Spinalized 
(n = 10) 
1.10** 
(0.78 – 2.28) 
0.80 
(0.50 – 0.98) 
6.50 
(4.75 – 8.50) 
7.00 
(4.35 – 9.25) 
Decerebrate 
(n = 9) 
1.10** 
(0.53 – 1.45) 
0.60 
(0.53 – 0.70) 
4.00** 
(3.00 – 5.00) 
7.00 
(3.50 – 8.00) 
 
Table 3.3. Median electrical stimulation parameters for the heel-medial 
gastrocnemius (MG) and toes-biceps femoris (BF) or tibialis anterior (TA) 
reflexes for intact, spinalized and decerebrate animal preparations. Values in 
brackets are interquartile ranges. †p < 0.05 denotes significant difference 
between groups (Kruskal-Wallis test). **p < 0.01 denotes significant difference 





Median electrical threshold values were significantly different between the 
three groups for heel-MG reflexes (p = 0.0005, Kruskal-Wallis test), with both 
spinalized and decerebrate animals indicated as having significantly lower 
thresholds than intact animals (p = 0.0042 and p = 0.0010 respectively, Dunn’s 
multiple comparisons test; Table 3.3). In contrast, no significant difference was 
found between preparations for toes-BF/TA thresholds (p = 0.3011, Kruskal-
Wallis test). Consequently, significant differences in heel-MG stimulation 
strengths were evident between the three preparations (p = 0.0017, Kruskal-
Wallis test) with lower stimulation strengths used in decerebrated compared 
to intact animals (p = 0.0011, Dunn’s multiple comparisons test). Stimulation 
strengths used to evoke toes-BF/TA reflexes were not significantly different 
between the three groups (p = 0.1097, Kruskal-Wallis test). 
 
3.3.2.1.3. Control reflex responses 
Control reflex responses for heel-MG were significantly different between the 
three preparations (p = 0.0370, Kruskal-Wallis test; Table 3.4); although no 
specific differences were indicated by the post-test, decerebrate animals had 
considerably higher control responses than intact and spinalized animals. 
Similarly control reflexes for toes-BF were significantly different between the 
three preparations (p = 0.0207, Kruskal-Wallis test), but in contrast to heel-MG 
responses, smaller responses were present in decerebrate and spinalized 
groups compared to intact animals, with only the latter indicating a significant 




seemed to be seen for toes-TA control reflex responses although no significant 







Median control reflex responses (µV.ms) 
Heel-MG† Toes-BF† Toes-TA 
Intact 
(n = 9) 
74 
(34 – 121) 
259 
(111 – 484) 
102 
(61 – 206) 
Spinalized 
(n = 10) 
79 
(53 – 183) 
79* 
(41 – 108) 
52 
(44 – 95) 
Decerebrate 
(n = 9) 
173 
(105 – 367) 
87 
(57 – 125) 
75 
(45 – 112) 
 
Table 3.4. Median control responses to electrical stimulation for heel-medial 
gastrocnemius (MG), toes-biceps femoris (BF) and toes-tibialis anterior (TA) 
reflexes prior to administration of capsaicin in intact, spinalized or decerebrate 
animals. Values in brackets are interquartile ranges. †p < 0.05 denotes 
significant difference between groups (Kruskal-Wallis test). *p < 0.05 denotes 






3.3.2.2. Effect of capsaicin 
3.3.2.2.1. Injection into the contralateral hindlimb 
Similar to heel-MG reflex responses in intact (n = 8) animals (section 3.3.1.2.1), 
500 µg capsaicin produced no significant inhibition in spinalized (n = 10) or 
decerebrate (n = 9) animals (p = 0.7032 and p = 0.6192 respectively, Friedman’s 
ANOVA; Figure 3.5A). Further comparison of preparations using negative AUC 
analysis confirmed no significant difference between the groups (p = 0.1672, 
one-way ANOVA; Figure 3.6A). 
 
For toes-BF responses, decerebrate (n = 9) animals were significantly inhibited 
(p < 0.0001, Friedman’s ANOVA; Figure 3.5B) by 500 µg capsaicin to a median 
of 33% (IQR 8 – 46%) of controls with inhibition lasting for a median duration 
of 63 min (IQR 63 – 63 min); this compares to values of 8% (IQR 6 – 50%) and 
63 min (IQR 41 – 63 min) in intact (n = 9) animals, with duration of inhibition 
not being significantly different between these two groups (p = 0.2941, Mann-
Whitney test). In contrast, no significant capsaicin-induced change in responses 
was observed in spinalized (n = 10) animals (p = 0.7521, Friedman’s ANOVA). 
Analysis of negative AUC values supported a significant difference in overall 
inhibition between intact, spinalized and decerebrate groups (p = 0.0002, one-
way ANOVA; Figure 3.6B) with significance indicated between spinalized 
animals and both intact and decerebrate groups (p = 0.0007 and p = 0.0011 





Following capsaicin injection, significant inhibition was observed in toes-TA 
responses in decerebrate (n = 9) animals to a median of 23% (IQR 15 – 50%) of 
controls (p < 0.0001, Friedman’s ANOVA; Figure 3.5C) and inhibition was 
maintained for a median duration of 63 min (IQR 49 – 63 min); this compares 
to  intact animals (n = 9) in which these reflexes were inhibited to 13% (IQR 0 – 
63%) of controls and for a median duration of 63 min (IQR 35 – 63 min) which 
was not significantly different (p = 0.9240, Mann-Whitney test) to 
decerebrates. Again, no significant inhibition was observed in spinalized (n = 
10) animals (p = 0.0730, Friedman’s ANOVA). Analysis of negative AUC values 
also indicated a significant difference in overall inhibition between the intact, 
spinalized and decerebrate groups (p = 0.0010, one-way ANOVA; Figure 3.6C) 
with these differences again indicated between spinalized animals and both 
intact and decerebrate groups (p = 0.0015 and p = 0.0065 respectively, Tukey’s 






Figure 3.5. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral hindlimb on electrically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) and toes-tibialis anterior (TA) reflexes 
in intact, spinalized and decerebrate animals. Values plotted are medians and 
errors are interquartile ranges. Dashed line indicates intact data from Study 1. 
*p < 0.05, **p < 0.01 or ***p < 0.001 denotes a significant difference in 
inhibition between spinal and intact and #p < 0.05 between spinal and 





Figure 3.6. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral hindlimb on electrically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) and toes-tibialis anterior (TA) reflexes 
in intact (n = 9), spinalized (n = 10) and decerebrate (n = 9) animals. Values 
plotted are area under curve (AUC) determinations for each animal, with 
horizontal bars indicating medians and interquartile ranges. **p < 0.01 or ***p 
< 0.001 denotes significant difference in inhibition between preparations 




3.3.2.2.2. Injection into the contralateral forelimb 
No significant inhibition of heel-MG reflexes was induced by capsaicin in 
decerebrate (n = 9) animals (p = 0.5815, Friedman’s ANOVA; Figure 3.7A); 
although responses had appeared to be reduced by this capsaicin dose in intact 
animals (section 3.3.1.2.2), again this was not significant. In contrast significant 
facilitation of MG responses was induced by capsaicin in spinalized (n = 10) 
animals to a median of 121% (IQR 107 – 184%) of controls (p = 0.0009, 
Friedman’s ANOVA). Further comparison of preparations using negative AUC 
analysis indicated a significant difference in overall inhibition between intact, 
spinalized and decerebrate animals (p = 0.0002, one-way ANOVA; Figure 3.8A) 
with these differences indicated between intact and both spinalized and 
decerebrate groups (p = 0.0004 and p = 0.0008 respectively, Tukey’s multiple 
comparisons test). 
 
After capsaicin injection into the contralateral forelimb, significant inhibition 
was observed in toes-BF responses in decerebrate (n = 9) animals to a median 
of 33% (IQR 28 – 73%) of controls (p < 0.0001, Friedman’s ANOVA; Figure 3.7B) 
and for a median duration of 51 min (IQR 33 – 63 min); in intact animals, 
inhibition had been to 14% (IQR 7 – 29%) of controls and duration was 63 min 
(IQR 63 – 63 min) and this was not significantly different to decerebrates (p = 
0.0701, Mann-Whitney test). In contrast capsaicin caused significant facilitation 
of toes-BF reflexes in spinalized (n = 10) animals to a median of 121% (IQR 117 




negative AUC supported an overall significant difference between intact, 
spinalized and decerebrate groups (p < 0.0001, one-way ANOVA; Figure 3.8B) 
with differences indicated between intact and decerebrate, spinalized and 
decerebrate as well as spinalized and intact groups (p = 0.0347, p = 0.0008 and 
p < 0.0001 respectively, Tukey’s multiple comparisons test). 
 
For toes-TA responses, significant inhibition was caused by capsaicin in 
decerebrate (n = 9) animals to a median of 29% (IQR 19 – 39%) of controls (p < 
0.0001, Friedman’s ANOVA; Figure 3.7C) and for a median duration of 51 min 
(IQR 25 – 61 min); corresponding values in intact animals were 8% (IQR 0 – 23%) 
and 63 min (IQR 47 – 63 min) which were not significantly different to 
decerebrates (p = 0.2081, Mann-Whitney test). No significant inhibition was 
caused by capsaicin in spinalized (n = 10) animals (p = 0.5864, Friedman’s 
ANOVA). Analysis of negative AUC also indicated a significant overall difference 
in inhibition between intact, spinalized and decerebrate groups (p < 0.0001, 
one-way ANOVA; Figure 3.8C) with post-tests indicating the differences 
between spinalized and both intact and decerebrate groups (p < 0.0001 and p 






Figure 3.7. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral forelimb on electrically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes in 
intact, spinalized and decerebrate animals. Values plotted are medians and 
errors are interquartile ranges. Dashed line indicates intact data from Study 1. 
*p < 0.05, **p < 0.01, ***p < 0.001 or ****p < 0.0001 denotes a significant 
difference in inhibition between spinal and intact; #p < 0.05 or ##p < 0.01 
between spinal and decerebrate and †p < 0.05 or ††p < 0.01 between intact 





Figure 3.8. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral forelimb on electrically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) and toes-tibialis anterior (TA) reflexes 
in intact (n = 9), spinalized (n = 10) and decerebrate (n = 9) animals. Values 
plotted are area under curve (AUC) determinations for each animal, with 
horizontal bars indicating medians and interquartile ranges. *p < 0.05, ***p < 
0.001 or ****p < 0.0001 denotes significant difference in inhibition between 




3.3.2.2.3. Effect of capsaicin injection site 
Comparison of the effect of hindlimb and forelimb capsaicin injection sites for 
inducing inhibition of heel-MG and toes-BF reflexes indicated a significant 
difference between sites in spinalized preparation (p = 0.0089 and p = 0.0115 
respectively, Mann-Whitney test) due to the forelimb injection causing 
significant facilitation; for heel-MG responses this disparity between injection 
sites was supported by a significant difference in overall ‘inhibition’ when 
comparing negative AUC values (p = 0.0499, unpaired t-test). However, no 
difference between injection sites was found for inhibition of toes-TA reflexes 
(depth, duration or overall level) in spinalized animals or for any reflex in 





3.3.3. Study 3: Effect of alfaxalone level on DNIC of reflexes 
Throughout this section, data will be compared to that obtained in decerebrate 
animals administered 500 µg capsaicin under 10-fold higher ‘normal’ levels of 
alfaxalone in Study 2. 
 
3.3.3.1. Control parameters 
3.3.3.1.1. Weight and anaesthetic levels 
Decerebrate animals maintained under low (~10 fold lower) alfaxalone levels 
had mean weights of 366 ± 10 g (n = 13), which compared to decerebrate 
animals exposed to normal alfaxalone levels (345 ± 19 g; n = 9), were not 
significantly different between groups (p = 0.2998, Mann-Whitney test). 
Following an initial bolus dose (see section 2.2.1.5), alfaxalone anaesthesia was 
administered at a mean rate of 43.58 ± 0.78 mg kg-1 hr-1 and 4.86 ± 0.07 mg kg-
1 hr-1 for normal and low alfaxalone decerebrate groups respectively which, as 











Median threshold (mA) 
Median stimulation strength 
(mA) 
Heel-MG Toes-BF/TA Heel-MG Toes-BF/TA 
Normal alfaxalone 
(n = 9) 
1.10 
(0.53 – 1.45) 
0.60 
(0.53 – 0.70) 
4.00 
(3.00 – 5.00) 
7.00 
(3.50 – 8.00) 
Low alfaxalone 
(n = 13) 
0.40*** 
(0.30 – 0.50) 
0.30**** 
(0.20 – 0.40) 
1.00*** 
(0.80 – 1.35) 
1.00**** 
(0.70 – 1.35) 
 
Table 3.5. Median electrical stimulation parameters for the heel-medial 
gastrocnemius (MG) and toes-biceps femoris (BF) or tibialis anterior (TA) 
reflexes for normal and low alfaxalone groups. Values in brackets are 
interquartile ranges. ***p < 0.001 or ****p < 0.0001 compared to normal 





Median electrical threshold values were significantly different between groups 
for heel-MG (p = 0.0003, Mann-Whitney test; Table 3.5) and toes-BF/TA (p < 
0.0001, Mann-Whitney test) reflexes with normal alfaxalone animals having 
significantly higher thresholds than low alfaxalone animals. Consequently, 
significantly higher stimulation strengths were required under normal 
alfaxalone conditions in order to evoke measurable reflexes in heel-MG (p = 
0.0001, Mann-Whitney test) and toes-BF/TA (p < 0.0001, Mann-Whitney test). 
 
3.3.3.1.3. Control reflex responses 
The size of heel-MG control reflexes prior to capsaicin injection was not 
significantly different between normal and low alfaxalone groups despite the 
median response seeming to be larger in the latter group (p = 0.5123, Mann-
Whitney test; Table 3.6). In contrast, toes-BF and toes-TA control responses 
were both significantly larger in the low alfaxalone group compared to animals 






Median control reflex responses (µV.ms) 
Heel-MG Toes-BF Toes-TA 
Normal alfaxalone 
(n = 9) 
173 
(105 – 367) 
87 
(57 – 125) 
75 
(45 – 112) 
Low alfaxalone 
(n = 13) 
261 
(119 – 542) 
299**** 
(250 – 748) 
219**** 
(154 – 798) 
 
Table 3.6. Median control responses to electrical stimulation for heel-medial 
gastrocnemius (MG), toes-biceps femoris (BF) and toes-tibialis anterior (TA) 
reflexes prior to administration of 500 µg capsaicin in normal and low 
alfaxalone groups. Values in brackets are interquartile ranges. ****p < 0.0001 





3.3.3.2. Effect of capsaicin 
3.3.3.2.1. Injection into the contralateral hindlimb 
Although no significant inhibition of heel-MG responses occurred under normal 
levels of alfaxalone (n = 9; section 3.3.2.2.1), significant inhibition to a median 
of 28% (IQR 9 - 104%) of controls was seen in the low alfaxalone group (n = 11; 
p < 0.0001, Friedman’s ANOVA; Figure 3.9A). Median duration of inhibition was 
57 mins (IQR 5 – 61 mins). Direct comparison of the degree of inhibition at the 
same post-capsaicin time points for the normal and low alfaxalone groups did 
not quite reach significance at any point (p > 0.05, Mann-Whitney test). 
Although negative AUC values also suggested a sizable disparity in overall 
inhibition between normal and low alfaxalone groups this did not reach 
significance (p = 0.1472, unpaired t-test; Figure 3.10A). 
 
Significant inhibition was induced by capsaicin in toes-BF responses to a median 
of 5% (IQR 1 – 17%) of controls under low alfaxalone (n = 11; p < 0.0001, 
Friedman’s ANOVA; Figure 3.9B) which lasted a median duration of 63 min (IQR 
63 – 63 min). This compared to a median inhibition of 33% (IQR 15 – 51%) and 
duration of 63 min (IQR 63 – 63 min) under normal (n = 9) alfaxalone conditions 
(section 3.3.2.2.1). Between these two alfaxalone levels no significant 
differences were found in median duration of inhibition (p > 0.9999, Mann-
Whitney test). Analysis of negative AUC values also found no significant 
difference in overall inhibition between the normal and low alfaxalone groups 





Significant inhibition was observed in toes-TA responses under low (n = 11) 
alfaxalone conditions to a median of 11% (0 – 33%) of pre-capsaicin controls (p 
< 0.0001, Friedman’s ANOVA; Figure 3.9C) which lasted for a median duration 
of 63 min (IQR 63 – 63 min). Compared to data obtained under normal 
alfaxalone levels (inhibition to 23% (IQR 15 – 50%) of controls lasting for 63 min 
(IQR 49 – 63 min) there was no significant difference (p = 0.5573, Mann-
Whitney test). Comparison of inhibition at the same time points also found no 
significant differences (p > 0.05, Mann-Whitney test) as was the case when 






Figure 3.9. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral hindlimb on electrically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes in 
normal and low alfaxalone groups. Values plotted are medians and errors are 
interquartile ranges. Dashed line indicates normal alfaxalone data from Study 
2. *p < 0.05 denotes significant difference in inhibition between alfaxalone 





Figure 3.10. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral hindlimb on electrically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) and toes-tibialis anterior (TA) reflexes 
in normal (n = 9) and low alfaxalone (n = 11) animals. Values plotted are area 
under curve (AUC) determinations for each animal, with horizontal bars 




3.3.3.2.2. Injection into the contralateral forelimb 
Similar to the effect of capsaicin in decerebrates under normal alfaxalone levels 
(section 3.3.2.2.2), no significant inhibition of heel-MG reflexes was induced 
under low alfaxalone (n = 10) conditions (p = 0.1372, Friedman’s ANOVA; Figure 
3.11A). Similarly, analysis of negative AUC values indicated a significant 
difference in overall inhibition between the normal and low alfaxalone groups 
(p = 0.0101, unpaired t-test; Figure 3.12A). 
 
Significant inhibition of toes-BF responses following capsaicin injection was 
observed under low (n = 10) alfaxalone conditions to a median of 11% (IQR 6– 
43%) of controls (p = 0.0111, Friedman’s ANOVA; Figure 3.11B) and the median 
duration of inhibition was 63 min (IQR 63 – 63min). This compares a median 
inhibition of 33% (IQR 28 – 73%) and duration of 51 min (IQR 33 – 63 min) under 
normal alfaxalone conditions (section 3.3.3.2.2). Although duration of 
inhibition was not significantly different (p = 0.0851, Mann-Whitney test). 
Analysis of negative AUC values further supported a significant alfaxalone-
dependent difference in overall inhibition (p = 0.0473, unpaired t-test; Figure 
3.12B). 
 
Similar to toes-BF responses, significant capsaicin-induced inhibition in toes-TA 
reflexes occurred under low (n = 10) alfaxalone conditions to a median of 22% 
(IQR 6 – 57%) of controls (p = 0.0009, Friedman’s ANOVA; Figure 3.11C), with 




normal alfaxalone levels, inhibition had been to 40% (IQR 13 – 68%) of controls 
and for a median duration of 51 min (IQR 25 – 61 min; section 3.3.2.2.2); 
comparison of duration of inhibition found a significant difference between 
normal and low alfaxalone groups (p = 0.0409, Mann-Whitney test). Analysis of 
negative AUC values however was not able to detect a significant difference 






Figure 3.11. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral forelimb on electrically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes in 
normal and low alfaxalone animals. Values plotted are medians and errors are 
interquartile ranges. Dashed line indicates normal alfaxalone data from Study 
2. *p < 0.05 denotes significant difference in inhibition between alfaxalone 





Figure 3.12. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral forelimb on electrically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) and toes-tibialis anterior (TA) reflexes 
in normal (n = 9) and low alfaxalone (n = 10) animals. Values plotted are area 
under curve (AUC) determinations for each animal, with horizontal bars 
indicating medians and interquartile ranges. *p < 0.05 denotes significant 




3.3.3.2.3. Effect of capsaicin injection site 
Comparison of inhibition of heel-MG, toes-BF or toes-TA responses due to 
hindlimb or forelimb injections in low alfaxalone experiments found no 
significant differences between these sites in terms of the depth, duration (in 
each case p > 0.05, Mann-Whitney test) or overall inhibition (i.e. AUC analysis; 





3.3.4. Study 4: Effect of DNIC on mechanically-evoked reflexes 
In this section, data will be compared to responses obtained in Study 1 in intact 
animals using electrical (test) stimuli and administered 500 µg capsaicin as a 
conditioning stimulus. 
 
3.3.4.1. Control parameters 
3.3.4.1.1. Weight and anaesthetic levels 
Animals used in experiments where responses were mechanically-evoked had 
a mean weight of 389 ± 17 g (n = 9) which was not significantly different to rats 
where electrical stimuli were used (369 ± 5 g (n = 9); p = 0.3283, Mann-Whitney 
test; see section 3.3.1.1.1). Following an initial bolus dose (see section 2.2.1.5), 
animals were infused with alfaxalone at a mean rate of 48.78 ± 2.26 mg kg-1 hr-
1 which again was not statistically different compared to the electrically-






3.3.4.1.2. Mechanical thresholds 
Median vF filament threshold values for evoking a response in heel-MG, toes-
BF and toes-TA were 60 g (IQR 18 – 80 g), 26 g (IQR 10 – 26 g) and 26 g (IQR 10 
– 60 g) respectively, which were not significantly different (p = 0.2547, Kruskal-
Wallis test). 
 
3.3.4.1.3. Control reflex responses 
As would be expected, as vF weight increased median control reflex responses 
significantly increased in heel-MG, toes-BF and toes-TA (p < 0.0001, Kruskal-
Wallis test; Table 3.7). No significant differences were found in the size of the 





von Frey (vF) 
weight (g) 
Median control reflex responses (µV.ms) 
Heel-MG† Toes-BF† Toes-TA† 
10 
31 
(12 – 89) 
39 
(15 – 79) 
40 
(3 – 77) 
26 
48 
(19 – 188) 
87 
(61 – 488) 
275 
(20 – 782) 
60 
731 
(86 – 1057) 
664 
(523 – 3049) 
1497* 
(536 – 4281) 
100 
1012 
(93 – 6877) 
1671* 
(927 – 5436) 
2213* 
(735 – 5244) 
180 
1471** 
(644 – 6048) 
2687* 
(1592 – 6921) 
1923* 
(1365 – 6464) 
300 
1333** 
(999 – 6708) 
3096* 
(1510 – 9731) 
2905* 
(1250 – 5988) 
 
Table 3.7. Median control responses in heel-medial gastrocnemius (MG), toes-
biceps femoris (BF) and toes-tibialis anterior (TA) to mechanical stimulation (n 
= 9) using increasing von Frey (vF) filaments prior to administration of 500 µg 
capsaicin. Values in brackets are interquartile ranges. †p < 0.05 denotes 
significant difference between filaments for a given reflex (Kruskal-Wallis test). 
*p < 0.05 or **p < 0.01 denotes significant difference compared to 10 g vF 





3.3.4.2. Effect of capsaicin 
Responses evoked by 10 g and 26 g vF monofilaments were found to be too 
variable and sometimes absent before and after capsaicin, therefore these 
responses have been omitted from results. 
 
3.3.4.2.1. Injection into the contralateral hindlimb 
Following injection of capsaicin, no significant inhibition of heel-MG responses 
(n = 9) to 60 g vF monofilaments was found (p = 0.1171, Friedman’s ANOVA; 
Figure 3.13A). However significant inhibition of these reflexes to 100 g, 180 g 
and 300 g vF weights did occur to a median of 15% (IQR 3 – 61%), 10% (IQR 0 – 
21%) and 27% (IQR 6 – 46%) of controls respectively (p = 0.0029, p = 0.0055 and 
p = 0.0011 respectively, Friedman’s ANOVA). Median duration of inhibition was 
13 min (IQR 0 – 41 min), 17 min (IQR 0 – 55 min) and 25 min (IQR 7 – 49 min) 
for 100 g, 180 g and 300 g vF weights respectively which was not significantly 
different between filaments (p = 0.6771, Kruskal-Wallis test). Analysis of 
negative AUC values did not reveal any significant difference between overall 
capsaicin-induced inhibition of heel-MG responses evoked by the 60 – 300 g 
von Frey weights (p = 0.0806, RM one-way ANOVA; Figure 3.14A). 
 
Significant capsaicin-induced inhibition of toes-BF reflexes (n = 9) evoked by 60 
g, 100 g, 180 g and 300 g monofilaments was found to medians of 19% (IQR 0 – 




respectively (p < 0.0001, p < 0.0001, p = 0.0005 and p = 0.0012 respectively, 
Friedman’s ANOVA; Figure 3.13B) and median duration of inhibition was 39 min 
(IQR 0 – 63 min), 47 min (IQR 8 – 63 min), 47 min (IQR 21 – 63 min) and 47 min 
(IQR 23 – 59 min) respectively, which was not significantly different between 
weights (p = 0.8968, Kruskal-Wallis test). Negative AUC analysis did not indicate 
any significant difference in the overall inhibition of the toes-BF response 
between the 60 – 300 g vF weights (p = 0.4588, RM one-way ANOVA; Figure 
3.14B). 
 
Capsaicin injected into the contralateral hindlimb caused a reduction in toes-
TA responses (n = 9) evoked by 60 g, 100 g, 180 g and 300 g monofilaments to 
medians of 49% (IQR 20 – 55%), 28% (IQR 17 – 33%), 34% (IQR 16 – 90%) and 
33% (IQR 6 – 99%) of controls respectively, however the inhibitory effect for 
responses evoked by the 180 g vF filament was not found to be significant (p = 
0.0002, p = 0.0012, p = 0.2578 and p = 0.0340 respectively, Friedman’s ANOVA; 
Figure 3.13C). Median duration of inhibition of the toes-TA response was 27 
min (IQR 2 – 49 min), 31 min (IQR 13 – 59 min) and 31 min (IQR 9 – 43 min) for 
60 g, 100 g and 300 g vF weights respectively which was not significantly 
different between filaments (p = 0.6068, Kruskal-Wallis test). Further 
comparison using negative AUC analysis found overall inhibition of toes-TA 
reflexes by capsaicin was not significantly different for the 60 – 300 g weights 





3.3.4.2.2. Mechanically versus electrically evoked reflex responses 
Comparison of mechanically evoked responses using 60 – 300 g vF 
monofilaments and electrically evoked responses indicated that the level of 
inhibition induced by capsaicin was similar between groups for heel-MG, toes-
BF and toes-TA reflexes (p = 0.5251, p = 0.8931 and p = 0.6014 respectively, 
Kruskal-Wallis test; Figure 3.13). Similarly, comparison of negative AUC values 
indicated no significant differences between groups for heel-MG, toes-BF and 






Figure 3.13. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral hindlimb on mechanically evoked (n = 9) (A) heel-medial 
gastrocnemius (MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior 
(TA) reflexes using 60 g, 100 g, 180 g and 300 g von Frey (vF) monofilaments. 
Values plotted are medians and errors are interquartile ranges. Electrically 





Figure 3.14. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral hindlimb on mechanically evoked (n = 9) (A) heel-medial 
gastrocnemius (MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior 
(TA) reflexes using 60 – 300 g von Frey (vF) monofilaments. Values plotted are 
area under curve (AUC) determinations for each animal with horizontal bars 




3.3.4.2.3. Injection into the contralateral forelimb 
Injection of capsaicin into the contralateral forelimb caused a marked reduction 
in heel-MG reflexes (n = 9) evoked by 60 g, 100 g, 180 g and 300 g vF 
monofilaments to medians of 11% (IQR 4 – 37%), 17% (IQR 5 – 27%), 5% (IQR 3 
– 29%) and 23% (IQR 4 – 43%) of controls respectively, although inhibition of 
responses evoked by the 60 g vF filament was not quite significant (p = 0.0533, 
p = 0.0006, p = 0.0001 and p < 0.0001 respectively, Friedman’s ANOVA; Figure 
3.15A). Median duration of inhibition was 41 min (IQR 5 – 61 min), 57 min (IQR 
43 – 61 min) and 49 min (IQR 43 – 61 min) for 100 g, 180 g and 300 g vF filaments 
respectively which was not significantly different (p = 0.7139, Kruskal-Wallis 
test). Similarly analysis of negative AUC values showed no significant difference 
in overall capsaicin-induced inhibition for 60 g, 100 g, 180 g and 300 g vF 
monofilaments (p = 0.6271, RM one-way ANOVA; Figure 3.16A). 
 
Significant capsaicin-induced inhibition of toes-BF responses (n = 9) evoked by 
60 g, 100 g, 180 g and 300 g monofilaments occurred to a median of 3% (IQR 0 
– 12%), 10% (IQR 4 – 30%), 4% (IQR 1 – 32%) and 14% (IQR 0 – 21%) respectively 
(p < 0.0001, p < 0.0001, p < 0.0001 and p < 0.0001 respectively, Friedman’s 
ANOVA; Figure 3.15B) with median duration of inhibition being 47 min (IQR 20 
– 61 min), 39 min (IQR 16 – 61 min), 55 min (IQR 45 – 63 min) and 39 min (IQR 
31 – 61 min) respectively which was not significantly different (p = 0.5478, 




inhibition was not significantly different between the vF weights (p = 0.2465, 
RM one-way ANOVA; Figure 3.16B). 
 
Significant inhibition of toes-TA responses (n = 9) using 60 g, 100 g, 180 g and 
300 g vF filaments was caused by capsaicin to a median of 2% (IQR 0 – 21%), 4% 
(IQR 0 – 19%), 13% (IQR 0 – 17%) and 19% (IQR 1 – 37%) of controls respectively 
(p = 0.0001, p < 0.0001, p < 0.0001 and p < 0.0001 respectively, Friedman’s 
ANOVA; Figure 3.15C) For a median duration of 35 min (IQR 10 – 51 min), 39 
min (IQR 12 – 63 min), 47 min (IQR 18 – 57 min) and 39 min (IQR 14 – 43 min) 
respectively, which was not significantly different between filaments (p = 
0.7942, Kruskal-Wallis test). Further comparison by analysis of negative AUC 
values found no significant differences in overall inhibition (p = 0.4265, RM one-
way ANOVA; Figure 3.16C). 
 
3.3.4.2.4. Mechanically versus electrically evoked reflex responses 
Comparing mechanically evoked reflex responses elicited by 60 – 300 g vF 
monofilaments with electrically evoked responses indicated no significant 
differences in the depth of capsaicin-evoked inhibition for the heel-MG, toes-
BF and toes-TA responses between the groups (p = 0.1955, p = 0.5872 and p = 
0.8912 respectively, Kruskal-Wallis test; Figure 3.15). Negative AUC analysis 
also indicated no significant differences between overall inhibition of heel-MG, 
toes-BF and toes-TA reflex responses (p = 0.1209, p = 0.6973 and p = 0.5718 





Figure 3.15. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral forelimb on mechanically evoked (n = 9) (A) heel-medial 
gastrocnemius (MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior 
(TA) reflexes using 60 – 300 g von Frey (vF) monofilaments. Values plotted are 
medians and errors are interquartile ranges. Electrically evoked responses are 





Figure 3.16. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral forelimb on mechanically evoked (n = 9) (A) heel-medial 
gastrocnemius (MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior 
(TA) reflexes using 60 – 300 g von Frey (vF) monofilaments. Values plotted are 
area under curve (AUC) determinations for each animal, with horizontal bars 




3.3.4.2.5. Effect of capsaicin injection site 
Comparison of the degree of inhibition of heel-MG responses between 
hindlimb and forelimb capsaicin injection sites indicated no significant 
differences using 60 – 300 g filaments (p > 0.05, Mann-Whitney test) although 
duration of inhibition was found to be significantly shorter after the hindlimb 
injection using 60 g or 300 g vF monofilaments with medians of 0 min (IQR 0 – 
0 min) and 25 min (IQR 7 – 49 min) respectively compared to 33 min (IQR 0 – 
61 min) and 49 min (IQR 43 – 61 min)(p = 0.009 and p = 0.0409 respectively, 
Mann-Whitney test). In addition, analysis of negative AUC values suggested 
overall inhibition was significantly less for the hindlimb compared to the 
forelimb injection site for the 100 g weight (p = 0.0203, unpaired t-test). 
 
For toes-BF and toes-TA reflexes, there was no significant difference between 
hindlimb and forelimb capsaicin injection sites with respect to depth, duration 
or overall inhibition of mechanically-evoked responses evoked by any vF 






DNIC has been proposed as a form of ‘counter-irritation’ and was first described 
in spinal convergent neurons after the application of a nociceptive conditioning 
stimulus outside of their RFs (Le Bars et al., 1979a, 1991). In fact much of the 
pre-clinical work undertaken on DNIC has been from single cells in the dorsal 
horn or the trigeminal nucleus caudalis, with only a few studies using reflexes, 
which did not include the variety of functional responses considered in the 
present investigation (Cadden et al., 1983; Villanueva et al., 1984; Gjerstad et 
al., 1999; Danziger et al., 2001). The present studies have therefore shown that 
reflex responses are inhibited by capsaicin in a dose-related manner and this 
inhibition is abolished in spinalized animals, altered by decerebration and is 
dependent on the modality of the test stimulus. 
 
Le Bars and co-workers first outlined that DNIC could be evoked using a variety 
of noxious conditioning stimulus modalities including pinch using serrated 
forceps, radiant heat, electrical stimulation and bradykinin (Le Bars et al., 
1979a). In fact noxious chemical stimulation has in many studies produced 
potent inhibitory effects when compared against noxious pinch, heat and 
electrical impulses, indicating it is an excellent conditioning stimulus for a 
sustained inhibitory effect (Le Bars et al., 1979a; Gjerstad et al., 1999; Tambeli 
et al., 2003). In this respect bradykinin exerted large inhibitory effects on dorsal 
horn responses and trigeminal nucleus caudalis cells for several minutes when 




investigating glutamate-evoked activity which have been due to spatial 
summation induced by recruitment of a large number of visceral nociceptors 
(Le Bars et al., 1979a; Dickenson et al., 1980; Villanueva et al., 1984). Other 
effective noxious chemical conditioning stimuli have included the selective C-
fibre irritant mustard oil (Young et al., 1995), which strongly inhibited spinal 
reflexes in rabbits for over 1 hour when applied to heterotopic skin sites (Harris 
and Clarke, 2003), and formalin, which produced profound inhibition of the tail-
flick response when injected into the hindlimb in rats within the first 10 minutes 
after injection (Wen et al., 2010).  
 
The present studies employed capsaicin as the chemical DNIC-inducing 
conditioning stimulus and have shown potent, long lasting inhibition of spinal 
‘test’ reflex responses following its intramuscular injection into the 
contralateral fore- or hindlimb in intact naïve animals, with responses inhibited 
to 8% of controls for periods up to and over 60 minutes. Capsaicin is an 
alkylamide found in Capsicum fruits and is an irritant responsible for the 
pungency of hot chilli peppers (National Center for Biotechnology Information, 
2019). It acts as a prototypic vanilloid receptor agonist and activates TRPV1 
channels to transduce pain in the form of a burning sensation (Bevan and 
Szolcsányi, 1990). That capsaicin produces inhibition of neural responses is not 
new. Capsaicin administered via intramuscular, subdermal and intracutaneous 
routes or applied to soft tissue (gingiva) of the mouth produced inhibitory 




Tambeli et al., 2003; Baad-Hansen et al., 2005). Dallel and co-workers reported 
that 0.1% capsaicin given intracutaneously into the RF of spinal trigeminal 
nucleus oralis WDR neurons had minimal effects on electrically evoked A-fibre 
responses but inhibited C-fibre responses to 23% of baseline which did not 
recover for 60 minutes post-capsaicin (Dallel et al., 1999). Similarly, C-fibre 
evoked recordings from individual WDR neurons in the lumbar dorsal horn 
were reduced to 62% of baseline responses after a 200 µg intramuscular 
injection of capsaicin into the contralateral gastrocnemius soleus muscle 
(Gjerstad et al., 1999). Noxious stimulus-induced antinociception (NSIA) is a 
similar inhibitory pain modulation system to DNIC and when the effect of NSIA 
on the nociceptive trigeminal jaw-opening reflex (JOR) was tested using 250 µg 
subdermal capsaicin injection to the hindpaw, the JOR was attenuated for 60 
minutes with some inhibitions lasting for 2.5 hours (Tambeli et al., 2003). 
 
Capsaicin-induced inhibition in the present studies was shown to be dose-
related with 50 µg evoking weaker inhibition and 500 µg showing a stronger 
inhibitory effect in terms of depth and duration. Clear inhibitory effects appear 
to require a certain degree of recruitment of peripheral nociceptors whether 
this is through increased spatial input from a larger area exposed to the 
conditioning stimulus or via increased temporal input from a stronger stimulus 
(Le Bars et al., 1979a). As the volume of capsaicin was kept constant for the 
different doses (100 µl per site), the spatial distribution of the injectate would 




be due to the increased activation of TRPV1 receptors within a consistent area. 
This stimulation of TRPV1 receptors either increased the number of C-fibres 
activated and/or caused an increased firing rate within these fibres to induce 
DNIC (i.e. a greater afferent barrage), resulting in a strong relationship between 
intensity of the conditioning stimulus and the strength of the resulting 
inhibition (Danziger et al., 2001; Le Bars and Willer, 2010). It would be expected 
that the 5 mg dose would have a greater inhibitory effect on reflex responses 
compared to the 500 µg dose, however this was not observed. This lack of 
increased inhibition for the higher dose may be due to saturation of the TRPV1 
receptor population whereby there were no more receptors to be activated or 
due to desensitization of the TRPV1 receptor which can occur after prolonged 
exposure to capsaicin (Caterina et al., 2000). As the levels of inhibition often 
seemed to be reduced at this higher dose, it seems the latter was the most 
likely cause. 
 
Similar to conditioning stimuli a wide selection of stimulus modalities have 
been used to evoke test responses such as noxious sustained pinch, tactile 
stimulation, radiant heat or electrical stimulation (Le Bars et al., 1979a). Few 
studies however have investigated in any detail the relationship between the 
test and conditioning stimuli in determining the level of DNIC produced, even 
though it is evident that they are interdependent (Le Bars et al., 1979a; Arendt-
Nielsen et al., 2008; Pud et al., 2009). For instance when using an electrical test 




stimulation for the conditioning stimulus led to differing degrees of DNIC 
(Danziger et al., 2001). Similarly, Dickenson and colleagues demonstrated that 
electrical test stimuli combined with bradykinin as the conditioning stimulus 
resulted in 89% inhibition, however when sustained pinch was combined with 
bradykinin, heat or pinch as the conditioning stimulus a maximal inhibition of 
60% was observed (Dickenson et al., 1980). This would indicate electrical test 
stimulation combined with bradykinin results in greater inhibition than a 
sustained pinch as the test stimulus. In addition, previous research has 
indicated that threshold current electrical test stimulation results in greater 
DNIC induced inhibition of up to 90% when compared to suprathreshold test 
stimulation suggesting that the effect of DNIC is greater when using reduced 
electrical test stimulation (Le Bars et al., 1979a; Dickenson et al., 1980). In the 
present studies, evoking reflex responses mechanically using graded vF 
filaments offered a more natural approach compared to electrical stimuli for 
evoking withdrawal reflexes, as afferent fibres of different diameter and state 
of myelination would be progressively activated in accordance to the pressure 
applied rather than simultaneously as caused by electrical means (Schaible and 
Grubb, 1993); it also allowed the effect of the same capsaicin conditioning 
stimulus to be investigated against six different test stimulus strengths in a 
short time frame. Consequently, it was found that in naïve animals, the level of 
DNIC was in fact similar for reflexes evoked by vF filaments in the 60 – 300 g 
range (unfortunately responses at lower weights were too inconsistent to be 
useful). Comparing modalities used to evoke reflex responses is difficult but the 




evoked responses also seemed generally comparable to that of mechanically-
evoked responses. Although 500 µg capsaicin was chosen for its profile in terms 
of depth and duration of induced inhibition, it could be that this conditioning 
stimulus was overly effective and did not allow subtle differences against the 
graded test stimuli to be teased out; further studies could therefore look at 
lower capsaicin doses for comparison. 
 
It has been shown that DNIC of nervous system excitability at lower spinal cord 
levels can be evoked by noxious stimuli applied to widespread areas of the body 
such as the tail, the hind and forelimbs, the ears, the muzzle and the viscera; 
the extent of evoked inhibition was found to be not only dependent on the 
strength of the stimulus but also on the location of the conditioning stimulus 
(Le Bars et al., 1979a). Thus, electrically-evoked responses in dorsal horn 
neurons were inhibited by noxious pinch to the tail and muzzle by 88% and 85% 
of controls respectively however to a lesser degree from the contralateral 
hindlimb, ears and forepaws (70%, 62% and 70% of controls respectively). It 
was suggested that these differences may be due to a higher degree of central 
representation from the tail and muzzle as they are important in the behaviour 
of rats (Le Bars et al., 1979a). Similarly, other studies have found that mustard 
oil applied to the snout and contralateral MG muscle in rabbits produced 
different degrees of inhibition of electrically-evoked reflex responses in MG, 
semitendinosus (ST) and TA (Harris and Clarke, 2003; Harris, 2016). However, 




injected into the contralateral hindlimb or contralateral forelimb in the intact 
animal which is similar to that found by Le Bars et al. (1979a) from these two 
locations.  
 
In contrast, spinalization (complete transection of the thoracic spinal cord) led 
to complete abolition of capsaicin-induced inhibition for all reflex responses at 
either injection site, and in fact heel-MG and toes-BF reflex responses showed 
significant facilitation following capsaicin injection into the contralateral 
forelimb. This shows that capsaicin-induced DNIC of these reflexes is mediated 
by supraspinal inhibitory pathways (see section 1.2.5) as has been shown 
previously for individual dorsal horn neurons using spinalization (Le Bars et al., 
1979b; Cadden et al., 1983) or reversible cold block of descending influences 
(Hall et al., 1982; Dickhaus et al., 1985; Gjerstad et al., 1999). Inhibition of dorsal 
horn responses has been observed in spinalized animals after noxious 
stimulation to widespread areas outside their RF (Gerhart et al., 1981; Cadden 
et al., 1983; Sandkühler et al., 1993) indicating that mechanisms within the 
spinal cord are also antinociceptive, particularly in studies with high cervical 
spinalization, therefore propriospinal mechanisms could also contribute to 
DNIC (Fitzgerald, 1982). However, the complete reversal of DNIC in the present 
studies suggests no contribution of segmental mechanisms below the thoracic 
region, particularly in respect of the hindlimb capsaicin injection given its 
location caudal to the spinal section. Facilitation of withdrawal reflex responses 




muscles where facilitation was induced by noxious pinch of the nose (Kalliomäki 
et al., 1992). Also tail flick withdrawal latency was facilitated by placing the 
hindpaw in hot water in intact animals as well as spinal (T6 - T7) preparations 
which was suggested to be aiding an escape reaction in rats where pain can be 
reduced by widespread noxious stimuli, however reflexes are differentially 
affected as part of an escape reaction (Morgan et al., 1994). However, the 
facilitation in the current study was observed in spinalized, not in intact, 
animals and from the forelimb therefore is not likely of direct neural origin.  
 
Decerebration is a technique to remove higher brain structures or sever 
sensory centres of the brain from peripheral inputs and can be achieved by 
mechanical removal or destruction of specific neural tissues (Sapru and Krieger, 
1978). Removal of the cerebral cortex and thalamus results in an insensate 
animal, therefore limits or completely eradicates the need for a continuous 
anaesthetic regime (Dobson and Harris, 2012; see below). What it also allowed 
was the contribution of forebrain structures to DNIC of reflexes to be studied.   
Removal of forebrain structures appeared to affect DNIC of reflexes in the 
current study with decerebrated animals showing a significantly reduced level 
and shorter duration of inhibition when capsaicin was injected into the forelimb 
as well as it appearing reduced after capsaicin injection into the hindlimb. This 
contrasts to previous electrophysiological studies which indicated that noxious 
heat immersion of the contralateral hindpaw did not alter pinch-evoked dorsal 




animals compared to intact anaesthetised animals (McGaraughty and Henry, 
1997) as well as early lesioning studies by Le Bars and co-workers. They found 
that DNIC was subserved by a supraspinal loop with the ascending parts of the 
loop contained within the ventrolateral quadrant of the cervical spinal cord 
where lesions were found to decrease DNIC (Villanueva et al., 1986b) and the 
descending loop located in the dorsolateral funiculus of the spinal cord 
(Basbaum and Fields, 1979; Villanueva et al., 1986a). Lesions of brainstem 
structures including the locus coeruleus/subcoeruleus (Bouhassira et al., 
1992a) and RVM (Bouhassira et al., 1993) were found to have no effect of the 
efficacy of DNIC . Similarly, thalamic lesions were found to have no effects on 
DNIC induced inhibition (Villanueva et al., 1986b; De Broucker et al., 1990) and 
neither were lesions to PAG, CNF and PB which are directly involved in pain 
modulation (Bouhassira et al., 1990). However, lesions to the SRD did produce 
a marked reduction, but not complete abolition, in the efficacy of DNIC 
(Bouhassira et al., 1992b). However, in contrast to the above findings, other 
studies using lidocaine injections into the MRF and medullary NRM were found 
to abolish or partially block spinal inhibition produced by DNIC (Morton et al., 
1987), so these areas may also be involved as well. A more recent study has 
suggested that the PB neurons, whilst not directly involved in DNIC induced 
inhibition, are key components to the supraspinal ascending-descending loop 





In addition to effects on DNIC, there were also differences between 
anaesthetised intact, decerebrated or spinalized animals on reflexes per se 
suggesting that these muscles are differentially controlled. In intact animals, 
heel-MG reflexes had significantly higher electrical thresholds when compared 
to toes-BF/TA and subsequently higher stimulation strengths were used to 
evoke the reflex response. This is similar to previous studies in the rat whereby 
thresholds for evoking reflexes in MG from the heel were significantly greater 
than those for evoking responses in TA and ST from the toes (Schouenborg and 
Kalliomäki, 1990). However, mean electrical thresholds for evoking the heel-
MG reflex were decreased in spinalized and decerebrate animals compared to 
intact animals, whereas thresholds for evoking flexor reflexes from the toes 
were not significantly different for the three preparations. This suggests that 
this extensor response in rats is tonically inhibited by descending pathways 
involving structures rostral to the colliculi which thereby set the gain of the 
reflex, whereas threshold values for flexors are consistently low and not 
modulated by descending pathways, allowing them to be the dominant 
responders. Decerebrate spinal preparations in rabbits are found to have 
significantly lower thresholds from evoking reflex responses from the heel, 
however are not altered in decerebrate non-spinal preparations (Harris and 
Clarke, 2003). Similarly, reflex responses evoked from the toes were found to 
be higher in decerebrate non-spinal rabbits but remain unaltered in 
decerebrate spinal rabbits indicating that thresholds are altered by various 
preparations (Harris and Clarke, 2003). Other studies have shown thresholds 




unanaesthetised decerebrate rats for periods of up to 8 hours (Schouenborg et 
al., 1992). Reduction in thresholds after spinalization is an indication of hyper-
excitability of reflex responses caused by disruption of tonic descending 
inhibitory pathways (Dickhaus et al., 1985; Cervero et al., 1991; Gjerstad et al., 
1999) and as such reflex responses in previous studies from various muscles are 
found to be hyper-excitable (Dickhaus et al., 1985; Schouenborg et al., 1992; 
Harris and Clarke, 2003). Similarly, heel-MG and toes-BF/TA responded 
differently to noxious capsaicin injection with toes-BF/TA responses appearing 
to be more susceptible to DNIC than heel-MG responses which would suggest 
these reflexes are differentially modulated via descending controls. When 
evoked using electrical stimulation heel-MG reflex responses were often not 
inhibited by the DNIC conditioning stimulus, however toes BF/TA were 
inhibited to varying degrees in intact preparations. Previous studies have 
indicated in rabbit that reflex responses in MG, TA and ST could all be inhibited 
for over 1 hour after the application of mustard oil to the snout or contralateral 
MG muscle (Harris and Clarke, 2003). 
 
Alfaxalone is a neuroactive steroid that enhances the interaction of the 
inhibitory neurotransmitter GABA with its ionotropic GABAA receptors by 
moving chloride into the cell, hyperpolarising the neuron and inhibiting action 
potential propagation thereby causing modulation of this ligand-gated chloride 
channel resulting in anaesthesia and muscle relaxation (Harrison and 




electrophysiology recordings increased nociceptive thresholds and decreased 
response magnitude, however maintained the ability to increase responses 
with increased stimulus strength (Hunt et al., 2016). This makes it an excellent 
and stable anaesthesia to use in reflex response studies (White et al., 2017). 
The present studies have shown that altering the level of alfaxalone 
anaesthesia had a significant effect on reflex parameters (lower median 
electrical thresholds and stimulation strengths when levels were reduced). 
These observations would be easily predicted in animals which are given a 
reduced anaesthesia rate as anaesthesia is known to impact on pain responses 
(Stamford, 1995). Intravenously administered alfaxalone has been found to 
cause complete loss of a toe-pinch reflex in iguanas after just over 2 minutes of 
a 5mg kg-1 dose suggesting that alfaxalone has strong depressive influences on 
reflexes (Knotek et al., 2013). 
 
However, the anaesthetic regime implemented in DNIC studies is often 
overlooked but could play a key role on the efficacy of DNIC (Jinks et al., 2003a). 
The use of decerebrate animals therefore also allows different levels of 
anaesthesia to be employed with the possibility of pain or distress fully 
removed (Silverman et al., 2005). Consequently, in the current studies, under 
low levels of alfaxalone there appeared to be greater DNIC efficacy than under 
high alfaxalone conditions indicating a stable level of anaesthesia is important. 
Although alfaxalone has not been previously studied, published literature 




isoflurane depressing DNIC induced by tail or hindpaw clamp on dorsal horn 
recordings evoked by noxious thermal stimulation to the hindpaw (Jinks et al., 
2003a). Similarly, mechanically evoked dorsal horn recordings (noxious pinch 
to the hindpaw) were strongly inhibited by noxious pinch to the muzzle, 
however this DNIC induced inhibition was lost when halothane anaesthesia was 
increased from 1.3% to 2.5% but was able to be restored by reducing halothane 
to previous levels (Tomlinson et al., 1983). When DNIC induced by noxious heat 
and bradykinin were compared in sodium pentobarbitone or halothane 
anaesthesia regimes, dorsal horn recordings evoked by electrical stimulation 
were inhibited in both regimes to varying degrees (Alarcón and Cervero, 1989). 
Using barbiturate anaesthesia the majority of neurons were inhibited in 
response to noxious heat and bradykinin by 40% and 46% respectively (Alarcón 
and Cervero, 1989). Contrastingly, using halothane anaesthesia caused 
inhibition of nearly all neurons in response to noxious heat and bradykinin by 
71% and 78% respectively indicating halothane anaesthesia inhibits more cells 
and to a higher magnitude than barbiturate regimes (Alarcón and Cervero, 
1989).  
 
Finally, another consideration is the manifestation of DNIC in different species 
of animal. In this study Sprague-Dawley rats have been used, however other 
studies have used many other species including the mouse (Fleischmann and 
Urca, 1989), cat (Morton et al., 1987, 1988; Alarcón and Cervero, 1989; Wen et 




and primate (Gerhart et al., 1981; Brennan et al., 1998). In the current studies 
preliminary experiments (results not shown) using a conditioning stimulus 
consisting of a noxious pinch to the contralateral forelimb or muzzle, or 
mustard oil to the muzzle, had no effect on electrically-evoked reflex responses 
in the rat. However noxious pinch to the muzzle has been found to be very 
potent in rats in other studies and has therefore elicited strong DNIC (Le Bars 
et al., 1979a; Schouenborg and Dickenson, 1985). Similarly, mustard oil is also 
considered to be a strong noxious stimulus capable of evoking DNIC in rabbits 
when applied to the snout (Harris and Clarke, 2003; Harris, 2016). Experiments 
in dogs found DNIC difficult to evoke using cold water to the paw (Hunt et al., 
2018), however other studies in humans have shown that noxious cold induces 








4. Diffuse noxious inhibitory controls of 
nociceptive withdrawal reflexes in the 
monosodium iodoacetate model of 






OA is a type of joint disease affecting articular cartilage, subchondral bone, 
synovium, the capsule and ligaments causing cartilage degeneration, 
fibrillation, fissures and complete loss of the joint surface leading to damage of 
the underlying bone (Cooper et al., 2015)(see section 1.1). In chronic pain 
states, such as OA, continued nociceptive input from the affected joint 
peripherally leads to central sensitization, part of which may result from altered 
descending pathways (Danziger et al., 1999)(see section 1.2.5). Modification of 
descending inhibitory pathways, including those involved in DNIC, potentially 
causes a reduction in their efficacy resulting in maintenance of chronic pain 
(Danziger et al., 1999). As spinally organised withdrawal reflexes are modulated 
by descending inhibitory pathways, which set an appropriate threshold for 
excitability as well as the dimensions of the reflex’s RF (Schouenborg et al., 
1992), OA-induced alterations in these pathways should be reflected in changes 
in reflex responses. 
 
Pre-clinical animal models are an important tool for investigating changes 
which occur during OA (see section 1.5.6). As previously discussed, there is no 
one animal model of OA that is perfect, each having its advantages and 
disadvantages. For the following studies the MIA model (see section 1.5.7) was 
chosen as the most appropriate due to its ease of induction, the rapid 
timeframe over which the model develops and, as peripheral and central 




occur and have been partially characterised in this model (Sagar et al., 2010, 
2011; Kelly et al., 2012, 2013a, 2013b). The MIA model mimics behavioural, 
pathogenic and pharmacologic features associated with human OA including 
synovial inflammation, chondropathy and osteophytosis (Bove et al., 2003; 
Mapp et al., 2013). At 14 days post-MIA injection, the MIA model is considered 
to be a neuropathic pain model, with extensive damage observed in the 
subchondral bone marrow and these areas are replaced by loose spindle fibres 
and separated from the normal trabecular bone and marrow areas (Guzman et 
al., 2003). Chondrocyte clusters (chondrones) are also observed between 
normal and necrotic cartilage (Guzman et al., 2003). Proteoglycan loss is 
widespread throughout the cartilage as well as signs of stresses in the cartilage 
with bone reabsorption continuing and the beginnings of osteophytes (Mapp 
et al., 2013). Between 21-28 days post injection the cartilage layer is extensively 
thinned, subchondral bone is thickened and osteophytes are continuing to 
grow (Fernihough et al., 2004). Throughout this period animals show significant 
pain behaviour in both weight bearing asymmetry, tactile allodynia and 






Experiments were performed on a total of 84 male Sprague-Dawley rats (mean 
weight 150 g, range 133 – 188 g) housed as previously described (see section 
2.1). Prior to electrophysiology, all animals underwent the following procedure 
to either induce the MIA model (n = 43) or to be part of the saline control group 
(n = 41).  
 
4.2.1. Induction of monosodium iodoacetate (MIA) model 
The MIA model was induced following a protocol outlined in previous studies 
(Guingamp et al., 1997; Kelly et al., 2013b; Mapp et al., 2013; Sagar et al., 2014). 
Asepsis was maintained throughout the procedure in accordance with a 
standard operating procedure (SOP) approved by the Named Veterinary 
Surgeon (NVS). Each animal was placed into a transparent induction chamber 
and anaesthetised using 3% isoflurane in 2 L min-1 oxygen until the animal lost 
its righting reflex. The rat was then transferred to a nose cone where the 
isoflurane was reduced to 2% in 2 L min-1 oxygen, with a pinch to the hindpaw 
ensuring the animal was areflexic and appropriately anaesthetised. The left 
hindlimb was shaved from the ankle joint to midway between the knee and hip 
joints and cleaned with Virusan gel (Clinipath Equipment Limited, Hull, UK) on 
a sterile swab. The animal was then placed on a sterile drape where the shaved 
area was again cleaned with Virusan gel. Using sterile gloves, and with the knee 
joint at a 90° angle, the joint space was injected with 1 mg sodium iodoacetate 




tendon using a 12 mm, 29-gauge needle fixed to a 0.5 ml insulin syringe (VWR 
International Ltd, Leicestershire, UK) which was filled prior to surgery from a 
freshly prepared stock solution of 20 mg MIA in 1 ml sterile saline (a separate 
Eppendorf of stock solution was made for each rat). Control animals received 
the same surgical procedure but only 50 µl sterile saline was injected. Following 
injection, animals were placed in a recovery cage heated to 37 °C until they 
were upright and fully recovered, before being returned to a clean home cage 
(up to four rats per cage). Following injection animals were monitored closely, 
with twice daily weight checks and gait scoring as well as checks for normal 
activity, hunched posture, starey coat, discharge from the eyes/nose, 
dehydration, a satisfactory wound, the presence of swelling or limping for the 
first 4 days post-injection and every other day thereafter for the duration of the 
study. 
 
4.2.2. Assessment of pain behaviour 
The MIA model is known for its association with mild pain-like behaviour 
(Ogbonna et al., 2013; Sagar et al., 2014). At least 1 day prior to injection 
animals were habituated to the behavioural testing equipment to reduce 
stress. Animals were assessed immediately before knee joint injection 
(baseline; day 0) and every 7 days during the 28-35 day post-injection period. 
Behavioural testing was performed at a similar time on each given day for 
consistency and to reduce the effect of circadian rhythms on pain (Konecka and 





4.2.2.1. Weight bearing analysis 
Pain arising from the injected joint can be measured indirectly by assessing the 
weight borne on each leg, or on hindlimbs, in OA patients and pre-clinical 
animal studies respectively and used as a measure of pain and discomfort 
(Swagerty and Hellinger, 2001; Bove et al., 2003; Combe et al., 2004; Bove et 
al., 2006; Kelly et al., 2013b; Mapp et al., 2013; Ogbonna et al., 2013; Moilanen 
et al., 2015). Weight bearing asymmetry was assessed using an incapacitance 
tester (Linton Instruments, Norfolk, UK) to measure weight distribution 
between the ipsilateral (injected) and contralateral (non-injected) hindlimb of 
each rat. This comprised of a Perspex box which was angled to allow the rat to 
place its forelimbs freely, whilst each hindlimb rested in the centre of two 
separate transducer pads which recorded the weight exerted by each one 
(Figure 4.1). Once a rat was settled in this position, recordings were taken over 
a three second period and averaged by the incapacitance tester. Readings were 
taken in triplicate and averaged for analysis. Results are presented as the gram 
weight difference between the ipsilateral and contralateral hindlimbs with 
respect to the ipsilateral limb, such that equal weight distribution is 
represented by 0 g, increased weight on the contralateral hindlimb is a positive 









4.2.2.2. Assessment of mechanical paw withdrawal thresholds 
Mechanical allodynia and hyperalgesia are key features of pain in OA (Schaible 
et al., 2002). These can be tested using vF monofilaments applied to the plantar 
surface of each hindpaw; a method which is regularly utilised in preclinical pain 
studies (Mapp et al., 2013; Ogbonna et al., 2013; Nwosu et al., 2016b). The 
methodology used was adapted from the up-down method (Chaplan et al., 
1994), by which animals were placed into Perspex boxes over a metal cross-grid 
floor, therefore allowing access to the plantar surface of each hindpaw (Figure 
4.2). Hindpaw withdrawal thresholds were then measured by applying each vF 
monofilament perpendicular to the skin in the mid-plantar region (just proximal 
to the less sensitive footpad) for 3 seconds. The range of vF monofilaments 
used were 0.16, 0.4, 0.6, 1.0, 2.0, 4.0, 6.0, 8.0, 15.0 and 26.0 g. Testing began 
by applying the 2.0 g monofilament, and if there was no response, successively 
higher filaments were applied until a rapid withdrawal occurred. At this point 
the next lower vF monofilament was reapplied, and if no response occurred the 
next higher force was again used; hence the up-down method. A total of 6 
withdrawal responses were recorded with the lowest consistent force required 
to evoke a withdrawal response classified as the PWT. To avoid lifting the paw 
during testing, and to prevent sensitization of the plantar surface, the 26.0 g 









4.2.3. Assessment of knee joint damage 
Following electrophysiological recordings (see below) and euthanasia by 
anaesthetic overdose, both hindlimbs were immediately removed just below 
the hip bone in a number of MIA and saline-injected animals. The skin was 
removed and hindlimbs were frozen at -20 °C for joint damage assessment at a 
later time point. 
 
Knee joint damage was subsequently quantified using a macroscopic 
photographic chondropathy score (PCS) methodology based on the appearance 
of the articular surfaces (Walsh et al., 2009). Following overnight thawing at -4 
°C, overlying muscle was removed from around the joint and the MCL and LCL 
cut followed by the ACL and PCL until the tibiofemoral joint could be separated 
to expose the cartilage on each surface. The femoral condyle and tibial plateau 
were then individually photographed and the severity and extent of loss of 
surface integrity of articular cartilage were recorded on a joint scoring sheet 
(Figure 4.3A)(Dougados et al., 1994). Joints were then annotated with 
approximate area of damage and severity and these areas graded according to 
Walsh et al. (2009)(Figure 4.3B). In addition, the photographs were used to 
separately assess joints using ImageJ software (version 1.51k; National 
Institutes of Health, Maryland, USA) to mark out areas with damage, hence 
calculate the percentage area with each category of surface damage for the 




these graded percentage data joint OA severity was then calculated and 
classified using the following three systems: 
 
i) Collin’s classification tree scoring (Figure 4.4A) which grades OA at the 
articular surface based on the presence, extent and severity of OA changes 
(Collins, 1949). Severity is allocated based on the appearance of the joint using 
the previously referred to grading system (Figure 4.3B), and results range from 
grade 0 to grade IV, with 0 representing limited damage. 
 
ii) Original Système Française D’Arthroscopie (SFA) scoring (Figure 4.4B) was 
derived by combining two formulas by Dougados et al. (1994) which depend on 
whether the compartment was medial or lateral and on the percentage of 
articular surface allocated to each severity grade (Figure 4.3B). Scores for joint 
damage can range from -9.2 to +2650.8 which results in joints with no damage 
as -9.2. 
 
iii) Revised SFA scoring (Figure 4.4C) derived using modifications of the original 
SFA scoring formulae (Ayral et al., 1994) where the medial and lateral sections 
of the tibial plateau and femoral condyle are graded based on the percentage 
of articular surface damage (Figure 4.3B). Scores are 0 to +400 which allows a 








Grade Surface Appearance 
0 Normal – smooth, unbroken surface, homogenous white to off-
white colour 
1 Swelling and softening – a little brown homogeneous colouration 
2 Superficial fibrillation – lightly broken surface, white to off-
white/light brown in colour 
3 Deep fibrillation – coarsely broken cartilage surface, dark brown, 
grey or red colour 
4 Subchondral bone exposed – stippled white and dark brown/red in 
colour 
 
Figure 4.3. Grading of severity and extent of loss of surface integrity of articular 
cartilage. (A) Joint scoring sheet for the tibial plateau (left) and femoral condyle 
(right)(Dougados et al., 1994). (B) Graded scoring system based on the surface 










Figure 4.4. (A) Classification tree for Collin’s grading of osteoarthritic (OA) 
changes at the articular surface (Collins, 1949). (B) Original Système Française 
D’Arthroscopie (SFA) score based on a global assessment of OA changes in the 
articular surfaces (Dougados et al., 1994). (C) Revised SFA score which is a 
modified version of the original SFA system allowing normal joints to be scored 
as 0 (Ayral et al., 1994). 
  
Collin’s Classification tree 
Original SFA Score 
 
Medial surface = −2.2 + (Grade1 × 1.3) + (Grade2 × 2.2) + (Grade3 × 3.4)  
    + (Grade4 × 7.2) 
 
Lateral surface = −2.4 + (Grade1 × 0.8) + (Grade2 × 2.3) + (Grade3 × 5.0) 
    + (Grade4 × 6.1) 
 
Total Joint = sum of the lateral/medial femoral condyle and tibial plateau 
Revised SFA Score 
 




4.2.4. Electrophysiological studies 
Animals were surgically prepared for electrophysiological studies as described 
in section 2.2.1. Reflexes were evoked using electrical or mechanical 
stimulation of the heel and toes and recorded in MG or BF and TA respectively, 
as previously detailed (section 2.2.2). Stock capsaicin solution was prepared to 
5 or 0.5 mg ml-1 injection concentrations (section 3.2.1) and injected as a 
conditioning stimulus into contralateral forelimb and hindlimb locations as 
previously described (section 2.2.3). 
 
The first set of experiments comprised four groups: MIA-injected (n = 9) or 
saline-injected (n = 10) with reflexes evoked electrically and MIA-injected (n = 
11) or saline-injected (n = 10) with reflexes evoked mechanically. For all groups 
100 µl of 5 mg ml-1 capsaicin (i.e. 500 µg) was used as the DNIC-inducing 
stimulus. 
 
Due to the strong relationship between the test and conditioning stimulus 
when investigating DNIC, a lower capsaicin dose (100 µl of 0.5 mg ml-1 i.e. 50 
µg) was used to induce inhibition in MIA and saline-injected animals to allow 
possible subtle differences in DNIC between groups to be detected. This lower 
conditioning stimulus was again tested in 4 groups: MIA (n = 10) and saline-
injected (n = 10) animals with reflexes evoked electrically and MIA (n = 13) or 





4.3.1. Joint severity scoring 
  
Figure 4.5. Examples of joint damage severity 28-35 days after saline (A, B) 
or MIA (C, D) injection into the knee joint of the left hindlimb. Images are 
of ipsilateral tibial plateaus (A, C) or femoral condyles (B, D). Images E – H 
are corresponding structures in the contralateral (i.e. non-injected) right 








Mean joint score 
Collins†††† SFA†††† Revised SFA†††† 
Saline 
Contralateral 
(n = 12) 
0 ± 0**** -9.2 ± 0**** 0 ± 0**** 
Ipsilateral 
(n = 5) 
0 ± 0**** -9.2 ± 0**** 0 ± 0**** 
MIA 
Contralateral 
(n = 15) 
0 ± 0**** 18.3 ± 5.1**** 3.8 ± 0.7**** 
Ipsilateral 
(n = 15) 
11.7 ± 0.2 756.4 ± 53.2 117.1 ± 8.3 
 
Table 4.1. Scoring of ipsilateral and contralateral hindlimb knee joints 28-35 
days post-saline or MIA injection using three different methods. Values are 
means and errors are standard error of means. ††††p < 0.0001 denotes 
significant difference between joints for a given scoring method (one-way 
ANOVA). ****p < 0.0001 denotes significance compared to MIA-injected 






Mean joint scores were significantly different using either the Collins, SFA or 
revised SFA methods of joint scoring (p < 0.0001 for all, one-way ANOVA; Table 
4.1) with the ipsilateral MIA-injected hindlimb showing significantly greater 
damage than the three other joints by all three scoring methods (p < 0.0001, 





4.3.2. Pain behaviour 
4.3.2.1. Weight bearing asymmetry 
The weight bearing data was tested across saline-injected animals that were 
later given either 500 µg or 50 µg capsaicin with electrically and mechanically-
evoked responses and found there was a significant difference between the 4 
groups but no differences between time points (p = 0.0009 and p = 0.1166 
respectively, two-way ANOVA). These differences were found to be between 
the 50 µg capsaicin dose animals with electrically-evoked responses due to 
some animals showing slightly larger differences between the hindlimbs. The 
same groups were tested across the MIA-injected animals and found to have 
no significant differences between groups however as expected had significant 
differences over time (p = 0.1203 and p < 0.0001 respectively, two-way 
ANOVA). 
 
The weight bearing data was therefore pooled across all groups to show any 
differences between saline and MIA-injected animal and indicated the 
difference between the ipsilateral and contralateral hindlimb was significantly 
larger in MIA compared to saline-injected animals (p < 0.0001, two-way 
ANOVA; Figure 4.6A) with mean values of 57.1 ± 2.7 g (n = 41) and 3.2 ± 0.5 g 






Figure 4.6. Pain behaviour post saline or MIA injection with (A) weight bearing 
asymmetry or (B) paw withdrawal thresholds. Values plotted are means and 
errors are standard error of means. ****p < 0.0001 denotes significant 
difference between saline and MIA-injected animals. †p < 0.05, ††p < 0.01, 
†††p < 0.001 or ††††p < 0.0001 denotes significant difference to previous time 




4.3.2.2. Paw withdrawal thresholds 
PWTs were tested across the 4 saline-injected groups (both capsaicin doses and 
electrically and mechanically-evoked reflex responses) and found that there 
was a significant difference between groups as well as between time points (p 
= 0.0023 and p < 0.0001 respectively, two-way ANOVA). These differences were 
indicated between the animals which had electrically-evoked responses and 
received a 500 µg capsaicin dose and the other 3 groups, with some animals in 
this group showing lower than expected thresholds for the earlier time points. 
The same groups were tested across the MIA-injected animals and found no 
significant differences between groups but again as expected differences 
between time points (p = 0.3507 and p < 0.0001 respectively, two-way ANOVA). 
 
The PWT data was therefore pooled across the 4 groups to show the overall 
effects between saline and MIA-injected animals and indicated that PWTs were 
significantly reduced in MIA-injected hindlimbs (p < 0.0001, two-way ANOVA; 
Figure 4.6B) to a mean of 4.6 ± 0.5 g (n = 43) at day 28-35 post-injection, 





4.3.3. Control parameters for electrophysiology 
4.3.3.1. Weight and anaesthetic parameters 
Animals whose reflexes were later electrically-evoked and given either 500 µg 
or 50 µg capsaicin dose had mean weights of 152 ± 5 g (n = 10) and 145 ± 2 g (n 
= 10) at the point of saline induction and 151 ± 1 g (n = 9) and 148 ± 2 g (n = 10) 
at the point of MIA induction respectively. Similarly, animals whose reflexes 
were later mechanically-evoked and given either 500 µg or 50 µg capsaicin dose 
had mean weights of 148 ± 5 g (n = 10) and 149 ± 3 g (n = 11) at the point of 
saline induction and 157 ± 4 g (n = 11) and 150 ± 2 g (n = 13) at the point of MIA 
induction respectively which were not significantly different across the 8 
groups (p = 0.3613, one-way ANOVA). 
 
At the time of electrophysiology mean weights of animals whose reflexes were 
later electrically-evoked and given 500 µg or 50 µg capsaicin injection were 380 
± 14 g and 361 ± 8 g in saline-injected animals and 383 ± 7 g and 358 ± 8 g in 
MIA-injected animals respectively. Animals whose reflexes were later 
mechanically-evoked and given 500 µg or 50 µg capsaicin injection were 364 ± 
11 g and 379 ± 9 g in saline-injected animals and 361 ± 9 g and 370 ± 8 g in MIA-
injected animals respectively which again were not significantly different 





Following an initial bolus dose (see section 2.2.1.5), alfaxalone anaesthesia was 
maintained using a CRI at mean rates of 47.67 ± 1.19 mg kg-1 hr-1 and 45.8 ± 
0.83 mg kg-1 hr-1 for saline-injected animals whose reflexes were electrically 
evoked and given 500 µg or 50 µg capsaicin injection and at 47.34 ± 0.48 mg kg-
1 hr-1 and 44.23 ± 0.90 mg kg-1 hr-1 in MIA-injected animals respectively. 
Similarly, alfaxalone anaesthesia was maintained at mean rates of 46.34 ± 0.70 
mg kg-1 hr-1 and 44.36 ± 0.43 mg kg-1 hr-1 for saline-injected animals whose 
reflexes were later mechanically-evoked and given 500 µg or 50 µg capsaicin 
injection and at 51.28 ± 3.30 mg kg-1 hr-1 and 45.03 ± 0.52 mg kg-1 hr-1 in MIA-
injected animals respectively which were significantly different between the 8 
groups (p = 0.0125, one-way ANOVA) with differences shown between MIA-
injected animals that were later given 500 µg capsaicin and had mechanically-
evoked responses and the lower dose capsaicin injection groups; saline and 
MIA-injected mechanically-evoked groups and the MIA-injected electrically-
evoked group (p = 0.0146, p = 0.0272 and p = 0.0154 respectively, Tukey’s 











Median threshold (mA) 
Median stimulation strength 
(mA) 
Heel-MG Toes-BF/TA Heel-MG†† Toes-BF/TA 
Saline 
(n = 10) 
500 
1.60 
(0.88 – 2.33) 
0.60 
(0.48 – 0.83) 
6.75 
(6.00 – 7.00) 
8.00 
(6.75 – 9.00) 
MIA 
(n = 8) 
500 
0.85 
(0.65 – 1.20) 
0.75 
(0.40 – 0.88) 
6.00 
(4.25 – 6.75) 
7.50 
(6.25 – 8.00) 
Saline 
(n = 10) 
50 
0.75 
(0.58 – 1.70) 
0.55 
(0.30 – 6.50) 
3.50 
(1.35 – 6.00) 
6.00 
(3.90 – 6.50) 
MIA 
(n = 10) 
50 
0.85 
(0.55 – 1.28) 
3.3 
(0.40 – 7.25) 
3.10 
(0.53 – 4.13) 
6.50 
(4.00 – 9.00) 
 
Table 4.2. Median electrical stimulation parameters for heel-medial 
gastrocnemius (MG) and toes-biceps femoris (BF) or tibialis anterior (TA) 
reflexes in saline and MIA-injected animals later injected with 500 µg or 50 µg 
capsaicin respectively. Values in brackets are interquartile ranges. ††p < 0.01 





Median electrical threshold values were not significantly different between 
groups for the heel-MG or toes-BF/TA reflex responses (p = 0.1983 and p = 
0.6574 respectively, Kruskal-Wallis test; Table 4.2). Similarly, no significance 
was indicated between saline and MIA-injected animals in the toes-BF/TA 
median electrical stimulation strengths (p = 0.1045, Kruskal-Wallis test). 
However, significant differences were indicated between groups for heel-MG 
median electrical stimulation strengths (p = 0.0056, Kruskal-Wallis test) with 
this difference indicated between the saline-injected animals given 500 µg 
capsaicin and the MIA-injected group given 50 µg capsaicin (p = 0.0068, Dunn’s 
multiple comparisons test). 
 
When data were pooled for all animals across saline and MIA-injected groups, 
no significant difference was observed in median electrical thresholds between 
heel-MG and toes-BF/TA (p = 0.0716, Mann-Whitney test) with medians of 0.9 
mA (IQR 0.68 – 1.68 mA) and 0.65 mA (IQR 0.40 – 1.34 mA) respectively. 
However, median stimulation strengths were significantly smaller for heel-MG 
reflexes compared to toes-BF/TA reflexes (p = 0.0002, Mann-Whitney test) with 











Median control reflex responses (µV.ms) 
Heel-MG Toes-BF Toes-TA 
Saline 
(n = 10) 
500 
114 
(79 – 226) 
94 
(76 – 211) 
63 
(55 – 99) 
MIA 
(n = 9) 
500 
117 
(78 – 165) 
104 
(62 – 200) 
95 
(63 – 105) 
Saline 
(n = 10) 
50 
198 
(88 – 318) 
141 
(118 – 330) 
95 
(63 – 281) 
MIA 
(n = 10) 
50 
116 
(95 – 162) 
162 
(53 – 197) 
55 
(46 – 129) 
 
Table 4.3. Median control responses to electrical stimulation for heel-medial 
gastrocnemius (MG), toes-biceps femoris (BF) and toes-tibialis anterior (TA) 
reflexes prior to administration of 500 µg or 50 µg capsaicin in saline and MIA-





The size of heel-MG, toes-BF and toes-TA reflex responses prior to 500 µg or 50 
µg capsaicin injection were not significantly different between saline (n = 10 
and n = 10) and MIA-injected (n = 9 and n = 10) animals for electrically-evoked 
reflex responses (p = 0.7480, p = 0.4230 and p = 0.4231, Kruskal-Wallis test; 
Table 4.3). For saline-injected animals there was a significant difference 
between the three reflex responses across both capsaicin doses (p = 0.0149, 
Kruskal-Wallis test) with toes-BF responses in the 50 µg capsaicin dose 
significantly larger than toes-TA responses prior to a 500 µg capsaicin dose (p = 
0.0062, Dunn’s multiple comparisons test). However, MIA-injected animals 
showed no significant differences between heel-MG, toes-BF and toes-TA reflex 












Median mechanical threshold 
(von Frey (vF) weight, g) 
Heel-MG Toes-BF Toes-TA 
Saline 
(n = 10) 
500 
43 
(26 – 60) 
26 
(26 – 35) 
18 
(10 – 60) 
MIA 
(n = 10) 
500 
26 
(22 – 60) 
26 
(10 – 26) 
26 
(10 – 26) 
Saline 
(n = 11) 
50 
26 
(10 – 60) 
26 




(n = 13) 
50 
26 
(26 – 60) 
26 
(18 – 60) 
26 
(18 – 26) 
 
Table 4.4. Median mechanical threshold parameters for the heel-medial 
gastrocnemius (MG), toes-biceps femoris (BF) and toes-tibialis anterior (TA) 
reflexes for saline and MIA-injected animals later injected with 500 µg or 50 µg 





Median mechanical threshold values were not significantly different between 
heel-MG, toes-BF and toes-TA in saline or MIA-injected animals which were 
given either 500 µg or 50 µg capsaicin (p = 0.1163 and p = 0.0911 respectively, 
Kruskal-Wallis test; Table 4.4). Similarly, there was no significant differences in 
the thresholds between saline and MIA-injected animals given either 500 µg or 
50 µg capsaicin in heel-MG, toes-BF and toes-TA reflex responses (p = 0.1498, 





4.3.3.5. Mechanical control reflex responses 
Treatment and von 
Frey weight (g) 
Median control reflex responses (µV) 
Heel-MG Toes-BF Toes-TA 






(0.005 – 0.021) 
0.043 
(0.012 – 0.149) 
0.016 
(0.007 – 0.040) 
0.032 
(0.014 – 0.093) 
0.048 
(0.013 – 0.146) 
0.062 







(0.073 – 0.641) 
0.097 
(0.023 – 0.536) 
0.509 
(0.036 – 1.092) 
0.259 
(0.108 – 0.517) 
60 
3.222 
(0.505 – 13.630) 
4.167 
(0.155 – 6.589) 
1.513 
(0.520 – 2.469) 
1.106 
(0.337 – 3.125) 
1.673 
(0.850 – 3.901) 
1.361 
(0.873 – 1.891) 
100 
6.186 
(1.412 – 20.637) 
12.626 
(3.371 – 21.600) 
3.461 
(1.585 – 4.068) 
2.621 
(1.785 – 6.091) 
2.923 
(1.450 – 5.875) 
2.147 
(1.331 – 3.376) 
180 
8.103 
(3.335 – 20.737) 
9.843 
(5.581 – 30.650) 
5.173 
(3.002 – 8.742) 
9.704 
(2.960 – 12.084) 
4.568 
(2.759 – 7.111) 
2.960 
(2.209 – 3.918) 
300 
10.477 
(3.945 – 21.924) 
12.570 
(6.762 – 44.222) 
5.835 
(2.444 – 12.195) 
9.710 
(2.837 – 15.728) 
4.642 
(2.370 – 8.113) 
3.324 




Table 4.5. Median control responses to mechanical stimulation for heel-medial gastrocnemius (MG), toes-biceps femoris (BF) and toes-tibialis 
anterior (TA) reflexes prior to administration of 500 µg or 50 µg capsaicin in saline (n = 10 and n = 11) and MIA-injected (n = 11 and n = 13) 






(0.010 – 0.055) 
0.016 
(0.007 – 0.035) 
0.029 
(0.015 – 0.111) 
0.009 
(0.003 – 0.048) 
0.036 
(0.007 – 0.219) 
0.029 
(0.018 – 0.060) 
26 
0.072 
(0.036 – 0.254) 
0.048 
(0.025 – 0.109) 
0.165 
(0.062 – 1.113) 
0.091 
(0.027 – 0.490) 
0.615 
(0.098 – 1.103) 
1.83 
(0.134 – 0.873) 
60 
7.019 
(1.291 – 16.016) 
4.461 
(3.376 – 7.153) 
1.780 
(1.126 – 3.566) 
0.703 
(0.197 – 3.317) 
2.790 
(1.846 – 4.849) 
1.461 







(1.483 – 6.513) 
3.872 
(2.268 – 8.363) 
3.892 
(2.676 – 5.609) 
3.180 
(2.054 – 4.591) 
180 
12.598 
(5.299 – 24.438) 
9.881 
(6.663 – 14.932) 
4.053 
(2.505 – 10.540) 
7.482 
(4.501 – 10.739) 
5.180 
(3.159 – 5.945) 
3.008 
(2.137 – 4.623) 
300 
14.879 
(5.700 – 21.587) 
9.471 
(5.863 – 15.471) 
6.004 
(1.829 – 11.455) 
8.769 
(6.553 – 13.297) 
5.737 
(3.760 – 6.547) 
3.398 




As vF weight (10 – 300 g) increased, median control reflex responses 
significantly increased for heel-MG, toes-BF and toes-TA reflex responses for 
animals injected with 500 µg or 50 µg capsaicin in saline (n = 10 and n = 11) and 
MIA-injected (n = 11 and n = 13) animals (p < 0.0001, Kruskal-Wallis test). 
Comparison of responses prior to capsaicin injection indicated control 
responses were not significantly different between MIA and saline-injected 
animals in any reflex response (p > 0.05, two-way ANOVA; Figure 4.7). Similarly 
no significant differences were observed in any reflex response evoked by vF 
filaments (10 – 300g) between MIA and saline-injected animals using direct 





Figure 4.7. Control responses prior to injection of 500 µg or 50 µg capsaicin for 
(A) heel-medial gastrocnemius (MG), (B) toes-biceps femoris (BF) and (C) toes-
tibialis anterior (TA) reflexes evoked using 10 g, 26 g, 60 g, 100 g, 180 g and 300 
g von Frey (vF) monofilaments in saline and MIA animals 28-35 days post-




4.3.4. Effect of 500 µg capsaicin on electrically-evoked responses 
4.3.4.1. Injection into the contralateral hindlimb 
Significant inhibition was induced in heel-MG responses by 500 µg capsaicin in 
saline-injected (n = 10) animals to a median of 81% (IQR 71 – 88%) of controls 
with a median duration of inhibition of 61 min (IQR 34 – 61 min), however no 
significant inhibition was found in MIA-injected (n = 9) animals (p = 0.0162 and 
p = 0.5428 respectively, Friedman’s ANOVA; Figure 4.8A). Analysis of negative 
AUC values did not indicate any significant difference in overall inhibition 
between saline and MIA groups (p = 0.7057, unpaired t-test; Figure 4.9A). 
 
Significant inhibition by capsaicin was induced in toes-BF to a median of 23% 
(IQR 9 – 34%) and 28% (IQR 3 – 32%) of controls in saline (n = 10) and MIA-
injected (n = 9) animals respectively (p > 0.0001 for both, Friedman’s ANOVA; 
Figure 4.8B). Median duration of inhibition was calculated as 63 min (IQR 63 – 
63 min) and 63 min (IQR 47 – 63 min) for saline and MIA-injected animals 
respectively which was significantly different between groups (p = 0.0325, 
Mann-Whitney test). Equally, analysis of negative AUC values indicated no 
significant difference in overall inhibition between the saline and MIA-injected 
groups (p = 0.3401, unpaired t-test; Figure 4.9B). 
 
Data for one toes-TA response were excluded from analysis for one saline-




capsaicin-induced inhibition was observed in toes-TA responses in saline (n = 9) 
and MIA-injected (n = 9) animals to medians of 28% (IQR 8 – 34%) and 26% (IQR 
8 – 39%) of controls respectively (p < 0.0001 for both, Friedman’s ANOVA; 
Figure 4.8C). Median duration of inhibition was 63 min (IQR 47 – 63 min) and 
63 min (IQR 47 – 63 min) in saline and MIA-injected animals respectively which 
was not significantly different between groups (p = 0.6199, Mann-Whitney 
test). Similarly, negative AUC values were not significantly different between 






Figure 4.8. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral hindlimb on electrically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes in 
28-35 day saline and MIA-injected animals. Values plotted are medians and 





Figure 4.9. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral hindlimb on electrically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes in 
28-35 day saline (n = 10; 10; 9, respectively) and MIA-injected (n = 9) animals. 
Values plotted are area under curve (AUC) determinations for each animal, with 




4.3.4.2. Injection into the contralateral forelimb 
Significant inhibition of heel-MG responses was induced in both saline (n = 10) 
and MIA-injected (n = 9) animals (p = 0.0070 and p = 0.0005 respectively, 
Friedman’s ANOVA; Figure 4.10A) to a median of 92% (IQR 80 – 109%) and 79% 
(IQR 60 – 87%) of controls respectively. Median duration of inhibition was also 
similar between saline and MIA-injected animals (p = 0.6171, Mann-Whitney 
test) lasting for a median of 39 min (IQR 28 – 61 min) and 57 min (IQR 39 – 59 
min) respectively. Similarly, analysis of overall inhibition using negative AUC 
values indicated no significant difference between the saline and MIA groups 
(p = 0.1686, unpaired t-test; Figure 4.11A). 
 
Significant inhibition following capsaicin injection was observed in toes-BF 
responses in saline (n = 10) and MIA (n = 9) groups to medians of 31% (IQR 19 
– 37%) and 25% (IQR 16 – 64%) of controls respectively (p < 0.0001, Friedman’s 
ANOVA; Figure 4.10B); median duration of inhibition was 63 min (IQR 43 – 63 
min) and 47 min (IQR 41 – 63min) respectively which was not significantly 
different (p = 0.2539, Mann-Whitney test). Analysis of negative AUC values 
indicated no significant difference in overall inhibition between saline and MIA 
groups (p = 0.4479, unpaired t-test; Figure 4.11B). 
 
Significant inhibition of toes-TA reflexes was produced by 500 µg capsaicin in 
saline (n = 10) and MIA-injected (n = 9) animals to medians of 27% (IQR 11 – 




ANOVA; Figure 4.10C). Median duration of inhibition was not significantly 
different between saline and MIA groups (p = 0.7058, Mann-Whitney test) with 
medians of 43 min (IQR 31 – 60 min) and 51 min (IQR 27 – 63 min) respectively. 
Similarly, analysis of negative AUC values also indicated no significant 






Figure 4.10. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral forelimb on electrically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes in 
28-35 day saline and MIA-injected animals. Values plotted are medians and 





Figure 4.11. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral forelimb on electrically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes in 
28-35 day saline (n = 10) and MIA-injected (n = 9) animals. Values plotted are 
area under curve (AUC) determinations for each animal, with horizontal bars 




4.3.4.3. Effect of capsaicin injection site 
Comparison of heel-MG responses between hindlimb and forelimb capsaicin 
injection sites for saline or MIA animals indicated no significant differences in 
the degree of inhibition (p = 0.2176 and p = 0.3401 respectively, Mann-Whitney 
test), inhibition duration (p = 0.2455 and p = 0.3008 respectively, Mann 
Whitney test) or overall (AUC) inhibition (p = 0.2419 and p = 0.5705 
respectively, unpaired t-test). 
 
Degree of inhibition of toes-BF responses post-capsaicin was not significantly 
different between conditioning sites for saline or MIA-injected animals (p = 
0.4359 and p = 0.3388 respectively, Mann-Whitney test), as was duration of 
inhibition (p = 0.2105 and p = 0.2433 respectively, Mann-Whitney test) and 
overall inhibition (p = 0.1126 and p = 0.2713 respectively, unpaired t-test). Toes-
TA responses were also similarly inhibited from both hindlimb and forelimb 
capsaicin injections for saline or MIA groups in terms of depth (p = 0.8421 and 
p = 0.3996 respectively, Mann-Whitney test), duration (p = 0.0737 and p = 
0.1325 respectively, Mann-Whitney test) and overall inhibition (p = 0.3805 and 





4.3.5. Effect of 50 µg capsaicin on electrically-evoked responses 
4.3.5.1. Injection into the contralateral hindlimb 
No significant inhibition was found in heel-MG responses by 50 µg capsaicin in 
saline-injected (n = 10) animals (p = 0.5509, Friedman’s ANOVA; Figure 4.12A), 
however significant inhibition was induced in MIA-injected (n = 10) animals (p 
= 0.0139, Friedman’s ANOVA) to a median of 69% (IQR 55 – 93%) of controls 
with a median duration of inhibition of 61 min (IQR 0 – 61 min). Analysis of 
negative AUC values did not indicate any significant difference (p = 0.3804, 
unpaired t-test; Figure 4.13A) in overall inhibition between the saline and MIA-
injected animals. 
 
Significant inhibition following capsaicin injection was observed in toes-BF 
responses in saline (n = 10) and MIA-injected animals (n = 10) to medians of 
80% (IQR 77 – 83%) and 68% (IQR 53 – 88%) of controls respectively (p < 0.0001 
and p = 0.0002 respectively, Friedman’s ANOVA; Figure 4.12B). Median 
duration of inhibition was 61 min (IQR 17 – 63 min) and 29 min (IQR 17 – 56 
min) for saline and MIA-injected animals respectively, which was not 
significantly different between groups (p = 0.2290, Mann-Whitney test). 
Similarly, analysis of negative AUC values indicated no significant difference in 
overall inhibition between saline and MIA-injected animals (p = 0.2637, 





No significant inhibition was observed in saline-injected (n = 10) animals in toes-
TA responses (p = 0.0780, Friedman’s ANOVA; Figure 4.12C). However, 
significant inhibition (p < 0.0001, Friedman’s ANOVA) was induced in MIA-
injected (n = 10) animals in toes-TA responses to medians of 88% (IQR 64 – 93%) 
of controls with a median duration of inhibition of 21 min (IQR 11 – 27 min). 
Analysis of negative AUC values did not reveal any significant differences in 
overall inhibition between the saline and MIA-injected animals (p = 0.4884, 






Figure 4.12. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral hindlimb on electrically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes in 
28-35 day saline and MIA-injected animals. Values plotted are medians and 
errors are interquartile ranges. *p < 0.05 denotes significant difference 





Figure 4.13. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral hindlimb on electrically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes in 
28-35 day saline (n = 10) and MIA-injected (n = 10) animals. Values plotted are 
area under curve (AUC) determinations for each animal, with horizontal bars 




4.3.5.2. Injection into the contralateral forelimb 
Significant inhibition was induced in heel-MG responses by 50 µg capsaicin in 
saline-injected (n = 10) animals (p = 0.0137, Friedman’s ANOVA; Figure 4.14A) 
to a median of 86% (IQR 77 – 102%) of controls with a median duration of 
inhibition of 13 min (IQR 0 – 61 min). However, no significant inhibition (p = 
0.9902, Friedman’s ANOVA) was observed in MIA-injected (n = 10) animals. 
Similarly, analysis of negative AUC values indicated no significant difference in 
overall inhibition between the saline and MIA-injected animals (p = 0.8377, 
unpaired t-test; Figure 4.15A). 
 
Significant inhibition following capsaicin injection was observed in toes-BF 
responses in saline (n = 10) and MIA-injected (n = 10) animals to a median of 
70% (IQR 58 – 85%) and 65% (IQR 51 – 77%) of controls respectively (p < 0.0001, 
Friedman’s ANOVA; Figure 4.14B); median duration of inhibition was 27 min 
(IQR 20 – 60 min) and 23 min (IQR 17 – 57 min) respectively which was not 
significantly different (p = 0.5408, Mann-Whitney test). Further analysis using 
negative AUC values indicated no significant difference in overall inhibition 
between saline and MIA-injected animals (p = 0.4996, unpaired t-test; Figure 
4.15B). 
 
Significant inhibition of toes-TA responses was produced by capsaicin injection 
in saline (n = 10) and MIA-injected (n = 10) animals (p < 0.0001, Friedman’s 




84%) of controls respectively. Median duration of inhibition was not 
significantly different between saline and MIA groups (p = 0.3922, Mann-
Whitney test) with medians of 25 min (IQR 17 – 36 min) and 19 min (IQR 8 – 33 
min) respectively. Further analysis using negative AUC values also indicated no 
significant difference in overall inhibition between saline and MIA-injected 






Figure 4.14. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral forelimb on electrically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes in 
28-35 day saline and MIA-injected animals. Values plotted are medians and 





Figure 4.15. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral forelimb on electrically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes in 
28-35 day saline and MIA-injected animals. Values plotted are area under curve 
(AUC) determinations for each animal, with horizontal bars indicating medians 




4.3.5.3. Effect of capsaicin injection site 
Comparisons of heel-MG responses between hindlimb and forelimb capsaicin 
injection sites for saline or MIA animals indicated no significant differences in 
the degree of inhibition (p = 3930 and p = 0.4359 respectively, Mann-Whitney 
test), inhibition duration (p = 0.9157 and p = 0.4844 respectively, Mann 
Whitney test) or overall (AUC) inhibition (p = 0.3908 and p = 0.9925 
respectively, unpaired t-test). 
 
No significant differences were observed in toes-BF responses post-capsaicin 
between the conditioning sites for saline or MIA-injected animals in terms of 
degree of inhibition (p = 0.4937 and p = 0.6842 respectively, Mann-Whitney 
test), duration of inhibition (p = 0.3755 and p = 0.7243 respectively, Mann-
Whitney test) or overall (AUC) inhibition (p = 0.6516 and 0.9818 respectively, 
unpaired t-test). 
 
Toes-TA reflexes were also similarly inhibited from both hindlimb and forelimb 
capsaicin injections for saline or MIA animals in terms of depth (p = 0.3630 and 
p = 0.9705 respectively, Mann-Whitney test), duration (p = 0.8502 and p = 
0.7494 respectively, Mann-Whitney test) and overall (AUC) inhibition (p = 





4.3.6. Effect of 500 µg capsaicin on mechanically-evoked responses 
Responses evoked by 10 g and 26 g vF monofilaments were found to be variable 
and sometimes absent before and after capsaicin, therefore these responses 
have been omitted from analysis. 
 
4.3.6.1. Injection into the contralateral hindlimb 
In the saline group (n = 10), significant inhibition of heel-MG responses evoked 
by 60 g, 100 g, 180 g and 300 g vF weights was caused by contralateral hindlimb 
injection of capsaicin (p < 0.0001, p < 0.0001, p = 0.0001 and p < 0.0001 
respectively, Friedman’s ANOVA) to a median of 13% (IQR 1 – 35%), 5% (IQR 0 
– 18%), 22% (IQR 5 – 38%) and 34% (IQR 11 – 47%) of controls respectively 
(Figures 4.16A, 4.17A, 4.18A and 4.19A). The corresponding level of inhibition 
in MIA-injected animals (n = 10) was to a median of 2% (IQR 1 – 21%), 1% (IQR 
1 – 14%), 21% (IQR 17 – 42%) and 40% (IQR 27 – 65%) of controls respectively 
(p = 0.0007, p < 0.0001, p = 0.0010 and p = 0.0055 respectively, Friedman’s 
ANOVA). Median duration of inhibition was 49 min (IQR 27 – 61 min), 57 min 
(IQR 30 – 61 min), 47 min (IQR 33 – 61 min) and 39 min (IQR 31 – 61 min) for 
60 g, 100 g, 180 g and 300 g vF weights respectively in saline-injected animals 
and 51 min (IQR 0 – 61 min), 53 min (IQR 0 – 58 min), 59 min (IQR 35 – 61 min) 
and 45 min (IQR 27 – 61 min) for the corresponding vF weights in MIA-injected 
animals; which were not significant between groups (p = 0.8960, p = 0.4901, p 
= 0.5306 and p = 0.9242 respectively, Mann-Whitney test). Analysis of negative 




reflexes to 60 – 300 g vF filaments between saline and MIA-injected animals (p 
= 0.4452, p = 0.1203, p = 0.7774 and p = 0.7924 respectively, unpaired t-test; 
Figure 4.20A). 
 
Following capsaicin administration, toes-BF reflexes evoked by 60 g, 100 g, 180 
g and 300 g monofilaments were significantly inhibited (p < 0.0001, Friedman’s 
ANOVA) to medians of 6% (IQR 1 – 15%), 12% (IQR 3 – 30%), 22% (IQR 12 – 36%) 
and 32% (IQR 25 – 49%) of controls respectively in saline-injected animals (n = 
10; Figures 4.16B, 4.17B, 4.18B and 4.19B). These reflexes in MIA-injected 
animals (n = 10) were significantly inhibited (p < 0.0001, Friedman’s ANOVA) to 
a median of 12% (IQR 2 – 26%), 25% (IQR 5 – 43%), 33% (IQR 12 – 37%) and 46% 
(IQR 10 – 56%) of controls at the corresponding vF weights. Median duration of 
inhibition was 47 min (IQR 35 – 63 min), 51 min (IQR 27 – 63 min), 53 min (IQR 
29 – 63 min) and 63 min (IQR 58 – 63 min) for 60 g, 100 g, 180 g and 300 g vF 
weights respectively in saline-injected animals and 33 min (IQR 0 – 63 min), 59 
min (IQR 26 – 63 min), 59 min (IQR 48 – 63 min) and 63 min (IQR 25 – 63 min) 
in MIA-injected animals; these durations were not significant between groups 
(p = 0.4551, p = 0.4781, p = 0.4467 and  p = 0.3870 respectively, Mann-Whitney 
test). Analysis of negative AUC values indicated no significant difference in 
overall inhibition of responses to 60 – 300 g vF filaments between treatment 
groups (p = 0.1822, p = 0.1033, p = 0.3018 and p = 0.9034 respectively, unpaired 





For toes-TA reflexes in saline-injected animals (n = 10), responses to 60 g, 100 
g, 180 g and 300 g monofilaments were significantly inhibited (p < 0.0001, 
Friedman’s ANOVA) to medians of 8% (IQR 4 – 35%), 11% (IQR 4 – 54%), 33% 
(IQR 19 – 58%) and 51% (IQR 42 – 63%) of controls respectively (Figures 4.16C, 
4.17C, 4.18C and 4.19C); for MIA-injected animals (n = 10), significant inhibition 
(p < 0.0001, p < 0.0001, p = 0.0001 and p = 0.0004 respectively, Friedman’s 
ANOVA) to medians of 6% (IQR 2 – 16%), 22% (IQR 3 – 39%), 32% (IQR 21 – 42%) 
and 39% (IQR 27 – 70%) of controls was produced in TA reflexes evoked by 
these same respective vF filaments. Median duration of inhibition was 41 min 
(IQR 17 – 63 min), 37 min (IQR 29 – 63 min), 35 min (IQR 27 – 44 min) and 63 
min (IQR 58 – 63 min) for 60 g, 100 g, 180g  and 300 g vF weights respectively 
in saline-injected animals and correspondingly 61 min (IQR 0 – 63 min), 59 min 
(IQR 38 – 63 min), 63 min (IQR 48 – 63 min) and 53 min (IQR 8 – 63 min) in MIA-
injected animals which indicated significance in responses evoked using the 180 
g vF weight (p = 0.7416, p = 0.3860, p = 0.0332 and  p = 0.6176 respectively, 
Mann-Whitney test). Comparison of negative AUC values similarly found that 
overall inhibition of toes-TA responses was not significantly different between 
saline and MIA-injected animals for any vF weight (p = 0.2296, p = 0.1607, p = 






Figure 4.16. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral hindlimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 60 g von Frey (vF) monofilament in 28-35 day saline and MIA-injected 
animals. Values plotted are medians and errors are interquartile ranges. *p < 
0.05 denotes significant difference between saline and MIA-injected animals at 





Figure 4.17. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral hindlimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 100 g von Frey (vF) monofilament in 28-35 day saline and MIA-injected 
animals. Values plotted are medians and errors are interquartile ranges. *p < 
0.05 denotes significant difference between saline and MIA-injected animals at 





Figure 4.18. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral hindlimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 180 g von Frey (vF) monofilament in 28-35 day saline and MIA-injected 
animals. Values plotted are medians and errors are interquartile ranges. *p < 
0.05 denotes significant difference between saline and MIA-injected animals at 





Figure 4.19. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral hindlimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 300 g von Frey (vF) monofilament in 28-35 day saline and MIA-injected 





Figure 4.20. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral hindlimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using 60 – 300 g von Frey (vF) monofilaments in 28-35 day saline (n = 10, closed 
symbols) and MIA-injected (n = 10, open symbols) animals. Values plotted are 
area under curve (AUC) determinations for each animal with horizontal bars 




4.3.6.2. Injection into the contralateral forelimb 
Significant inhibition (p < 0.0001, Friedman’s ANOVA; Figures 4.21A, 4.22A, 
4.23A and 4.24A) was induced in heel-MG using 60 g, 100 g, 180 g and 300 g 
monofilaments to medians of 7% (IQR 2 – 12%), 1% (IQR 0 – 11%), 10% (IQR 3 
– 34%) and 30% (IQR 15 – 36%) of controls respectively in saline-injected 
animals (n = 10). These reflexes in MIA-injected animals (n = 9) were 
significantly inhibited (p < 0.0001, Friedman’s ANOVA) to medians of 1% (IQR 1 
– 4%), 6% (IQR 1 – 24%), 30% (IQR 17 – 55%) and 56% (IQR 52 – 63%) of controls 
at the corresponding vF weights. Median duration of inhibition was 35 min (IQR 
0 – 42 min), 29 min (IQR 0 – 41 min), 33 min (IQR 19 – 53 min) and 35 min (IQR 
25 – 57 min) for 60 g, 100 g, 180 g and 300 g vF weights respectively in saline-
injected animals and 57 min (IQR 23 – 61 min), 53 min (IQR 37 – 59 min), 45 
min (IQR 19 – 61 min) and 29 min (IQR 11 – 59 min) in MIA-injected animals 
which indicated significance between groups in responses evoked by the 100 g 
vF weight (p = 0.1238, p = 0.0254, p = 0.4529 and p = 0.7037 respectively, Mann-
Whitney test). Further analysis using negative AUC values indicated that overall 
inhibition was significantly different between saline and MIA-injected animals 
in responses evoked using the 60 g filament, however reflexes evoked by 100 
g, 180 g and 300 g showed no significant differences between treatment groups 






In the saline group (n = 10), significant inhibition of toes-BF reflexes evoked by 
60 g, 100 g, 180 g and 300 g vF weights was induced by contralateral hindlimb 
injection of capsaicin (p < 0.0001, Friedman’s ANOVA; Figures 4.21B, 4.22B, 
4.23B and 4.24B) to medians of 3% (IQR 0 – 31%), 5% (IQR 1 – 31%), 16% (IQR 
2 – 54%) and 34% (IQR 5 – 64%). The corresponding level of inhibition in the 
MIA-injected group (n = 9) was to a median of 15% (IQR 12 – 24%), 23% (IQR 4 
– 35%), 29% (IQR 17 – 64%) and 45% (IQR 24 – 68%) of controls respectively (p 
< 0.0001, Friedman’s ANOVA). Median duration of inhibition was 25 min (IQR 0 
– 63 min), 53 min (IQR 25 – 63 min), 43 min (IQR 27 – 63 min) and 41 min (IQR 
15 – 63 min) for 60 g, 100 g, 180 g and 300 g vF filaments respectively in saline-
injected animals and 55 min (IQR 10 – 63 min), 47 min (IQR 23 – 61 min), 31 
min (IQR 13 – 63 min) and 63 min (IQR 45 – 63 min) for the corresponding vF 
weights in MIA-injected animals; which were not significant between groups (p 
= 0.6372, p = 0.7603, p = 0.6970 and p = 0.1990 respectively, Mann-Whitney 
test). Analysis of negative AUC values found no significant difference in overall 
inhibition of toes-BF responses between saline and MIA-injected animals (p = 
0.7144, p = 0.9687, p = 0.9365 and p = 0.8000 respectively, unpaired t-test; 
Figure 4.25B). 
 
Following capsaicin injection toes-TA responses evoked by 60 g, 100 g, 180 g 
and 300 g monofilaments were significantly inhibited (p < 0.0001, Friedman’s 
ANOVA; Figures 4.21C, 4.22C, 4.23C and 4.24C) to medians of 7% (IQR 2 – 32%), 




saline-injected animals (n = 10); for MIA-injected animals (n = 9), significant 
inhibition (p < 0.0001 Friedman’s ANOVA) to medians of 16% (IQR 11 – 39%), 
27% (IQR 10 – 44%), 43% (IQR 37 – 60%) and 77% (IQR 65 – 97%) of controls 
was produced in toes-TA reflexes by these same respective vF filaments. 
Median duration of inhibition was 53 min (IQR 26 – 63 min), 49 min (IQR 27 – 
63 min), 51 min (IQR 27 – 63 min) and 39 min (IQR 23 – 60 min) for 60 g, 100 g, 
180 g and 300 g vF weights respectively in saline-injected animals and 
correspondingly 55 min (IQR 19 – 63 min), 59 min (IQR 29 – 63 min), 35 min 
(IQR 27 – 63 min) and 19 min (IQR 9 – 63 min) in MIA-injected animals which 
were not significantly different between groups (p = 0.7940, p = 0.8218, p = 
0.6640 and p = 0.3614 respectively, Mann-Whitney test). Comparison of 
negative AUC values found that overall inhibition of toes-TA responses was not 
significantly different between saline and MIA-injected animals for any vF 
weight (p = 0.7320, p = 0.6973, p = 0.5141 and p = 0.2954 respectively, unpaired 






Figure 4.21. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral forelimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 60 g von Frey (vF) monofilament in 28-day in saline and MIA-injected 
animals. Values plotted are medians and errors are interquartile ranges. *p < 






Figure 4.22. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral forelimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 100 g von Frey (vF) monofilament in 28-day in saline and MIA-injected 
animals. Values plotted are medians and errors are interquartile ranges. *p < 






Figure 4.23. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral forelimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 180 g von Frey (vF) monofilament in 28-day in saline and MIA-injected 
animals. Values plotted are medians and errors are interquartile ranges. *p < 






Figure 4.24. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral forelimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 300 g von Frey (vF) monofilament in 28-day in saline and MIA-injected 
animals. Values plotted are medians and errors are interquartile ranges. *p < 







Figure 4.25. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral forelimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using 60 – 300 g von Frey (vF) monofilaments in 28-day saline (n = 10, closed 
symbols) and MIA-injected (n = 9, open symbols) animals. Values plotted are 
area under curve (AUC) determinations for each animal with horizontal bars 




4.3.6.3. Effect of capsaicin injection site 
In nearly all cases, comparison of heel-MG, toes-BF and toes-TA responses 
between hindlimb and forelimb capsaicin injection sites indicated no significant 
difference in the degree, duration or overall inhibition between saline or MIA-
injected animals (p > 0.05, Mann-Whitney or unpaired t-test). The one 
exception being that duration of inhibition was significantly shorter after 
forelimb compared to hindlimb injection for heel-MG reflexes evoked by the 
100 g monofilament in saline-injected animals with medians of 29 min (IQR 0 – 






4.3.7. Effect of 50 µg capsaicin on mechanically-evoked responses 
Responses evoked by 10 g and 26 g vF monofilaments were found to be variable 
and sometimes absent before and after capsaicin, therefore these responses 
have been omitted from results. 
 
4.3.7.1. Injection into the contralateral hindlimb 
In the saline group (n = 10), no significant inhibition was induced in heel-MG by 
60 g, 100 g, 180 g or 300 g vF weights (p = 0.5695, p = 0.3639, p = 0.1898 and p 
= 0.4784 respectively, Friedman’s ANOVA) or in MIA-injected animals (n = 11) 
evoked by 180 g and 300 g vF weights (p = 0.4981 and p = 0.6085 respectively, 
Friedman’s ANOVA; Figures 4.26A, 4.27A, 4.28A and 4.29A). However, 
significant inhibition was induced in responses evoked by 60 g and 100 g vF 
weights in MIA-injected animals (p = 0.0003 and p = 0.0081 respectively, 
Friedman’s ANOVA) to medians of 55% (IQR 23 – 98%) and 65% (IQR 54 – 101%) 
respectively. Median duration of inhibition was calculated as 13 min (IQR 0 – 
61 min) and 17 min (IQR 0 – 21 min) for 60 g and 100 g vF weights respectively 
in MIA-injected animals which was not significant between groups (p = 0.6802, 
Mann-Whitney test). Analysis of negative AUC values indicated no significant 
differences in overall inhibition of heel-MG reflexes between saline and MIA-
injected animals (p = 0.3757, p = 0.8095, p = 0.4907 and p = 0.4978 respectively, 





Toes-BF responses evoked by 60 g, 100 g, 180 g and 300 g monofilaments were 
inhibited by 50 µg capsaicin into the contralateral hindlimb to medians of 56% 
(IQR 36 – 82%), 51% (IQR 42 – 70%), 82% (IQR 60 – 89%) and 80% (IQR 69 – 
95%) of controls respectively in saline-injected animals (n = 10), however the 
inhibitory effect for responses evoked by the 300 g vF filament was not found 
to be significant (p = 0.0009, p = 0.0002, p = 0.0418 and p = 0.1243 respectively, 
Friedman’s ANOVA; Figures 4.26B, 4.27B, 4.28B and 4.29B). These reflexes in 
MIA-injected animals (n = 11) were significantly inhibited (p = 0.0046, p < 
0.0001, p = 0.0038 and p = 0.0002 respectively, Friedman’s ANOVA) to a median 
of 56% (IQR 6 – 117%), 26% (IQR 5 – 96%), 51% (IQR 26 – 79%) and 65% (IQR 16 
– 87%) of controls at the corresponding vF weights. Median duration of 
inhibition was calculated as 0 min (IQR 0 – 17 min), 7 min (IQR 0 – 23 min), 17 
min (IQR 8 – 38 min) and 15 min (IQR 6 – 30 min) for 60 g, 100 g, 180 g and 300 
g vF weights respectively in saline-injected animals and 0 min (IQR 0 – 15 min), 
51 min (IQR 0 – 63 min), 23 min (IQR 11 – 43 min) and 31 min (IQR 11 – 47 min) 
in MIA-injected animals which was significant between groups (p = 0.7178, p = 
0.1018, p = 0.4959 and p = 0.3568 respectively, Mann-Whitney test). Analysis 
of negative AUC values revealed significant differences in overall inhibition 
between saline and MIA-injected animals of responses to the 100 g vF weight 
in the toes-BF reflex response (p = 0.0305, unpaired t-test; Figure 4.30B), 
however did not reveal any significant differences in responses to any other 
filaments (60 g, 180 g and 300 g)(p = 0.6508, p = 0.1616 and p = 0.1579 





For toes-TA reflexes in saline-injected animals (n = 10), responses to 60 g, 100 
g, 180 g and 300 g vF filaments were inhibited to medians of 63% (IQR 41 – 
93%), 78% (IQR 52 – 101%), 95% (IQR 84 – 98%) and 87% (IQR 70 – 99%) of 
controls respectively, however the inhibitory effect for responses evoked by 
the 300 g vF filament was not found to be significant (p = 0.0368 p = 0.0005, p 
= 0.0303 and p = 0.0681 respectively, Friedman’s ANOVA; Figures 4.26C, 4.27C, 
4.28C and 4.29C). Similarly, for MIA-injected animals (n = 11) significant 
inhibition (p = 0.0018, p < 0.0001, p = 0.0004 and p = 0.0018 respectively, 
Friedman’s ANOVA) to medians of 50% (IQR 11 – 92%), 58% (IQR 27 – 92%), 
77% (IQR 69 – 89%) and 84% (IQR 66 – 88%) of controls was produced in toes-
TA reflexes evoked by these same respective vF filaments. Median duration of 
inhibition was calculated as 9 min (IQR 0 – 17 min), 11 min (IQR 0 – 24 min), 19 
min (IQR 7 – 48 min) and 10 min (IQR 0 – 30 min) for 60 g, 100 g,180 g and 300 
g vF weights respectively in saline-injected animals and correspondingly 15 min 
(IQR 0 – 43 min), 23 min (IQR 7 – 63 min), 23 min (IQR 11 – 35 min) and 43 min 
(IQR 23 – 63 min) in MIA-injected animals which was not significant between 
groups (p = 0.5523, p = 0.02520, p = 0.9063 and p = 0.0513 respectively, Mann-
Whitney test). Comparison of negative AUC values found significant differences 
in overall inhibition of toes-TA responses evoked by the 100 g vF filament (p = 
0.0335, unpaired t-test; Figure 4.30C), however, responses evoked by 60 g, 180 
g and 300 g vF filaments did not indicate any significant differences (p = 0.6738, 





Figure 4.26. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral hindlimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 60 g von Frey (vF) monofilament in 28-35 day saline and MIA-injected 
animals. Values plotted are medians and errors are interquartile ranges. *p < 
0.05 denotes significant difference between saline and MIA-injected animals at 





Figure 4.27. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral hindlimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 100 g von Frey (vF) monofilament in 28-35 day saline and MIA-injected 
animals. Values plotted are medians and errors are interquartile ranges. *p < 
0.05 denotes significant difference between saline and MIA-injected animals at 





Figure 4.28. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral hindlimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 180 g von Frey (vF) monofilament in 28-35 day saline and MIA-injected 
animals. Values plotted are medians and errors are interquartile ranges. *p < 
0.05 denotes significant difference between saline and MIA-injected animals at 





Figure 4.29. Effect of intramuscular injection of 500 µg capsaicin into the 
contralateral hindlimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 300 g von Frey (vF) monofilament in 28-35 day saline and MIA-injected 
animals. Values plotted are medians and errors are interquartile ranges. *p < 
0.05 denotes significant difference between saline and MIA-injected animals at 





Figure 4.30. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral hindlimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using 60 – 300 g von Frey (vF) monofilaments in 28-35 day saline (n = 10, closed 
symbols) and MIA-injected (n = 11, open symbols) animals. Values plotted are 
area under curve (AUC) determinations for each animal with horizontal bars 
indicating medians and interquartile ranges. *p < 0.05 denotes significant 




4.3.7.2. Injection into the contralateral forelimb 
Following 50 µg capsaicin to the contralateral forelimb, heel-MG responses 
evoked by 60 g, 100 g, 180 g and 300 g vF filaments were inhibited to medians 
of 73% (IQR 62 – 136%), 62% (IQR 41 – 85%), 83% (IQR 62 – 86%) and 83% (IQR 
76 – 90%) of controls respectively in saline-injected animals (n = 9), however 
the inhibitory effect for responses evoked by the 300 g vF filament was not 
found to be significant (p = 0.0011, p < 0.0001, p = 0.0005 and p = 0.0615 
respectively, Friedman’s ANOVA; Figures 4.31A, 4.32A, 4.33A and 4.34A). 
Similarly, in MIA-injected animals (n = 11), heel-MG responses evoked by the 
corresponding vF weights were inhibited to medians of 64% (IQR 51 – 93%), 
97% (IQR 68 – 100%), 99% (IQR 77 – 104%) and 94% (IQR 84 – 110%) of controls, 
however responses evoked by 100 g and 300 g were not found to be significant 
(p = 0.0006, p = 0.0622, p = 0.0407 and p = 0.1229 respectively, Friedman’s 
ANOVA). Median duration of inhibition in saline-injected animals was 0 min 
(IQR 0 – 3 min), 9 min (IQR 0 – 33 min), 53 min (IQR 13 – 59 min) and 61 min 
(IQR 13 – 61 min)  for 60 g, 100 g, 180 g and 300 g vF weights respectively and 
1 min (IQR 0 – 61 min), 1 min (IQR 0 – 61 min), 9 min (IQR 0 – 61 min) and 0 min 
(IQR 0 – 61 min)  in MIA-injected animals; these durations were not significantly 
different between groups (p = 0.1968, p = 0.8913, p = 0.2768 and p = 0.0650, 
Mann-Whitney test). Furthermore, analysis of negative AUC values revealed no 
significant differences in overall inhibition of responses to 60 – 300 g vF 
filaments between groups (p = 0.7835, p = 0.7281, p = 0.8554 and p = 0.4589 





In saline-injected animals (n = 9), significant inhibition of toes-BF responses 
evoked by 60 g, 100 g, 180 g and 300 g monofilaments was induced (p = 0.0001, 
p = 0.0153, p < 0.0001 and p = 0.0001 respectively, Friedman’s ANOVA; Figures 
4.31B, 4.32B 4.33B and 4.34B) to medians of 15% (IQR 9 – 47%), 65% (IQR 33 – 
82%), 75% (IQR 70 – 92%) and 87% (IQR 68 – 107%) of controls respectively. 
The corresponding level of significant inhibition in MIA-injected animals (n = 11) 
was to medians of 53% (IQR 17 – 81%), 28% (IQR 21 – 56%), 54% (IQR 29 – 69%) 
and 63% (IQR 44 – 73%) of controls respectively (p < 0.0001, Friedman’s 
ANOVA). Median duration of inhibition was calculated as 11 min (IQR 0 – 47 
min), 0 min (IQR 0 – 31 min), 15 min (IQR 0 – 43 min) and 11 min (IQR 0 – 25 
min) for 60 g, 100 g, 180 g and 300 g vF weights respectively in saline-injected 
animals and 0 min (IQR 0 – 7 min), 23 min (IQR 0 – 31 min), 35 min (IQR 11 – 55 
min) and 35 min (IQR 15 – 63 min) for the corresponding vF weights in MIA-
injected animals; these durations were significantly different for the 300 g vF 
weight, however no other differences were found (p = 0.0928, p = 0.3448, p = 
0.2356 and p = 0.0286, Mann-Whitney test). Analysis of negative AUC values 
revealed significant differences in overall inhibition of toes-BF responses to 180 
g and 300 g vF filaments (p = 0.0204 and p = 0.0220 respectively, unpaired t-
test; Figure 4.35B), however, no other differences between groups were 





Following capsaicin administration, toes-TA reflex responses evoked by 60 g, 
100 g, 180 g and 300 g vF filaments were inhibited to medians of 40% (IQR 22 – 
62%), 86% (IQR 74 – 100%), 82% (IQR 74 – 99%) and 80% (IQR 76 – 94%) of 
controls respectively in saline-injected animals (n = 9), however the inhibition 
evoked using 180 g was not significant (p < 0.0001, p = 0.0088, p = 0.6771 and 
p = 0.0411 respectively, Friedman’s ANOVA; Figures 4.31C, 4.32C, 4.33C and 
4.34C). Similarly, these reflexes in MIA-injected animals (n = 11) were inhibited 
to medians of 52% (IQR 23 – 64%), 60% (IQR 56 – 73%), 105% (IQR 92 – 120%) 
and 101% (IQR 82 – 104%) of controls at the corresponding vF weights, however 
the inhibition evoked using 300 g was not significant (p = 0.0001, p < 0.0001, p 
= 0.0016 and p = 0.0557 respectively, Friedman’s ANOVA). Median duration of 
inhibition was calculated as 7 min (IQR 0 – 39 min), 7 min (IQR 0 – 17 min), 11 
min (IQR 0 – 27 min) and 19 min (IQR 0 – 43 min) for 60 g, 100 g, 180 g and 300 
g vF weights respectively in saline-injected animals and 23 min (IQR 0 – 47 min), 
19 min (IQR 0 – 51 min), 15 min (IQR 0 – 39 min) and 15 min (IQR 0 – 39 min) in 
MIA-injected animals, which was not significantly different between groups (p 
= 0.5208, p = 0.1481, p = 0.4525 and p = 0.9175 respectively, Mann-Whitney 
test). Analysis of negative AUC values revealed no significant differences in 
overall inhibition of responses to 60 – 300 g vF filaments (p = 0.2175, p = 0.5542, 





Figure 4.31. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral forelimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 60 g von Frey (vF) monofilament in 28-35 day saline and MIA-injected 
animals. Values plotted are medians and errors are interquartile ranges. *p < 
0.05 denotes significant difference between saline and MIA-injected animals at 





Figure 4.32. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral forelimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 100 g von Frey (vF) monofilament in 28-35 day saline and MIA-injected 





Figure 4.33. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral forelimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 180 g von Frey (vF) monofilament in 28-35 day saline and MIA-injected 
animals. Values plotted are medians and errors are interquartile ranges. *p < 
0.05 denotes significant difference between saline and MIA-injected animals at 





Figure 4.34. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral forelimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 300 g von Frey (vF) monofilament in 28-35 day saline and MIA-injected 
animals. Values plotted are medians and errors are interquartile ranges. *p < 
0.05 denotes significant difference between saline and MIA-injected animals at 





Figure 4.35. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral forelimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using 60 – 300 g von Frey (vF) monofilaments in 28-35 day saline (n = 9, closed 
symbols) and MIA-injected (n = 11, open symbols) animals. Values plotted are 
area under curve (AUC) determinations for each animal with horizontal bars 
indicating medians and interquartile ranges. *p < 0.05 denotes significant 




4.3.7.3. Effect of capsaicin injection site 
Comparison of heel-MG, toes-BF and toes-TA responses between hindlimb and 
forelimb capsaicin injection sites indicated no significant differences in the 
degree, duration or overall (AUC) inhibition between saline or MIA-injected 






OA is a degenerative joint disease which can be investigated in animals using 
various animal models (see section 1.5.6). After 28-35 days the MIA model has 
been shown to have severe cartilage lesions across the whole articular surface 
(0.3 mg and 3.0 mg dose) with chondral erosions and exposing the subchondral 
bone on both the tibial plateau and femoral condyle (Guingamp et al., 1997). 
The non load-bearing regions of the joint such as the patella and femoral groove 
have been shown to be much less affected, however large osteophytes can be 
observed in the periphery of the femoral condyles and tibial plateaus after 30 
days (0.3 mg and 3.0 mg dose) and still persist after 49 days (1 mg 
dose)(Guingamp et al., 1997; Mapp et al., 2013). Macroscopic chondropathy 
scores were shown to be significantly increased after 21 days in MIA-injected 
animals (1 mg dose) characterised by cartilage damage in both the medial and 
lateral tibiofemoral compartments (Nwosu et al., 2016a). In the present study 
MIA animals had severe cartilage damage 28-35 days post-injection with the 
majority of cartilage on both the tibial plateaus and femoral condyles 
completely destroyed. The surface of the joint indicated deep fibrillation as well 
as large “stippled white” areas where the underlying subchondral bone was 
exposed. In some of the scored MIA joints, the presence of osteophytes in the 
periphery of the joint could be observed and although this was not taken into 
account in the scoring of joints it is a key feature of the development and 
severity of OA. Although the present study did not investigate the histology of 




observed in animals injected with MIA (Guingamp et al., 1997; Guzman et al., 
2003; Fernihough et al., 2004; Pomonis et al., 2005; Ferland et al., 2011; Mapp 
et al., 2013; Nwosu et al., 2016a, 2016b). Histology at 22 days post MIA injection 
(1 mg dose) revealed chondrocyte necrosis with loss of the matrix which results 
in a significant decrease in the thickness of the cartilage. This marked change in 
the cartilage often leads to separation of the necrotic cartilage from the 
subchondral bone resulting in fibrillation and ulceration of the cartilage, 
eventually exposing the underlying subchondral bone (van der Kraan et al., 
1989; Guingamp et al., 1997; Guzman et al., 2003; Pomonis et al., 2005). After 
14 days, synovial inflammation has been observed in the MIA model (1 mg 
dose) which, persisting for the duration of the disease, is associated with 
increased osteophyte formation in both human and mouse OA (Dieppe and 
Lohmander, 2005). Additionally, assessing radiographs of MIA-injected joints (1 
mg) after 29 days indicated obvious joint degeneration which was characterised 
by osteolysis and swelling as well as displacement of the patella, along with 
significant reductions in bone marrow density (BMD) and bone mineral content 
(BMC) at 24 days using the same concentration (Pomonis et al., 2005). In the 
present studies, the MIA model led to significantly increased joint severity 
scores in the ipsilateral hindlimb compared to saline injected controls and 
contralateral hindlimbs after the 28-35 day post injection period. All 3 scoring 
methods indicated the same differences that the MIA-injected ipsilateral 
hindlimb was significantly altered from the ipsilateral saline-injected limb as 
well as both contralateral groups, however the SFA scoring and revised SFA 




method. Other studies have assessed joint scoring based on damage 
characterised by cartilage thinning, loss of proteoglycan staining and cleft 
formation, indicating a 2 mg MIA model had significant joint damage scores at 
28 days post injection (Fernihough et al., 2004). What is clear from previous 
macroscopic and histological investigations is that the MIA model is strongly 
related to the concentration of MIA injected, with dosages ranging from 0.01 
mg to 3.0 mg, however 1 mg and 2 mg are more commonly used to produce 
measurable pathological changes associated with human OA. This is evidenced 
by the injection of 0.03 mg and 0.1 mg doses of MIA which had significantly less 
severe cartilage lesions with cartilage in load-bearing areas showing signs of 
thinning when compared to 0.3 mg and 3.0 mg doses and doses of 0.01 mg 
showed no macroscopic changes at all after 30 days (Guingamp et al., 1997). 
The efficacy of the MIA animal model in producing pain behaviour was 
measured in the form of PWTs to assess mechanical allodynia and hyperalgesia 
as an induced stimulus response, and weight bearing to assess any deficit in the 
OA limb. As expected, weight bearing and PWTs were found to be significantly 
reduced in the MIA injected limb, with this increased sensitivity being apparent 
at the latest by day 7 (the first post-injection behavioural testing point in these 
particular studies). Previous studies using the same MIA dose have shown that 
a reduction in ipsilateral weight bearing is present at 7 days post-injection (Bove 
et al., 2003). These authors also found that increasing the amount of MIA 
injected (to 3 mg) produced no greater pain behaviour than 1 mg. Studies using 
2 mg MIA showed animals had weight bearing asymmetry at day 5 which was 




period, as were deficits in the current studies (Bove et al., 2003; Fernihough et 
al., 2004). Similarly, PWTs using vF monofilaments were found to dramatically 
decrease post-injection and stay at a similar level for the duration of the 28 day 
post injection period (Fernihough et al., 2004; Ferland et al., 2011). The 
pathological and behavioural changes measured indicate that the OA model 
was established in the present studies and produced consistent quantifiable 
pain behaviour that was maintained until the period of electrophysiology 
testing. 
 
There is evidence to suggest that in OA, a change in descending controls occurs 
and this may be reflected in a change in the efficacy of DNIC which is believed 
to contribute significantly to enhanced pain responses and the spread of pain 
in OA (Arendt-Nielsen et al., 2010). However, the present electrophysiological 
studies investigating the efficacy of DNIC in saline and MIA-injected animals 
indicated there were no significant differences observed in animals at day 28-
35 post-injection. Previous studies investigating DNIC in animal models of 
chronic pain conditions indicate DNIC inhibition is abolished in moderate to 
severe chronic pain models after 14 days (Danziger et al., 1999, 2001; Okada-
Ogawa et al., 2009; Bannister et al., 2015; Lockwood et al., 2019b). In a 2 mg 
MIA model, DNIC investigated in single cell responses in the dorsal horn 14-20 
days post-injection were not altered after application of a noxious pinch 
conditioning stimulus showing that DNIC in chronic OA has been eliminated 




adjuvant (CFA) to the ankle) electrically-stimulated extracellular recordings 
from neurons in the nucleus caudalis were subjected to mechanical and 
thermal stimulation 3-4 weeks post injection and it was found that DNIC was 
reduced in these animals compared to the control (Danziger et al., 1999). This 
lack of inhibition is also observed in spinal nerve ligation (SNL) injured animals, 
14-18 days post surgery, where mechanically-evoked deep dorsal horn neurons 
were inhibited by noxious ear pinch in sham surgery animals but this DNIC 
inhibition was not present in operated animals (Bannister et al., 2015). The MIA 
and CFA models are both considered to have a neuropathic component in their 
later stages, comparably SNL nerve injury is a model of neuropathic pain, 
therefore the alteration of DNIC in both studies show that descending pathways 
are altered in neuropathic pain models. Similarly, in chronic morphine treated 
animals, a model to represent medication overuse which can produce chronic 
daily headache in humans, DNIC of medullary dorsal horn neurons induced by 
thermal conditioning stimulation was again abolished compared to controls 
(Okada-Ogawa et al., 2009). 
 
The current study investigated the effect of two doses of capsaicin on DNIC of 
NWRs and did not find any difference between the saline and MIA-injected 
animals at either dose. DNIC investigated after 14-20 days in animals given 2 
mg MIA to the knee joint found extracellular single unit responses from the 
deep dorsal horn WDR neurons in laminae V – VI were inhibited using 




(Lockwood et al., 2019b). This would suggest that chemical capsaicin 
stimulation is potentially still too noxious to observe subtle differences 
between saline and MIA animals and that mechanical conditioning stimulation 
may be more suited for investigating these changes. This has been observed 
previously whereby after noxious ear pinch there was a consistent lack of 
reduction in evoked responses, however after noxious ipsilateral knee pinch 
some inhibition was observed indicating that inhibition was possible to induce 
if the conditioning stimulus was highly noxious (Lockwood et al., 2019b). This 
difference between noxious ear pinch and noxious ipsilateral knee pinch may 
also be due to the conditioning stimulus site in that pinch to the knee may have 
been more efficacious in inducing inhibition in evoked responses compared to 
ear pinch (Lockwood et al., 2019b). In the current study inhibition differences 
are observed between the two conditioning stimulus sites (hindlimb and 
forelimb) in both saline and MIA-injected animals suggesting that the site of 
stimulation is a key factor in inducing DNIC inhibition.  
 
In the current study both electrical and mechanical test stimulus modalities 
were utilised to further investigate the test and conditioning stimulus 
relationship. No significant differences between saline and MIA-injected 
animals were determined using either electrical or mechanical test stimulation, 
however these results would suggest that mechanically-evoked reflex 
responses are more useful as they allowed a range of stimulation intensities to 




saline-injected animals it did allow a test versus conditioning effect to be 
observed with results indicating that as vF weight was increased the DNIC 
induced inhibition was reduced at both doses of capsaicin. In previous studies, 
electrically-evoked single convergent neurons in the nucleus caudalis were 
subjected to graded mechanical and electrical conditioning stimulation of the 
hindpaw in nerve-injured rats and it was found that in response to both graded 
mechanical and electrical stimulation DNIC inhibition was significantly larger as 
the stimulus intensity increased (Danziger et al., 2001). However, DNIC 
inhibition triggered by mechanical stimulation was significantly increased when 
applied to the operated hindpaw compared to the non-operated hindpaw in 
nerve injured rats, but this was not the case for electrical stimulation, whereby 
DNIC induced inhibitions were similar regardless of the stimulation site 
(Danziger et al., 2001). These differences in DNIC induced inhibitions clearly 
indicate the importance of the test stimulus. 
 
It is important to note that all the previously mentioned studies investigating 
DNIC in chronic pain models are undertaken in responses from extracellular 
recordings of the dorsal horn or the nucleus caudalis whereas the present study 
has uniquely recorded from reflex responses in hindlimb muscles. It is therefore 
an important consideration that the lack of difference between saline and MIA 
animals in the present study may be due to the site of the recorded response 






5. Diffuse noxious inhibitory controls of 
nociceptive withdrawal reflexes in the 
monosodium iodoacetate model of 






Previous investigations of the MIA (1 mg dose) model of OA pain have 
established a biphasic response in pain behaviour assessment, where day 1 
after injection animals display significant deficit in weight-bearing, which peaks 
at day 3-4 after which the deficit reduces slightly and by day 7 a steady level of 
weight bearing pain behaviour is established for the duration of the study (Bove 
et al., 2003; Pomonis et al., 2005). Contrastingly, PWTs in the MIA (2 mg dose) 
model reduce by day 5 post injection and this was maintained for the duration 
of the study (31 days)(Fernihough et al., 2004). This initial pain behaviour is 
associated with inflammation present in the joint immediately after the MIA (1 
mg dose) injection, and after this has dissipated, pain behaviour lessens slightly 
(Bove et al., 2003; Fernihough et al., 2004). Inflammation is maximal on day 1 
followed by a subsidence of inflammation at day 3 which largely resolves by day 
7 (Bove et al., 2003). Histologically, from day 1 after 1 mg MIA injection 
chondrocytes appear shrunken and show fragmented nuclei in the entire 
thickness of articular cartilage in both the tibial plateau and femoral condyle 
(Guzman et al., 2003; Schaible, 2013). The synovial membrane is expanded by 
proteinaceous fibrin and oedema fluid as well as infiltrating macrophages, 
neutrophils, plasma cells and lymphocytes which indicates an inflammatory 
response (Bove et al., 2003; Guzman et al., 2003; Schaible, 2013). By day 7, 
chondrocytes have marked loss of cellular detail with collapse of the cartilage 
matrix and loss of proteoglycan, as well as damage to the subchondral bone, 




and subchondral bone, indicating the beginning of changes in the subchondral 
bone and bone reabsorption (Guzman et al., 2003; Mapp et al., 2013). The 
confirmation of inflammation indicates an established initial inflammatory pain 
phase in the early MIA model (Thakur et al., 2012).  
 
Previous studies in chronic pain models have indicated that DNIC are affected, 
likely due to a change in the balance of descending inhibitory and facilitatory 
pathways, which therefore contributes to the maintenance of chronic pain 
(Bannister et al., 2015, 2017). However, the point at which these changes occur 
during the disease progression of animal models is unknown. As previous 
studies (Chapter 4) did not detect a difference in DNIC of reflexes at later stages 
of the model (i.e. where the model has a neuropathic component), the present 






Experiments were performed on a total of 17 male Sprague-Dawley rats (mean 
weight 307 g, range 289 – 331 g) housed as previously described (see section 
2.1). Prior to electrophysiology all animals in this chapter underwent the 
procedure to induce the MIA model (n = 9) or saline control (n = 8)(see section 
4.2.1). Pain behaviour was assessed as previously described (see section 4.2.2) 
but was performed daily post MIA or saline-injection up until day 3 or 4, prior 
to electrophysiological recording of reflexes responses (heel-MG, toes-BF, toes-
TA)(section 2.2) evoked using mechanical stimuli (see section 2.2.2). 
Mechanical stimulation was chosen for the test stimulation based on findings 
in the previous chapter in that it gave a range of test stimulus intensities which 
were more natural and therefore presented a ‘more sensitive’ means by which 
a difference between the two groups may be found. Joints from 3-day MIA and 
saline-injected animals were collected and scored using the previously 
described method (see section 4.2.3). 
 
Efficacy of DNIC on reflexes in MIA and saline-injected animals on day 3-4 post 
injection was assessed using a 50 µg capsaicin injection (100 µl of 500 µg ml-1) 
into the contralateral fore- or hindlimb (see section 3.2.1). The lower strength 
of conditioning stimulus was chosen for the following experiments to increase 






5.3.1. Joint severity scoring 
Figure 5.1. Examples of joint damage severity 3-4 days after saline (A, B) or MIA 
(C, D) injection into the knee joint of the left hindlimb. Images are of ipsilateral 
tibial plateaus (A, C) or femoral condyles (B, D). Images E – H are corresponding 










Mean joint score 
Collins† SFA†† Revised SFA†† 
Saline 
Contralateral 
(n = 2) 
0 ± 0 -9.2 ± 0* 0 ± 0* 
Ipsilateral 
(n = 2) 
0 ± 0 -9.2 ± 0* 0 ± 0* 
MIA 
Contralateral 
(n = 4) 
0 ± 0 -9.2 ± 0** 0 ± 0** 
Ipsilateral 
(n = 6) 
1.3 ± 0.4 62.8 ± 12.8 10.7 ± 2.0 
 
Table 5.1. Scoring of ipsilateral and contralateral hindlimb knee joints 3-4 days 
post-saline or MIA injection using three different methods. Values are means 
and errors are standard error of means. †p < 0.05 or ††p < 0.01 denotes 
significant difference between joints for a given scoring method (one-way 
ANOVA). *p < 0.05 or **p < 0.01 denotes significance compared to MIA-injected 






Mean joint scores were significantly different using either the Collins, SFA or 
revised SFA methods of joint scoring (p = 0.0468, p = 0.0012 and p = 0.0018, 
one-way ANOVA; Table 5.1), with the ipsilateral MIA-injected hindlimb showing 
significantly greater damage than the SFA and revised SFA scoring methods (p 





5.3.2. Pain behaviour 
5.3.2.1. Weight bearing asymmetry 
The difference in weight bearing between the ipsilateral and contralateral 
hindlimb was significantly larger in MIA-injected animals compared to saline-
injected controls (p < 0.0001, two-way ANOVA; Figure 5.2A) with mean values 
of 43.8 ± 7.4 g (n = 9) and 3.9 ± 0.7 g (n = 8) respectively at day 3-4 post-injection, 
with significant differences shown from day 1 to day 3-4 between groups (p = 
0.0037, p < 0.0001 and p < 0.0001 respectively, Sidak’s multiple comparisons 
test). Over the 3-4 day post injection period, difference in weight bearing 
between the hindlimbs was not significantly altered in saline-injected animals 
(p > 0.05, Sidak’s multiple comparisons test). Weight bearing difference 
between the hindlimbs was significantly increased on day 1 compared to day 0 
post-MIA injection however, did not significantly increase between day 1 and 2 
or day 2 and day 3-4 (p = 0.0018, p = 0.0882 and p = 0.4457 respectively, Sidak’s 






Figure 5.2. Pain behaviour post-saline or MIA injection by measuring (A) weight 
bearing asymmetry or (B) paw withdrawal thresholds. Values plotted are means 
and errors are standard error of means. **p < 0.01 or ****p < 0.0001 denotes 
significant difference between saline and MIA-injected animals and ††p < 0.01, 
†††p < 0.001 or ††††p < 0.0001 denotes significant difference to previous time 




5.3.2.2. Paw withdrawal thresholds 
PWTs were significantly reduced in MIA-injected animals compared to saline-
injected animals (p < 0.0001, two-way ANOVA; Figure 5.2B) to means of 5.8 ± 
0.3 g (n = 9) and 21.2 ± 1.9 g (n = 8) respectively at day 3-4 post-injection, with 
significant differences shown from day 1 to day 3-4 between groups (p < 
0.0001, Sidak’s multiple comparisons test). Over the 3-4 day post injection 
period, PWTs were significantly lower on day 2 compared to day 1 in saline-
injected animals (p = 0.0009, Sidak’s multiple comparisons test). Similarly, 
PWTs were significantly lower on day 1 compared to day 0 post MIA-injection 





5.3.3. Control parameters for electrophysiology 
5.3.3.1. Weight and anaesthetic levels 
Mean weights of animals on the day of injection were 306 ± 5 g (n = 8) and 307 
± 4 g (n = 9) for saline and MIA groups respectively; no significant differences 
were found between groups (p = 0.9066, Mann-Whitney test). On the day of 
electrophysiology (day 3-4) mean weights of animals in saline and MIA groups 
were 323 ± 5 g and 324 ± 5 g respectively; again, not significantly different (p > 
0.9999, Mann-Whitney test). 
 
Following an initial bolus dose (see section 2.2.1.5), alfaxalone anaesthesia was 
maintained using a CRI at a mean rate of 47.25 ± 2.28 mg kg-1 hr-1 and 46.53 ± 
0.92 mg kg-1 hr-1 saline and MIA-injected animals respectively, which was not 










Median mechanical threshold 
(vF weight) 
Heel-MG Toes-BF Toes-TA 
Saline 
(n = 8) 
60 
(26 – 60) 
10 




(n = 9) 
26 
(18 – 60) 
10 
(10 – 26) 
10 
(10 – 26) 
 
Table 5.2. Median mechanical threshold parameters for the heel-medial 
gastrocnemius (MG), toes-biceps femoris (BF) and tibialis anterior (TA) reflexes 






Median mechanical thresholds were found to be significantly higher between 
the three reflex responses in saline-injected animals but not MIA-injected 
animals (p = 0.0248 and p = 0.1383 respectively, Kruskal-Wallis test; Table 5.2). 
Comparison between saline and MIA-injected animals for heel-MG, toes-BF or 
toes-TA responses indicated no significant differences (p = 0.2248, p = 0.8100 










Median control reflex responses (µV) 
Heel-MG Toes-BF Toes-TA 
Saline 
(n = 8) 
10 
0.018 
(0.004 – 0.029) 
0.073 
(0.005 – 0.386) 
0.073 
(0.005 – 0.627) 
26 
0.025 
(0.010 – 0.126) 
0.334 
(0.088 – 0.536) 
0.344 
(0.162 – 1.498) 
60 
6.541 
(1.507 – 12.784) 
2.084 
(0.800 – 4.407) 
2..346 
(1.173 – 3.807) 
100 
12.715 
(6.447 – 25.781) 
6.920 
(3.541 – 10.899) 
4.575 
(2.685 – 4.954) 
180 
18.975 
(13.317 – 30.214) 
11.714 
(4.569 – 19.548) 
4.531 
(3.918 – 5.858) 
300 
21.618 
(13.172 – 30.333) 
13.315 
(4.795 – 21.225) 
5.239 
(4.676 – 6.448) 
MIA 
(n = 9) 
10 
0.014 
(0.012 – 0.023) 
0.083 
(0.010 – 0.197) 
0.179 
(0.011 – 0.298) 
26 
0.086 
(0.037 – 0.534) 
0.154 
(0.093 – 1.012) 
0.605 
(0.077 – 1.399) 
60 
3.726 
(2.129 – 5.278) 
2.228 
(1.025 – 2.793) 
2.117 





(1.866 – 4.921) 
4.032 
(2.208 – 6.683) 
180 
4.993** 
(4.062 – 11.806) 
5.201 
(2.992 – 9.139) 
4.528 
(2.955 – 7.620) 
300 
4.406** 
(4.113 – 12.070) 
8.787 
(4.280 – 10.657) 
4.316 
(3.311 – 7.145) 
 
Table 5.3. Median control responses to mechanical stimulation for heel-medial 
gastrocnemius (MG), toes-biceps femoris (BF) and toes-tibialis anterior (TA) 
reflexes prior to administration of 50 µg capsaicin in 3-4 day saline and MIA-
injected animals. Values in brackets are interquartile ranges. *p < 0.05 or **p < 
0.01 denotes significance compared to equivalent saline control (Mann-




As expected, as vF weight (10 – 300 g) increased, median control reflex 
responses significantly increased for heel-MG, toes-BF and toes-TA responses 
in both saline (n = 8) and MIA-injected (n = 9) animals (p < 0.0001, Kruskal-Wallis 
test). Comparison of responses prior to capsaicin injection indicated heel-MG 
control responses were significantly smaller in MIA-injected animals compared 
to saline-injected animals (p < 0.0001, two-way ANOVA) with responses evoked 
by 100 g, 180 g and 300 g vF filaments indicated as significantly smaller in MIA-
injected animals compared to saline-injected animals (p = 0.0363, p = 0.0001 
and p = 0.0003 respectively, Sidak’s multiple comparison test; Figure 5.3). Toes-
BF responses also exhibited similar results with MIA-injected animals indicting 
smaller responses that saline-injected animals (p = 0.0032, two-way ANOVA) 
and again with the larger 180g and 300g vF filaments (p = 0.0337 and p = 0.0484, 
Sidak’s multiple comparisons test). Direct pairwise comparison also indicted the 
same results for heel-MG responses evoked from the same vF filaments (100g, 
180g and 300g, p = 0.0464, p = 0.0025 and p = 0.0055 respectively, Mann-
Whitney test; Table 5.3) , however no significant differences in toes-BF and 
toes-TA responses were found between MIA and saline groups for each (10 – 






Figure 5.3. Control responses for (A) heel-medial gastrocnemius (MG), (B) toes-
biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes evoked using 10 
g, 26 g, 60 g, 100 g, 180 g and 300 g von Frey (vF) monofilaments in saline and 
MIA animals 3-4 days post-injected. Values plotted are medians and errors are 
interquartile ranges. *p < 0.05 or ***p < 0.001 denotes significant difference 




5.3.4. Effect of 50 µg capsaicin in 3-4 day saline and MIA-injected animals 
Responses evoked by 10 g and 26 g vF monofilaments were found to be variable 
and sometimes absent before and after capsaicin, therefore these responses 
have been excluded. 
 
5.3.4.1. Injection into the contralateral hindlimb 
In the saline group (n = 6), significant inhibition of heel-MG responses evoked 
by 60 g, 100 g, 180 g and 300 g vF filaments was caused by contralateral 
hindlimb injection of capsaicin (p < 0.0001, p < 0.0001, p = 0.0063 and p = 
0.0430 respectively, Friedman’s ANOVA) to a median of 16% (IQR 7 – 39%), 44% 
(IQR 42 – 62%), 56% (IQR 41 – 75%) and 61% (IQR 48 – 90%) of controls 
respectively (Figures 5.4A, 5.5A, 5.6A and 5.7A). The corresponding level of 
inhibition in MIA-injected animals (n = 8) was to a median of 71% (IQR 51 – 
89%), 67% (IQR 34 – 91%), 75% (IQR 65 – 101%) and 96% (IQR 77 – 101%) of 
controls respectively (p = 0.0243, p = 0.0004, p = 0.0008 and p = 0.0378 
respectively, Friedman’s ANOVA). Median duration of inhibition was 17 min 
(IQR 1 – 26 min), 39 min (IQR 22 – 49 min), 21 min (IQR 0 – 25 min) and 23 min 
(IQR 8 – 40 min) for 60 g, 100 g, 180 g and 300 g vF weights respectively in 
saline-injected animals and 9 min (IQR 1 – 19 min), 11 min (IQR 0 – 51 min), 17 
min (IQR 3 – 54 min) and 9 min (IQR 0 – 28 min) for the corresponding vF 
weights in MIA-injected animals; which were not significant between groups (p 
= 0.4895, p = 0.5035, p = 0.8162 and p = 0.2371 respectively, Mann-Whitney 




overall inhibition of heel-MG reflexes evoked using the 60 g vF weight between 
saline and MIA-injected animals (p = 0.0335, unpaired t-test; Figure 5.8A). 
However, no significant differences were observed between saline and MIA-
injected animals in heel-MG responses evoked by 100 g, 180 g or 300 g vF 
weights (p = 0.1449, p = 0.3149 and p = 0.5415 respectively, unpaired t-test). 
 
Following capsaicin administration, toes-BF reflexes evoked by 60 g, 100 g, 180 
g and 300 g monofilaments were significantly inhibited (p = 0.0037, p < 0.0001, 
p = 0.0008 and p < 0.0001 respectively, Friedman’s ANOVA) to medians of 21% 
(IQR 14 – 51%), 26% (IQR 12 – 63%), 15% (IQR 10 – 58) and 46% (IQR 26 – 70%) 
of controls respectively in saline-injected animals (n = 8; Figures 5.4B, 5.5B, 5.6B 
and 5.7B). These reflexes in MIA-injected animals (n = 6) were significantly 
inhibited (p = 0.0128, p = 0.0004, p = 0.0019 and p = 0.0001 respectively, 
Friedman’s ANOVA) to a median of 85% (IQR 63 – 108%), 57% (IQR 48 – 82%), 
58% (IQR 38 – 80%) and 67% (IQR 42 – 83%) of controls at the corresponding 
vF weights. Median duration of inhibition was 35 min (IQR 0 – 63 min), 45 min 
(IQR 14 – 63 min), 63 min (IQR 44 – 63 min) and 51 min (IQR 38 – 63 min) for 
60 g, 100 g, 180 g and 300 g vF filaments respectively in saline-injected animals 
and 12 min (IQR 0 – 23 min), 5 min (IQR 0 – 44 min), 31 min (IQR 16 – 63 min) 
and 35 min (IQR 24 – 57 min) in MIA-injected animals; these were not 
significantly different between groups (p = 0.2984, p = 0.1645, p = 0.1608 and 
p = 0.1605 respectively, Mann-Whitney test). Analysis of negative AUC values 




the 180 g vF weight (p = 0.0229, unpaired t-test; Figure 5.8B). However, no 
significant differences were observed between saline and MIA-injected animals 
in heel-MG responses evoked by 60 g, 100 g or 300 g vF weights (p = 0.0983, p 
= 0.0564 and p = 0.2217 respectively, unpaired t-test). 
 
For toes-TA reflexes in saline-injected animals (n = 8), responses to 60 g, 100 g, 
180 g and 300 g monofilaments were significantly inhibited (p = 0.0039, p < 
0.0001, p = 0.0006 and p < 0.0001 respectively, Friedman’s ANOVA) to medians 
of 32% (IQR 18 – 65%), 58% (IQR 40 – 77%), 74% (IQR 64 – 83%) and 66% (IQR 
62 – 71%) of controls respectively (Figures 5.4C, 5.5C, 5.6C and 5.7C) and MIA-
injected animals (n = 6) evoked by the 60 g vF weight (p = 0.0328, Friedman’s 
ANOVA) to a median of 97% (IQR 79 – 108%) of controls. However, no 
significant inhibition was induced in toes-TA by 100 g, 180 g or 300 g vF weights 
(p = 0.0865, p = 0.2361 and p = 0.1601 respectively, Friedman’s ANOVA). 
Median duration of inhibition was 24 min (IQR 0 – 50 min), 27 min (IQR 11 – 54 
min), 27 min (IQR 18 – 42 min) and 29 min (IQR 15 – 42 min) for 60 g, 100 g, 
180 g and 300 g vF weights respectively in saline-injected animals and 8 min 
(IQR 0 – 29 min) for MIA-injected animals using the 60 g vF weight, which was 
not significant between groups (p = 0.6107, p = 0.5005, p = 0.2368 and p = 
0.4049 respectively, Mann-Whitney test). Analysis of negative AUC revealed 
significant differences in overall inhibition between saline and MIA-injected 
animals of responses to the 300 g vF weight in the toes-TA reflex response (p = 




differences of responses to any other filaments (p = 0.1894; 60 g, p = 0.2051; 






Figure 5.4. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral hindlimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 60 g von Frey (vF) monofilament in 3-4 day saline and MIA-injected 
animals. Values plotted are medians and errors are interquartile ranges. *p < 
0.05 denotes significant difference between saline and MIA-injected animals at 





Figure 5.5. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral hindlimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 100 g von Frey (vF) monofilament in 3-4 day saline and MIA-injected 
animals. Values plotted are medians and errors are interquartile ranges. *p < 
0.05 denotes significant difference between saline and MIA-injected animals at 





Figure 5.6. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral hindlimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 180 g von Frey (vF) monofilament in 3-4 day saline and MIA-injected 
animals. Values plotted are medians and errors are interquartile ranges. *p < 
0.05 denotes significant difference between saline and MIA-injected animals at 





Figure 5.7. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral hindlimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 300 g von Frey (vF) monofilament in 3-4 day saline and MIA-injected 
animals. Values plotted are medians and errors are interquartile ranges. *p < 
0.05 denotes significant difference between saline and MIA-injected animals at 





Figure 5.8. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral hindlimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using 60 – 300 g von Frey (vF) monofilaments in 3-4 day saline (n = 6, closed 
symbols) and MIA-injected (n = 8, open symbols) animals. Values plotted are 
area under curve (AUC) determinations for each animal with horizontal bars 
indicating medians and interquartile ranges. *p < 0.05 denotes significant 




5.3.4.2. Injection into the contralateral forelimb 
Following 50 µg capsaicin to the contralateral forelimb, heel-MG responses 
were significantly inhibited (p = 0.0001, p < 0.0001, p = 0.0070 and p < 0.0001 
respectively, Friedman’s ANOVA) by 60 g, 100 g, 180 g and 300 g vF filaments 
to medians of 23% (IQR 7 – 56%), 49% (IQR 33 – 62%), 70% (IQR 69 – 84%) and 
72% (IQR 71 – 99%) of controls in saline-injected animals (n = 7; Figures 5.9A, 
5.10A, 5.11A and 5.12A). Similarly, in MIA-injected animals (n = 9), heel-MG 
responses evoked by the corresponding vF weights were inhibited to medians 
of 28% (IQR 9 – 46%), 67% (IQR 55 – 82%), 83% (IQR 65 – 90%) and 87% (IQR 75 
– 93%) of controls, however responses evoked by 300 g were not found to be 
significant (p < 0.0001, p < 0.0001, p = 0.0050 and p = 0.2171 respectively, 
Friedman’s ANOVA). Median duration of inhibition in saline-injected animals 
was 25 min (IQR 9 – 25 min), 25 min (IQR 21 – 25 min), 13 min (IQR 13 – 37 min) 
and 21 min (IQR 13 – 29 min) for 60 g, 100 g, 180 g and 300 g vF weights 
respectively and 21 min (IQR 7 – 35 min), 17 min (IQR 0 – 31 min) and 21 min 
(IQR 5 – 29 min) for MIA-injected animals; these durations were not 
significantly different between groups (p = 0.7374, p = 0.1122, p = 0.9430 and 
p = 0.7749, Mann-Whitney test). Furthermore, analysis of negative AUC values 
revealed no significant difference in overall inhibition of responses to 60 – 300 
g vF filaments between treatment groups (p = 0.7082, p = 0.4612, p= 0.5373 





In saline-injected animals (n = 7), significant inhibition of toes-BF responses 
evoked by 60 g, 100 g, 180 g and 300 g monofilaments was induced (p < 0.0001, 
Friedman’s ANOVA; Figures 5.9B, 5.10B, 5.11B and 5.12B) to medians of 56% 
(IQR 44 – 85%), 61% (IQR 38 – 82%), 60% (IQR 26 – 93%) and 55% (IQR 29 – 
73%) of controls respectively. The corresponding level of inhibition in MIA-
injected animals (n = 9) was to medians of 53% (IQR 41 – 72%), 83% (IQR 75 – 
95%), 66% (IQR 42 – 83%) and 85% (IQR 39 – 87%) of controls respectively (p = 
0.0001, p < 0.0001, p < 0.0001 and p < 0.0001 respectively, Friedman’s ANOVA). 
Median duration of inhibition was 19 min (IQR 0 – 23 min), 19 min (IQR 0 – 19 
min), 23 min (IQR 0 – 47 min) and 35 min (IQR 19 – 63 min) for 60 g, 100 g, 180 
g and 300 g vF weights respectively in saline-injected animals and 15 min (IQR 
0 – 23 min), 15 min (IQR 13 – 29 min), 23 min (IQR 2 – 49 min) and 39 min (IQR 
14 –61 min) for the corresponding vF weights in MIA-injected animals; these 
durations were not significantly different between groups (p = 0.6148, p = 
0.6153, p = 0.9855 and p = 0.8959, Mann-Whitney test). Analysis of negative 
AUC values indicated no significant differences in overall inhibition between 
saline and MIA-injected animals for toes-BF responses evoked by 60 – 300 g vF 
filaments (p = 0.3099, p = 0.8179, p = 0.7947 and p = 0.8411 respectively, 
unpaired t-test; Figure 5.13B). 
 
Following capsaicin administration, toes-TA reflex responses evoked by 60 g, 
100 g, 180 g and 300 g vF filaments were significantly inhibited in saline-injected 




Friedman’s ANOVA) to medians of 66% (IQR 50 – 95%), 78% (IQR 55 – 101%), 
96% (IQR 79 – 99%) and 74% (IQR 65 – 85%) of controls respectively (Figures 
5.9C, 5.10C, 5.11C and 5.12C); for MIA-injected animals (n = 9), significant 
inhibition (p = 0.0002, p < 0.0001, p = 0.0049 and p = 0.0036 respectively, 
Friedman’s ANOVA) to medians of 55% (IQR 52 – 84%), 79% (IQR 68 – 104%), 
95% (IQR 86 – 107%) and 99% (IQR 69 – 108%) of controls was produced in toes-
TA reflexes by these same respective vF filaments. Median duration of 
inhibition was 15 min (IQR 11 – 35 min), 19 min (IQR 15 – 23 min), 15 min (IQR 
0 – 35 min) and 27 min (IQR 7 – 35 min) for 60 g, 100 g, 180 g and 300 g vF 
weights respectively in saline-injected animals and correspondingly 19 min (IQR 
6 – 43 min), 19 min (IQR 9 – 33 min), 11 min (IQR 0 – 29 min) and 11 min (IQR 
4 – 31 min) in MIA-injected animals; these durations were not significantly 
different between groups (p = 0.9366, p = 0.8552, p = 0.7053 and p = 0.4492 
respectively, Mann-Whitney test). Comparison of negative AUC values found 
that overall inhibition of toes-TA responses was not significantly different 
between saline and MIA-injected animals for any (60 – 300 g) vF weight (p = 







Figure 5.9. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral forelimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 60 g von Frey (vF) monofilament in 3-4 day saline and MIA-injected 





Figure 5.10. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral forelimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 100 g von Frey (vF) monofilament in 3-4 day saline and MIA-injected 
animals. Values plotted are medians and errors are interquartile ranges. **p < 
0.01 denotes significant difference between saline and MIA-injected animals at 





Figure 5.11. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral forelimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 180 g von Frey (vF) monofilament in 3-4 day saline and MIA-injected 





Figure 5.12. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral forelimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using a 300 g von Frey (vF) monofilament in 3-4 day saline and MIA-injected 
animals. Values plotted are medians and errors are interquartile ranges. *p < 
0.05 denotes significant difference between saline and MIA-injected animals at 





Figure 5.13. Effect of intramuscular injection of 50 µg capsaicin into the 
contralateral forelimb on mechanically evoked (A) heel-medial gastrocnemius 
(MG), (B) toes-biceps femoris (BF) and (C) toes-tibialis anterior (TA) reflexes 
using 60 – 300 g von Frey (vF) monofilaments in 3-4 day saline (n = 7, closed 
symbols) and MIA-injected (n = 9, open symbols) animals. Values plotted are 
area under curve (AUC) determinations for each animal with horizontal bars 




5.3.4.3. Effect of capsaicin injection site 
In nearly all cases, comparison of heel-MG, toes-BF and toes-TA responses 
between hindlimb and forelimb capsaicin injection sites indicated no significant 
difference in the degree, duration or overall inhibition between saline or MIA-
injected animals (p > 0.05, Mann-Whitney or unpaired t-test). The exceptions 
being that degree of inhibition was significantly smaller after hindlimb 
compared to forelimb injection for heel-MG reflexes evoked by the 60 g vF 
weight in MIA-injected animals with medians of 71% (IQR 51 – 89%) and 28% 
(IQR 9 – 46%) respectively (p = 0.0464, Mann-Whitney test). In saline-injected 
animals, duration of inhibition was significantly shorter after forelimb 
compared to hindlimb injection for toes-BF reflexes evoked by the 180 g 
monofilament with medians of 23 min (IQR 0 – 47 min) and 63 min (IQR 44 – 63 
min) respectively (p = 0.0379, Mann-Whitney test) and overall inhibition of 
toes-BF responses evoked by the 100 g vF weight was significantly smaller after 
forelimb compared to hindlimb injection with values of 590 (IQR 355 – 2909) 






Joint pathology of 3-4 day MIA-injected (2 mg dose) animals indicate little to no 
cartilage degradation and often do not have significant joint scoring compared 
to controls, indicating gross pathology is virtually unchanged from controls 
(Lockwood et al., 2019b). However, staining of the joints with safranin-O 
reveals that weak cartilage staining can be detected at 3 days post-MIA (1 mg 
dose) injection in both the patellofemoral and tibiofemoral joints, indicating 
that histologically cartilage degradation has started to occur and no staining 
was present by 1 week post injection (Takahashi et al., 2018). Histologically on 
day 1 after 1 mg dose of MIA, synovial membrane and subjacent connective 
tissue necrosis were present with acute inflammatory cell infiltration and 
oedema into the fat pad and nearby connective tissues (Clements et al., 2009). 
In keeping with the biphasic response, there is an initial period of knee swelling, 
implying transient synovial inflammation, which correlates with human OA, 
however it is not currently known why this resolves in the MIA model whereas 
in human disease recurrent inflammatory phases are noted (Saxne, 2003; 
Fernihough et al., 2004). The knee swelling is not always observed in knee 
diameter measurements in 1 mg MIA models which are often not significantly 
different from controls (Nwosu et al., 2016a), but is observed after a 2 mg dose 
MIA where knee diameter measurements were found to increase by 
approximately 2 mm at day 3 post injection, indicating a robust inflammatory 
response which returned to normal levels by day 5 (Fernihough et al., 2004). 




of inflammatory cells including monocytes, neutrophils and basophils, all of 
which are present from day 1 and increase exponentially to day 3, after which 
they begin to subside (Clements et al., 2009). Gross examination of the joints in 
the present study and subsequent severity scoring indicated there were no 
gross lesions with very little to no cartilage damage in the ipsilateral MIA-
injected joint which is in-keeping with previous studies. However, the surface 
of the joints had brown homogenous discolouration and, in some animals, 
superficial fibrillation and a lightly broken surface was observed more 
commonly in the tibial plateau compared to saline-injected animals, which had 
a smooth and unbroken surface and was a white to off-white colour. MIA-
injected animals in the present study had joint scores that indicated more 
damage in the ipsilateral limb compared to the contralateral side and the 
hindlimbs of saline controls.  
 
Pain behaviour in the form of weight bearing asymmetry and mechanical 
allodynia are observed in the MIA model from an early stage (Bove et al., 2003; 
Ferland et al., 2011; Nwosu et al., 2016a; Lockwood et al., 2019b). As early as 
day 1 post 1 mg MIA injection weight bearing asymmetry was apparent in 
previous studies, which often recovers slightly by day 7 and maintains a deficit 
in weight bearing for the duration of the study, which is consistent with the 
biphasic response observed in this model (Clements et al., 2009; Nwosu et al., 
2016a). Contrastingly, mechanical allodynia measured in the form of PWTs 




this low level for the duration of the study (Nwosu et al., 2016a; Lockwood et 
al., 2019b). In the current study, pain behaviour testing indicated MIA animals 
favoured the contralateral uninjured hindlimb and exhibited significant 
mechanical allodynia in the ipsilateral hindlimb as early as day 1 post-injection, 
and this was maintained over the 3-4 day testing period which is consistent with 
previous studies (Bove et al., 2003; Ferland et al., 2011; Nwosu et al., 2016a; 
Lockwood et al., 2019b). When compared to animals tested at a later stage of 
model development (day 28-35), no greater difference in weight-bearing 
appeared to be present, however PWTs were significantly lower at the later 
stage suggesting an increase in pain sensitivity at this point (data not shown). 
This contradicts previous studies which indicate that weight bearing asymmetry 
is more sensitive to the biphasic nature of the MIA model, with an initial 
indication of pain behaviour during the inflammatory phase which recovers 
when this has dissipated and worsens again due to progressive damage within 
the joint (Fernihough et al., 2004; Nwosu et al., 2016a; Lockwood et al., 2019b). 
This direct comparison was not made in the present studies as 28-35 day 
animals did not have behavioural testing on day 3-4. However this does differ 
in mechanical allodynia which has previously decreased in the injured paw and 
stayed consistently low for the duration of the study using both a 1 mg and 2 
mg dose (Fernihough et al., 2004; Nwosu et al., 2016a; Abaei et al., 2016; 





DNIC investigations during the early phase of the model have indicated that 
there does appear to be a difference in the level of inhibition evoked between 
early and late phase in the MIA model (Danziger et al., 1999; Lockwood et al., 
2019b). In the current study, injection of capsaicin into the contralateral hind 
and forelimb induced significant inhibition of reflex responses evoked by a 
range of vF monofilaments (60 – 300 g) in the early MIA model as well as saline 
controls. However, interestingly, when capsaicin was injected into the 
contralateral hindlimb there were significant indications that the efficacy of 
observed inhibition in reflex responses was reduced in MIA-injected animals 
compared to saline controls, although this deficit in DNIC appeared to be 
sensitive to the strength of the test stimulus and the reflex response measured. 
Contrastingly, previous studies in early phase animal OA models have indicated 
that there is no difference in the efficacy of DNIC compared to controls 
(Danziger et al., 1999; Lockwood et al., 2019b). In early phase (2-6 day) MIA-
injected animals, DNIC induced inhibition of mechanically evoked neuronal 
firing in spinal single unit recordings evoked by noxious pinch to the ear and 
knee was comparable to early phase sham-injected animals, indicating DNIC 
induced inhibition is not altered in the early inflammatory stages (Lockwood et 
al., 2019b, 2019a). Similarly, other animal models of early OA have shown DNIC 
induced inhibitions triggered by thermal or mechanical conditioning 
stimulation are not altered compared to controls (Danziger et al., 1999). Acute 
(24 – 48 hour) and chronic (3-4 week) monoarthritis induced by injection of CFA 
into the ankle joint was found to mimic each other during behavioural testing, 




the arthritic joint, however they showed different electrophysiological profiles 
(Danziger et al., 1999). Acute monoarthritic animals displayed increased DNIC-
induced inhibition of trigeminal neurons in response to mechanical and thermal 
stimulation of the arthritic joint compared to the same stimulations of the 
normal joint, however chronic monoarthritic animals exhibited similar DNIC-
induced inhibitions after mechanical and thermal stimulation to the arthritic 
and normal joint (Danziger et al., 1999). This would suggest that inputs 
activated during chronic monoarthritis fail to recruit DNIC and therefore may 
be functionally different to those activated during the acute inflammatory 
stage (Danziger et al., 1999). Chronic pain is known to lead to peripheral and 
central sensitization (see section 1.2.5) which would be the case with the MIA 
model. However, most previous studies have evaluated the histological 
changes and pain related behaviours; not much is known about the changes in 
transmission of nociceptive information from the damaged joint to the CNS 
(Schuelert and McDougall, 2009). Some recent studies have shown that MIA-
induced OA leads to an increased firing rate and reduced activation threshold 
of afferent nerve fibres (Schuelert and McDougall, 2006) which subsequently 
leads to sensitization of spinal neurons in the dorsal horn (Harvey and 
Dickenson, 2009). Another study revealed that there was a direct relationship 
between the concentration of MIA injected and afferent nerve fibre activity 
where an increase in concentration of MIA produced graded sensitization of 
joint nociceptors (Schuelert and McDougall, 2009). The MIA model can 
therefore alter the excitability of spinal neurons resulting in sensitization which 




of MIA intra-articularly (Harvey and Dickenson, 2009). This therefore shows 
that changes to the CNS in the MIA model in the later chronic phase (day 28-
35) of the model may be different than the changes in the initial phase (day 3-
4). The study of this thesis therefore offers a new insight into DNIC in acute OA 
pain whereby recordings from the periphery are not the same as recordings 
from the spinal cord, this is an important finding that highlights the complex 
nature of DNIC and that the methodology of the study should be carefully 
considered as reflex responses offer an additional layer of knowledge to this 
subject. 
 
These studies have also indicated that the site of the conditioning stimulus may 
be important in trying to detect a difference in DNIC in pre-clinical models. This 
reduction in efficacy of DNIC does not appear to be mirrored in the reflex 
responses after capsaicin injection to the forelimb which may suggest injection 
sites are utilising different mechanisms of action in early MIA-injected animals. 
Previous investigations of the effect of high intensity stimulation on spinal 
reflex responses indicated that significant depressions of the MG muscle could 
be induced in spinalized animals for periods greater than 20 mins which could 
be supressed with very low doses of naloxone, suggesting this inhibition was 
mediated by opioid µ receptors (Clarke et al., 1989). Another study indicated 
site specific differences in inducing long-lasting depression of reflex responses 
in response to high-intensity stimulation of the ipsilateral and contralateral 




inhibitions were significantly reduced by idazoxan but were unaffected by 
naloxone, however forelimb induced inhibitions could be reduced by idazoxan 
and naloxone given independently and complete abolishment of the inhibition 
could be achieved giving both together (Taylor et al., 1991). These studies 
indicate that both noradrenergic and opioidergic mechanisms mediate 
heterotrophic inhibition indicating that in the present studies, early 
inflammatory MIA-injected animals may be activating different descending 












6.1. Discussion of findings 
Overall, the findings in this thesis highlight the complexity of investigating 
underlying mechanisms of OA knee pain in experimental models and the 
influence of ‘test’ versus ‘conditioning’ stimuli, the stage of the model, the 
location of the conditioning stimulus and the reflex response chosen, when 
studying DNIC. DNIC has been extensively studied in humans, where it is termed 
CPM, in order to represent the human behavioural aspect of the phenomena 
(Kennedy et al., 2016). Despite DNIC having many variables by which it is 
affected (see section 1.3.3) it is considered to be a consistent measure with its 
reliability dependent on stimulation parameters and the methodology of the 
study (Kennedy et al., 2016). Different test stimulus modalities in the current 
study used electrical stimulation as an excellent way to deliver consistent 
quantifiable stimuli, whilst mechanical stimulation, although more variable in 
its application, was more physiologically relevant and could be graded with the 
use of multiple vF filaments. In human studies, various stimulus modalities have 
been used to evoke test responses, such as thermal contact-heat via a 
thermode, mechanical pressure applied using vF filaments and electrical 
stimulation, whilst typical conditioning stimuli consist of thermal contact-heat, 
cold pressor test and hot water baths (Nir and Yarnitsky, 2015). Using thermal 
and mechanical modalities, pain thresholds, suprathreshold pain and temporal 
summation as the test stimulus indicated that varying its modality in human 
studies results in varying DNIC responses to each DNIC paradigm (Nahman-




pressure pain threshold (PPT) and thermal temporal summation which were 
both inhibited during the conditioning stimulus, however the other test stimuli 
did not (Nahman-Averbucha et al., 2013). These electrophysiological studies 
demonstrated that a capsaicin conditioning stimulus inhibited test reflex 
responses in a dose-related manner whereby inhibition was increased by 
increasing the dosage in the smaller two doses but was not increased any more 
by the largest dose. Previous investigations in humans have found that DNIC 
inhibition is dependent on intensity of the conditioning stimulus, with two 
temperatures of a water bath used as the conditioning stimulus (41 °C and 45 
°C), whereby the higher temperature elicited significant inhibition but the lower 
temperature did not (Kakigi, 1994). Another study investigating more 
conditioning stimuli intensities found that temperatures above 45 °C reduced 
evoked responses in a dose-dependent manner when applied to the 
contralateral hand, where 45 °C, 46 °C and 47 °C produced increasingly larger 
inhibitory effects on a nociceptive flexion reflex (Willer et al., 1989). Location 
of the conditioning stimulus is also an important factor in DNIC with previous 
human studies indicating that applying the conditioning stimulus to the 
shoulder and the hand resulted in greater inhibition from stimulation at the 
shoulder (Haefeli et al., 2014). However, another study investigating the back 
and forearms as conditioning stimulation sites found no differences in the 
evoked inhibition between the two locations (Klyne et al., 2015). This agrees 
with the results in the present study which found site specific differences 




appeared to have larger and longer lasting inhibitory effects compared to 
hindlimb. 
 
The capsaicin induced inhibition in the present study could be completely 
abolished in spinalized animals, agreeing with previous studies that the 
mechanisms underlying DNIC arise entirely from supraspinal sources (Le Bars 
et al., 1979a, 1979b; Hall et al., 1982; Cadden et al., 1983; Dickhaus et al., 1985; 
Morton et al., 1987; Gjerstad et al., 1999). In humans with spinal cord injury 
(SCI), individuals with SCI and neuropathic pain associated with their condition 
were found to have reduced DNIC, however individuals that had SCI but no 
neuropathic pain were found to have DNIC reductions that were to a similar 
degree as healthy controls (Albu et al., 2015; Gruener et al., 2016). 
Contrastingly, individuals with tetraplegia due to a traumatic section of the C5, 
C6 or C7 spinal cord had an inability to trigger inhibitory effects on a nociceptive 
flexion reflex in the leg in response to a clearly nociceptive stimulus applied to 
the contralateral fingers (Roby-Brami et al., 1987). This indicates that in humans 
with complete transection of the spinal cord the inhibitory effects triggered by 
heteroptopic nociceptive stimuli are therefore sustained by a loop which 
includes supraspinal structures (Roby-Brami et al., 1987; Le Bars et al., 1991; 
Albu et al., 2015; Gruener et al., 2016). DNIC inhibition in the present studies 
was reduced by pre-collicular decerebration, indicating inhibition of reflexes in 
these studies may be partially controlled by structures rostral to the colliculi 




brainstem regions). Previous animal studies have indicated regions responsible 
for the source of DNIC pathways, however lesioning these regions has never 
fully abolished DNIC (see section 1.3.1). The results in this study contradict 
previous results in humans which suggest that only brainstem structures are 
involved in mediating DNIC and specifically that spinothalamic pathways are 
not involved in DNIC. Profound inhibition could be induced in the flexion reflex 
in patients with unilateral thalamic vascular lesions when conditioning stimuli 
was applied to the analgesic hand, whereas it could not be induced in patients 
with unilateral lesions of the retro-olivary portion of the medulla (Wallenberg’s 
syndrome, WS)(De Broucker et al., 1990). The same conditioning procedure 
applied to the non-analgesic hand of WS patients resulted in inhibition that was 
not different from healthy controls (De Broucker et al., 1990). This research 
therefore suggests that spinoreticular tracts are key neuronal links in 
endogenous analgesia (Pud et al., 2005). Similarly in humans, involvement of 
an opioidergic link was found by investigating DNIC in healthy subjects where 
i.v. naloxone resulted in complete abolition of flexion reflex inhibitions, 
indicating inhibitions triggered by DNIC involve endogenous opioids (Willer et 
al., 1990). This thesis also investigated the effect of alfaxalone anaesthesia on 
DNIC for the first time and, concurring with previous work on anaesthetics, 
found under low alfaxalone levels animals had greater DNIC than under normal 
alfaxalone conditions (Tomlinson et al., 1983; Jinks et al., 2003a). In human 
experiments, DNIC is investigated in conscious subjects and therefore it is 





There are very few studies investigating DNIC in reflex responses in humans, 
however DNIC has been shown to have strong inhibitory effects on electrically 
stimulated nociceptive reflexes with thermal, mechanical or chemical 
conditioning stimuli (Willer et al., 1984, 1989). Reflex responses measured in 
the BF muscles in humans were significantly inhibited by ice water applied to 
the contralateral hand and foot with no significant interaction measured 
between the size of the reflex and the intensity of the pain (Terkelsen et al., 
2001). In all of these studies the test stimulus for evoking the reflex response 
was electrical stimulation of the sural nerve in the form of surface electrodes 
which is a very similar method to the electrically stimulated responses used in 
this thesis (Willer et al., 1984; Terkelsen et al., 2001). There are no human 
studies comparable to the mechanical stimulation used in the present studies 
to evoke reflex responses however mechanical stimulation is often used in pain 
studies in humans in the form of PPT measurement which is very reliable for 
analysing pain. None of these studies have compared multiple reflex responses 
like the experiments undertaken in this thesis. The current study indicated that 
the flexor reflexes are more susceptible to DNIC than extensor reflexes which 
would suggest that muscles are differentially controlled (section 1.4.2) and 






DNIC has been extensively investigated in humans with OA (Kosek and 
Ordeberg, 2000; Quante et al., 2008; Graven-Nielsen et al., 2012; Arendt-
Nielsen et al., 2015) but also in other chronic pain conditions such as myofascial 
TMD (Maixner et al., 1995; Bragdon et al., 2002), fibromyalgia (Kosek and 
Hansson, 1997; Lautenbacher and Rollman, 1997; Staud et al., 2003; Julien et 
al., 2005), chronic lower back pain (Peters et al., 1992), irritable bowel 
syndrome (IBS)(Wilder-Smith et al., 2004; Song et al., 2006) and chronic tension 
headaches (Pielsticker et al., 2005; Sandrini et al., 2006), where it has been 
found to be less efficacious. In contrast, DNIC was found to be preserved in 
patients with long-term trapezius myalgia (Leffler et al., 2002a), acute and 
chronic rheumatoid arthritis (Leffler et al., 2002b), vestibulodynia 
(Johannesson et al., 2007) and Parkinson’s disease (Mylius et al., 2009), which 
was the case in the chronic pain animals in the present study. A potential cause 
for these differences between chronic pain conditions may be due to different 
physiological mechanisms underlying pain, different noxious conditioning 
procedures, different testing techniques as well as differences in pain 
duration/intensity (Leffler et al., 2002b). Electrophysiologically, the present 
study investigated the efficacy of DNIC in both acute and chronic phases of the 
MIA model, finding DNIC less efficacious in the acute phase but restored in the 
chronic phase. This was surprising as previous animal studies had shown the 
opposite results with DNIC reduced as the disease progresses (Lockwood et al., 
2019b). However, one study has shown a complete lack of DNIC in human OA 
separated into high and low pain groups suggesting the acute pain (low pain) 




current study may possibly be attributed to the measured response whereby 
the present study recorded functionally relevant multi-synaptic reflex 
responses in peripheral muscles, whereas previous work investigated single 
spinal dorsal horn neurons (Lockwood et al., 2019b). It is currently unknown 
whether less efficacious DNIC is a result of the ongoing chronic pain or whether 
it predisposes them to acute or chronic pain (Granovsky, 2013). Results of one 
previous animal study suggested that efficient descending inhibition can 
provide protection against the development of experimental chronic 
neuropathic pain and particularly the transition of acute to chronic neuropathic 
pain (De Felice et al., 2011). This hypothesis compliments a study in humans 
which indicated impaired DNIC may predict the development of chronic pain, 
where patients with less efficacious DNIC in a pain-free state before 
thoracotomy surgery had a higher chance for development of chronic but not 
acute pain post-surgery (Yarnitsky et al., 2008). Similarly, effective DNIC was 
linked to a lower risk of developing chronic post-surgery pain with an odds ratio 
of 0.52 (Yarnitsky et al., 2008). Another study investigating DNIC in acute post-
caesarean pain found the opposite, suggesting more research is needed in this 
area (Landau et al., 2010). Other studies have reported that impairment of DNIC 
was present in patients with painful hip and knee OA but that DNIC function 
was restored after successful joint replacement surgery which suggests that 
reduced efficacy of DNIC was maintained by the chronic pain and that ongoing 
pain from one site may interact with DNIC evoked by pain in another area 
(Kosek and Ordeberg, 2000; Arendt-Nielsen et al., 2010; Graven-Nielsen et al., 




although what is clear is that the loss of DNIC provides evidence of altered 
central pain processing (Graven-Nielsen et al., 2012). It has been postulated 
that descending inhibition is reorganised in that neurons in the dorsal horn and 
at supraspinal sites change their response characteristics following peripheral 
nerve damage and that these changes in plasticity are time dependent 
(Pertovaara et al., 1997; Chapman et al., 1998; Sotgiu and Biella, 1998; Woolf 
and Mannion, 1999). In studies investigating the loss of DNIC in animal chronic 
pain models it has been found that a reduction in descending noradrenergic 
inhibition and enhanced descending serotonergic facilitation acting at 5-HT3 
receptors has been shown in the chronic pain phase of the MIA and SNL models 
(Bannister et al., 2015; Lockwood et al., 2019a).  
 
In the current study the difference between acute and chronic stages of OA was 
ascertained by the degree of gross macroscopic joint damage and this was 
compared to pain behaviour and the effectiveness of DNIC. MIA-injected 
animals exhibited significant pain behaviour by day 1 post-injection with gross 
joint pathology expressing key indicators of the progression of OA over short 
(day 3-4) and later (day 28-35) stages of the model, which has been well 
documented in previous work (Schaible, 2013; Mapp et al., 2013; Nwosu et al., 
2016b). However, in human OA there is often a large discrepancy between joint 
damage and pain symptoms (Arendt-Nielsen et al., 2010); this was reflected in 
the current study with pain behaviours in acute and chronic states of the MIA 




pathology. A recent study has been able to subgroup patients based on the 
degree of knee OA and pain using quantitative sensory testing (QST) and 
Kellgren and Lawrence (KL) grading scores whereby 217 individuals were 
categorised into four groups; low pain/low KL, low pain/high KL, high pain/low 
KL and high pain/high KL (Arendt-Nielsen et al., 2015). DNIC was assessed 
between groups and found that higher pain groups had significantly less 
effective DNIC (Arendt-Nielsen et al., 2015). This postulates the question that if 
joint damage is not a reliable measure for predicting pain in human OA, could 
DNIC be a better predictor? However, other investigations looking at the same 
four groups in human OA found there was no significant difference with respect 
to DNIC (Finan et al., 2013). Despite these variations there is a strong belief that 
DNIC and its underlying mechanisms can be useful in predicting and treating 
chronic pain (Granovsky, 2013). This can only be utilised for making better 
individual patient decisions if there is a greater understanding of the physiology 
of DNIC (Granovsky, 2013). 
 
6.1.1. Future directions 
An initial future direction to the current studies would be to analyse the C-fibre 
responses from electrically stimulated recordings. Whilst DNIC is observed in A-
fibre responses, its inhibitory effects are to a much stronger degree in C-fibre 
responses and so adding this element to the analysis would give a greater idea 
of the effect of capsaicin on reflex responses but also would fully analyse the 





The work presented in this thesis suggests a difference in capsaicin-induced 
DNIC of electrophysiologically recorded reflexes in the MIA model of OA pain 
depending on the post-injection time period i.e. on days 3-4 or days 28-35, 
which in this model of OA pain can be regarded as acute and chronic pain states, 
as well as inflammatory and neuropathic pain. A future study investigating 
change in DNIC efficacy at post-injection time points between these acute and 
chronic states e.g. on day 7, 14 and 21 post MIA injection, would allow better 
understanding of when DNIC in this preparation switches and give greater 
insight into the gross joint pathology that is present when DNIC efficacy is no 
longer altered. 
 
The MIA model combined with the measurement of spinally organised reflexes 
is ideal for investigating mechanistic changes occurring within the CNS and as 
such could be used to determine which pathways are affected when DNIC is 
altered. Thus, spinal administration of 5-HT and NA antagonists via an 
intrathecal cannula would help to determine which of these transmitters and 
their receptors may alter as OA develops. Alongside this it would be possible to 
investigate the immunohistochemistry of the changes in receptor populations 
(e.g. α2 adrenoceptors) within the spinal cord at various stages of the MIA 
model, again linking these changes to alterations in DNIC efficacy between 





As decerebration affected the efficacy of DNIC in ‘normal’ healthy animals, in 
addition to midbrain/brainstem areas, a role for higher brain regions is 
suggested. This opens the possibility of lesioning specific areas of the brain to 
try to determine the location of regions contributing to the inhibition. 
 
6.2. Concluding remarks 
Overall, the studies presented in this thesis provide new information on the 
effects of variables on DNIC such as anaesthesia, which is often disregarded in 
such studies, as well as the importance of the balance between test versus 
conditioning stimuli. This thesis has demonstrated that animals with chronic OA 
pain do not have compromised DNIC of reflex responses and that the acute 
inflammatory phase of the disease can have less effective DNIC. These findings 
demonstrate that DNIC is highly variable, depending on the investigation 
parameters, and show that reflex responses should be considered as a test 
response when investigating DNIC. This thesis ultimately adds to the wealth of 
information regarding chronic pain in OA and understanding these underlying 
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